<SEC-DOCUMENT>0001178913-23-001807.txt : 20230511
<SEC-HEADER>0001178913-23-001807.hdr.sgml : 20230511
<ACCEPTANCE-DATETIME>20230511060726
ACCESSION NUMBER:		0001178913-23-001807
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		28
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230511
DATE AS OF CHANGE:		20230511

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chemomab Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001534248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				813676773
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38807
		FILM NUMBER:		23908662

	BUSINESS ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002
		BUSINESS PHONE:		972-77-331-0156

	MAIL ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Anchiano Therapeutics Ltd.
		DATE OF NAME CHANGE:	20180906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioCancell Ltd.
		DATE OF NAME CHANGE:	20111104
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>zk2329603.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--INTEGIX by Ez-XBRL-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:cmmb="http://www.anchiano.com/20230331"  >
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
  <title>Chemomab Therapeutics Ltd. - 1534248 - 2023</title>
</head>
<body><div style="font-size: 10pt;">

<div style="display:none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric name="dei:AmendmentFlag" contextRef="C_20230101to20230331" id="FFact_288" >false</ix:nonNumeric>
    <ix:nonNumeric name="dei:CurrentFiscalYearEndDate" contextRef="C_20230101to20230331" id="FFact_289" >--12-31</ix:nonNumeric>
    <ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="C_20230101to20230331" id="FFact_290" >Q1</ix:nonNumeric>
    <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="C_20230101to20230331" id="FFact_292" >0001534248</ix:nonNumeric>
    <ix:footnote id="FN20220809022016820" xml:lang="en-US">20 Ordinary Shares are equal to 1 American Depositary Share (ADS).</ix:footnote>
    </ix:hidden>
  <ix:references> <link:schemaRef xlink:type="simple" xlink:href="cmmb-20230331.xsd"/>
    </ix:references>
  <ix:resources>
    <xbrli:context id="C_20230101to20230331">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositarySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230508">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-05-08</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220401to20220425_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-04-25</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230301to20230322_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2023-03-22</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20220331">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220331">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221231">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230331">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:unit id="Share">
      <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unit>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unit>
    <xbrli:unit id="USD_per_share"><xbrli:divide>
      <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator>
      <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide>
      </xbrli:unit>
    <ix:relationship fromRefs="Fxbrl_20220801220211119" toRefs="FN20220809022016820"/>
    <ix:relationship fromRefs="Fxbrl_20221108042029242" toRefs="FN20220809022016820"/>
    <ix:relationship fromRefs="Fxbrl_20220801220307005" toRefs="FN20220809022016820"/>
    <ix:relationship fromRefs="Fxbrl_20221108042048740" toRefs="FN20220809022016820"/>
    <ix:relationship fromRefs="Fxbrl_20230501140723514" toRefs="FN20220809022016820"/>
    <ix:relationship fromRefs="Fxbrl_20230501140837133" toRefs="FN20220809022016820"/>
    <ix:relationship fromRefs="Fxbrl_20230501141042185" toRefs="FN20220809022016820"/>
    <ix:relationship fromRefs="Fxbrl_20230501141120971" toRefs="FN20220809022016820"/>
    </ix:resources>
  </ix:header></div>

<div>

<div>

<div style="line-height:1.25"> <hr style="border:none;border-bottom:1px solid black;border-top:4px solid black;height:10px;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center" />
</div>

<div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-weight:400">&#160;</div>

<div style="text-align:center;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">UNITED
STATES</span></span></div>

<div style="text-align:center;line-height:1.25;color:#212529;font-family:'Times New Roman', serif;font-size:14pt;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:14pt"><span>SECURITIES
AND EXCHANGE COMMISSION</span></span></span></div>

<div style="text-align:center;line-height:1.25;color:#212529;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>WASHINGTON,
DC 20549</span></span></span></div>

<div style="text-align:center;line-height:1.25;color:#212529;font-family:'Times New Roman', serif;font-weight:bold">&#160;</div>

<div style="text-align:center;line-height:1.25;color:#212529;font-family:'Times New Roman', serif;font-size:14pt;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:14pt"><span>FORM
<ix:nonNumeric id="FFact_1" name="dei:DocumentType" contextRef="C_20230101to20230331">10-Q</ix:nonNumeric></span></span></span></div>

<div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-weight:400">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>(Mark
One)</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonNumeric id="FFact_2" name="dei:DocumentQuarterlyReport" contextRef="C_20230101to20230331" format="ixt:fixed-true">&#9746;</ix:nonNumeric></span>&#160;<span style="font-weight:bold">QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">For
the quarterly period ended </span><ix:nonNumeric id="Fxbrl_20221026220521273" name="dei:DocumentPeriodEndDate" contextRef="C_20230101to20230331" format="ixt:date-monthname-day-year-en"><span style="font-weight:bold">March
31, </span><span style="font-weight:bold"><ix:nonNumeric id="Fxbrl_20221026220738505" name="dei:DocumentFiscalYearFocus" contextRef="C_20230101to20230331">2023</ix:nonNumeric></span></ix:nonNumeric></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25;color:#212529;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>OR</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonNumeric id="FFact_4" name="dei:DocumentTransitionReport" contextRef="C_20230101to20230331" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span>&#160;<span style="font-weight:bold">TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></span></span></span><br /><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">&#160;</span></span></span></span></div>

<div style="text-align:center;line-height:1.25;color:#212529;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>For
the transition period from to</span></span></span></div>

<div style="text-align:center;line-height:1.25;color:#212529;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Commission
File Number: <ix:nonNumeric id="FFact_5" name="dei:EntityFileNumber" contextRef="C_20230101to20230331">001-38807</ix:nonNumeric></span></span></span></div>

<div style="text-align:center;line-height:1.25;color:#212529;font-family:'Times New Roman', serif;font-weight:bold">&#160;</div>

<div style="text-align:center;line-height:1.25;color:#212529;font-family:'Times New Roman', serif;font-size:16pt;font-weight:bold"><span style="font-size:16pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="FFact_6" name="dei:EntityRegistrantName" contextRef="C_20230101to20230331">Chemomab
Therapeutics Ltd.</ix:nonNumeric></span></span></span></div>

<div style="text-align:center;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(Exact
Name of Registrant as Specified in its Charter)</span></span></span><br /><span style="font-family:Times New Roman,Times,serif"><span>&#160;</span></span></div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:49.04%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="FFact_7" name="dei:EntityIncorporationStateCountryCode" contextRef="C_20230101to20230331" format="ixt-sec:edgarprovcountryen">Israel</ix:nonNumeric></span></span></span></div>
        </td>
    <td style="width:2.08%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25">&#160;</div> </td>
    <td style="width:48.88%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="FFact_8" name="dei:EntityTaxIdentificationNumber" contextRef="C_20230101to20230331">81-3676773</ix:nonNumeric></span></span></span></div>
        </td> </tr>
  <tr>
    <td style="width:49.04%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25">&#160;</div> </td>
    <td style="width:2.08%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25">&#160;</div> </td>
    <td style="width:48.88%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width:49.04%;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(State
        or other jurisdiction of</span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>incorporation
        or organization)</span></span></span></div> </td>
    <td style="width:2.08%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="text-align:center;line-height:1.25">&#160;</div> </td>
    <td style="width:48.88%;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(I.R.S.
        Employer</span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Identification
        No.)</span></span></span></div> </td> </tr>
  <tr>
    <td style="width:49.04%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="text-align:center;line-height:1.25">&#160;</div> </td>
    <td style="width:2.08%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25">&#160;</div> </td>
    <td style="width:48.88%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="text-align:center;line-height:1.25">&#160;</div> </td> </tr>
  <tr>
    <td colspan="3" style="width:100%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="FFact_9" name="dei:EntityAddressAddressLine1" contextRef="C_20230101to20230331">Kiryat
        Atidim</ix:nonNumeric>, <ix:nonNumeric id="FFact_10" name="dei:EntityAddressAddressLine2" contextRef="C_20230101to20230331">Building 7</ix:nonNumeric></span></span></span></div>
        </td> </tr>
  <tr>
    <td colspan="3" style="width:100%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="FFact_11" name="dei:EntityAddressCityOrTown" contextRef="C_20230101to20230331">Tel
        Aviv</ix:nonNumeric>, <ix:nonNumeric id="FFact_12" name="dei:EntityAddressCountry" contextRef="C_20230101to20230331" format="ixt-sec:countrynameen">Israel</ix:nonNumeric>&#160;<ix:nonNumeric id="FFact_13" name="dei:EntityAddressPostalZipCode" contextRef="C_20230101to20230331">6158002</ix:nonNumeric></span></span></span></div>
        </td> </tr>
  <tr>
    <td colspan="3" style="width:100%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(Address
        of principal executive offices including zip code)</span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:center;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Registrant&#8217;s
telephone number, including area code: +<ix:nonNumeric id="FFact_14" name="dei:CityAreaCode" contextRef="C_20230101to20230331">972</ix:nonNumeric>-<ix:nonNumeric id="FFact_15" name="dei:LocalPhoneNumber" contextRef="C_20230101to20230331">77-331-0156</ix:nonNumeric></span></span></span></div>

<div style="text-align:center;line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Securities
registered pursuant to Section 12(b) of the Exchange Act:</span></span></span></span></div>

<div style="text-align:center;line-height:1.25;color:#212529;font-family:'Times New Roman', serif">&#160;</div>

<table border="0" cellpadding="2" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">
  <tr>
    <td style="width:38.15%;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);vertical-align:top">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Title
        of each class</span></span></span></span></div> </td>
    <td style="width:24.87%;vertical-align:middle;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Trading
        Symbol(s)</span></span></span></span></div>
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif">&#160;</div> </td>
    <td style="width:36.99%;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0);vertical-align:top">
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Name
        of each exchange on which registered</span></span></span></span></div> </td> </tr>
  <tr>
    <td style="width:38.15%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="FFact_16" name="dei:Security12bTitle" contextRef="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember">American
        Depositary Shares, each representing twenty (20)</ix:nonNumeric> ordinary shares, no par value per share</span></span></span></div>
        <div style="text-align:center;line-height:1.25">&#160;</div> </td>
    <td style="width:24.87%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0)">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="FFact_17" name="dei:TradingSymbol" contextRef="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember">CMMB</ix:nonNumeric></span></span></span></div>
        </td>
    <td style="width:36.99%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-right:2px solid rgb(0, 0, 0)">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="FFact_18" name="dei:SecurityExchangeName" contextRef="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric>
        Capital Market</span></span></span></div> </td> </tr>
  <tr>
    <td style="width:38.15%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0)">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="FFact_19" name="dei:Security12bTitle" contextRef="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember">Ordinary
        shares, no par value per share</ix:nonNumeric>&#160;</span></span></span></div> </td>
    <td style="width:24.87%;vertical-align:top;border-top:2px solid rgb(0, 0, 0);border-left:2px solid rgb(0, 0, 0);border-bottom:2px solid rgb(0, 0, 0)">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20221108153004455" name="dei:TradingSymbol" contextRef="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember">n/a</ix:nonNumeric></span></span></span></div>
        </td>
    <td style="width:36.99%;vertical-align:top;border-width:2px;border-style:solid;border-color:rgb(0, 0, 0)">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20220810204332751" name="dei:SecurityExchangeName" contextRef="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric>
        Capital Market*</span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif">&#160;</div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>*Not
for trading; only in connection with the registration of American Depository Shares</span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.</span></span></span></div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:100%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="FFact_22" name="dei:EntityCurrentReportingStatus" contextRef="C_20230101to20230331">Yes</ix:nonNumeric>&#160;&#9746;&#160;
        &#160; No &#9744;</span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files).</span></span></span></div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:100%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="FFact_23" name="dei:EntityInteractiveDataCurrent" contextRef="C_20230101to20230331">Yes</ix:nonNumeric>&#160;&#9746;&#160;
        &#160; No &#9744;</span></span></span></div> </td> </tr>
  </table>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller
reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></span></span></div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:22.56%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Large accelerated
        filer</span></span></span></div> </td>
    <td style="width:3.1%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#9744;</span></span></span></div>
        </td>
    <td style="width:25.38%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25">&#160;</div> </td>
    <td style="width:25.18%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Accelerated filer</span></span></span></div>
        </td>
    <td style="width:3.02%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#9744;</span></span></span></div>
        </td>
    <td style="width:20.77%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width:22.56%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="FFact_24" name="dei:EntityFilerCategory" contextRef="C_20230101to20230331" format="ixt-sec:entityfilercategoryen">Non-accelerated
        filer</ix:nonNumeric></span></span></span></div> </td>
    <td style="width:3.1%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#9746;</span></span></span></div>
        </td>
    <td style="width:25.38%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25">&#160;</div> </td>
    <td style="width:25.18%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Smaller reporting
        company</span></span></span></div> </td>
    <td style="width:3.02%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="FFact_25" name="dei:EntitySmallBusiness" contextRef="C_20230101to20230331" format="ixt:fixed-true">&#9746;</ix:nonNumeric></span></span></span></div>
        </td>
    <td style="width:20.77%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width:22.56%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25">&#160;</div> </td>
    <td style="width:3.1%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25">&#160;</div> </td>
    <td style="width:25.38%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25">&#160;</div> </td>
    <td style="width:25.18%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Emerging growth
        company</span></span></span></div> </td>
    <td style="width:3.02%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="FFact_26" name="dei:EntityEmergingGrowthCompany" contextRef="C_20230101to20230331" format="ixt:fixed-true">&#9746;</ix:nonNumeric></span></span></span></div>
        </td>
    <td style="width:20.77%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25">&#160;</div> </td> </tr>
  </table>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric id="FFact_27" name="dei:EntityExTransitionPeriod" contextRef="C_20230101to20230331" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></span></div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</span></span></span></div>

<div style="text-indent:18pt;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:100%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif">Yes &#9744;&#160; &#160; No <ix:nonNumeric id="FFact_28" name="dei:EntityShellCompany" contextRef="C_20230101to20230331" format="ixt:fixed-false">&#9746;</ix:nonNumeric></span></div>
        </td> </tr>
  </table>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-indent:18pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>As
of May 8, 2023,&#160;the registrant had <ix:nonFraction id="Fxbrl_20221026225744475" name="dei:EntityCommonStockSharesOutstanding" contextRef="C_20230508" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">11,049,812</ix:nonFraction>&#160;American
Depositary Shares outstanding.</span></span></span></div>

<div style="text-indent:18pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:Times New Roman, Times, serif">

<div style="page-break-after:always"> <hr style="background:rgb(0, 0, 0);width:100%;border-top:2px solid black" /> </div> </div> </div>

<div>

<div style="text-align:center;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</div>

<div style="text-align:center;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CHEMOMAB
THERAPEUTICS LTD. </span></span></div>

<div style="text-align:center;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</div>

<div style="text-align:center;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">QUARTERLY
REPORT ON FORM 10-Q</span></span></div>

<div style="text-align:center;line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">FOR
THE QUARTER ENDED MARCH 31, 2023</span><span>&#160;</span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:center;line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">TABLE
OF CONTENTS</span><span>&#160;</span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;color:rgb(0, 0, 255);font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="#PARTIFINANCIALINFORMATIO_integixAnchor">PART
        I. &#8211; FINANCIAL INFORMATION</a></span></span></span></span></div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)">
        <div style="text-align:right;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1</span></span></span></span></div></td></tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">&#160;</div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td></tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="background-color:rgb(204, 238, 255)">
        <div style="margin-left:28pt">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#Item1_integixAnchor"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Item
        1.Financial Statements</span></span></a></span></span></p></div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)">
        <div style="text-align:right;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1</span></span></span></span></div></td></tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td></tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)">
        <div style="text-indent:28pt;line-height:1.25;color:rgb(0, 0, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="#Item2_integixAnchor">Item
        2.Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></span></span></span></div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>10</span></span></span></span></td></tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td></tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)">
        <div style="text-indent:28pt;line-height:1.25;color:rgb(0, 0, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="#Item3_integixAnchor">Item
        3.Quantitative and Qualitative Disclosures About Market Risk.</a></span></span></span></span></div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>18</span></span></span></span></td></tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="text-align:right;line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td></tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)">
        <div style="text-indent:28pt;line-height:1.25;color:rgb(0, 0, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="#Item4_integixAnchor">Item
        4.Controls and Procedures.</a></span></span></span></span></div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>18</span></span></span></span></td></tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td></tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;color:rgb(0, 0, 255);font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="#PARTII_integixAnchor">PART
        II. &#8211; OTHER INFORMATION</a></span></span></span></span></div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>19</span></span></span></span></td></tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td></tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)">
        <div style="text-indent:28pt;line-height:1.25;color:rgb(0, 0, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="#Item1LegalProceedings_integixAnchor"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Item
        1.Legal Proceedings</span></span></span></span></span></span></span></span></a></span></span></span></span></span></span></span></span></div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>19</span></span></span></span></td></tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td></tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)">
        <div style="text-indent:28pt;line-height:1.25;color:rgb(0, 0, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="#Item1A_integixAnchor">Item
        1A.Risk Factors</a></span></span></span></span></div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>19</span></span></span></span></td></tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td></tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)">
        <div style="text-indent:28pt;line-height:1.25;color:rgb(0, 0, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="#Item22_integixAnchor">Item
        2.Unregistered Sales of Equity Securities and Use of Proceeds.</a></span></span></span></span></div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>19</span></span></span></span></td></tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td></tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)">
        <div style="text-indent:28pt;line-height:1.25;color:rgb(0, 0, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="#tem3_integixAnchor">Item
        3.Defaults Upon Senior Securities.</a></span></span></span></span></div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)">
        <div style="text-align:right;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>21</span></span></span></span></div></td></tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td></tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)">
        <div style="text-indent:28pt;line-height:1.25;color:rgb(0, 0, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="#Item4_integixAnchor">Item
        4.Mine Safety Disclosures.</a></span></span></span></span></div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>19</span></span></span></span></td></tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td></tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)">
        <div style="text-indent:28pt;line-height:1.25;color:rgb(0, 0, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="#Item5_integixAnchor">Item
        5.Other Information.</a></span></span></span></span></div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>19</span></span></span></span></td></tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td></tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)">
        <div style="text-indent:28pt;line-height:1.25;color:rgb(0, 0, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="#Item6_integixAnchor">Item
        6.Exhibits.</a></span></span></span></span></div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>20</span></span></span></span></td></tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(255, 255, 255)">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td></tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="width:89%;vertical-align:bottom;font-family:Times New Roman, Times, serif;background-color:rgb(204, 238, 255)">
        <div style="line-height:1.25;color:rgb(0, 0, 255);font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="#SIGNATURES_integixAnchor">SIGNATURES</a></span></span></span></span></div></td>
    <td style="width:11%;vertical-align:bottom;font-family:Times New Roman, Times, serif;text-align:right;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>21</span></span></span></span></td></tr>
  </table>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div>

<div style="text-align:center;line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">&#160;</span></span></span></div>

<div style="text-align:center;line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">CAUTIONARY
NOTE ABOUT FORWARD-LOOKING STATEMENTS</span><span>&#160;</span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">This
Quarterly Report on Form 10-Q contains forward-looking statements. All statements other than statements of historical fact are &#8220;forward-looking
statements&#8221; for purposes of this Quarterly Report on Form 10-Q. These statements involve known and unknown risks, uncertainties
and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance
or achievements expressed or implied by the forward-looking statements. In some cases, you can identify forward-looking statements by
terms including &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;could,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221;
&#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;potential,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221;
&#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; or the negative of these terms or other similar expressions. Forward-looking
statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties.
Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions
due to certain factors, including, without limitation, the risks set forth under the caption &#8220;Risk Factors&#8221; below, which are
incorporated herein by reference as well as those business risks and factors described elsewhere in this report and in our other filings
with the Securities and Exchange Commission (the &#8220;SEC&#8221;), specifically our most recent Annual Report on Form 10-K, our Quarterly
Reports on Form 10-Q and our filed Current Reports on Form 8-K. All forward-looking statements speak only as of the date made, and we
undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events
or otherwise, except as required by law.</span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:center;line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">CERTAIN
TERMS USED IN THIS QUARTERLY REPORT ON FORM 10-Q</span><span>&#160;</span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
used in this Quarterly Report on Form 10-Q, unless the context otherwise requires:</span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:5%;vertical-align:middle;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:3%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></div></td>
    <td style="width:92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">references
        to &#8220;Chemomab Therapeutics Ltd.&#8221;, &#8220;Chemomab,&#8221; the &#8220;Company,&#8221; &#8220;us,&#8221; &#8220;we&#8221; and
        &#8220;our&#8221; refer to Chemomab Therapeutics Ltd. an Israeli company and its consolidated subsidiaries, although with respect to the
        presentation of financial results for historical periods that preceded the Merger (as defined below), these terms refer to the financial
        results of Chemomab Ltd., which was the accounting acquirer in the Merger;</span></span></div></td></tr>
  </table>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:5%;vertical-align:middle;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:3%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></div></td>
    <td style="width:92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">references
        to &#8220;ordinary shares,&#8221; &#8220;our shares&#8221; and similar expressions refer to the Company&#8217;s ordinary shares, no nominal
        (par) value;</span></span></div></td></tr>
  </table>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:5%;vertical-align:middle;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:3%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></div></td>
    <td style="width:92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">references
        to &#8220;ADS&#8221; refer to the American Depositary Shares listed on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) under the symbol
        &#8220;CMMB,&#8221; each representing twenty (20) ordinary shares;</span></span></div></td></tr>
  </table>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:5%;vertical-align:middle;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:3%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></div></td>
    <td style="width:92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">references
        to &#8220;dollars,&#8221; &#8220;U.S. dollars&#8221; and &#8220;$&#8221; are to U.S. Dollars;</span></span></div></td></tr>
  </table>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:5%;vertical-align:middle;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:3%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></div></td>
    <td style="width:92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">references
        to &#8220;NIS&#8221; are to New Israeli Shekels;</span></span></div></td></tr>
  </table>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:5%;vertical-align:middle;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:3%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></div></td>
    <td style="width:92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">references
        to the &#8220;SEC&#8221; are to the U.S. Securities and Exchange Commission; and</span></span></div></td></tr>
  </table>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:5%;vertical-align:middle;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:3%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></div></td>
    <td style="width:92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">references
        to the &#8220;Merger&#8221; refer to the merger involving Anchiano Therapeutics Ltd. and Chemomab Ltd., whereby a wholly owned subsidiary
        of Anchiano Therapeutics Ltd. merged with and into Chemomab Ltd., with Chemomab Ltd. surviving as a wholly owned subsidiary of Anchiano
        Therapeutics Ltd. Upon consummation of the Merger, Anchiano Therapeutics Ltd. changed its name to &#8220;Chemomab Therapeutics Ltd.&#8221;
        and the business conducted by Chemomab Ltd. became primarily the business conducted by the Company.</span></span></div></td></tr>
  </table>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div>

<div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span id="PARTIFINANCIALINFORMATIO_integixAnchor"></span>&#160;<span>PART
I. &#8211; FINANCIAL INFORMATION</span></span></span></div>

<div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</div>

<div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-weight:bold"><span id="Item1_integixAnchor"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Item
1. Financial Statements</span></span></span></div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif;font-style:italic">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:100%;vertical-align:top">
        <div style="text-align:center;margin-right:14.2pt;margin-left:14.2pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Chemomab
        Therapeutics Ltd. and</span></span></div>
        <div style="text-align:center;margin-right:14.2pt;margin-left:14.2pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">its
        subsidiaries</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        <div style="text-align:center;margin-right:14.2pt;margin-left:14.2pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Condensed
        Consolidated Interim</span></span></div>
        <div style="text-align:center;margin-right:14.2pt;margin-left:14.2pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial
        Statements</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        <div style="text-align:center;margin-right:14.2pt;margin-left:14.2pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As
        of March 31, 2023</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:1.25">&#160;</span></span></span></div>
        <div style="text-align:center;margin-right:14.2pt;margin-left:14.2pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Unaudited)</span></span></div></td></tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div>

<div style="text-align:right;line-height:1.25;font-style:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Chemomab
Therapeutics Ltd.</span></span></div>

<div style="text-align:right;line-height:1.25;font-style:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and
its subsidiaries</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-style:normal">

<div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unaudited
Condensed Consolidated Interim Financial Statements as of March 31, 2023</span></span><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-weight:bold;font-style:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contents</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25">

<table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;color:#000000;width:100%">
  <tr>
    <td rowspan="1" style="width:95%">&#160;</td>
    <td rowspan="1" style="width:5%;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;<span style="font-weight:bold">Page</span></span></span></td></tr>
  <tr>
    <td rowspan="1" style="width:95%">&#160;</td>
    <td rowspan="1" style="width:5%;text-align:center">&#160;</td></tr>
  <tr>
    <td style="width:95%">
        <div>
        <div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#BalanceSheets_integixAnchor">Condensed
        Consolidated Interim Balance Sheets </a></span></span></div></div></td>
    <td style="width:5%">
        <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div></td></tr>
  <tr>
    <td style="width:95%">
        <div>&#160;</div></td>
    <td style="width:5%">
        <div>&#160;</div></td></tr>
  <tr>
    <td style="width:95%">
        <div>
        <div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#StatementsofOperations_integixAnchor">Condensed
        Consolidated Interim Statements of Operations </a></span></span></div></div></td>
    <td style="width:5%">
        <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4</span></span></div></td></tr>
  <tr>
    <td style="width:95%">
        <div>&#160;</div></td>
    <td style="width:5%">
        <div>&#160;</div></td></tr>
  <tr>
    <td style="width:95%">
        <div>
        <div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#ChangesinEquity_integixAnchor">Condensed
        Consolidated Interim Statements of Changes in Equity</a></span></span></div></div></td>
    <td style="width:5%">
        <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5-6</span></span></div></td></tr>
  <tr>
    <td style="width:95%">
        <div>&#160;</div></td>
    <td style="width:5%">
        <div>&#160;</div></td></tr>
  <tr>
    <td style="width:95%">
        <div>
        <div style="text-align:left;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><a href="#Cashflows_integixAnchor">Condensed
        Consolidated Interim Statements of Cash Flow</a></span></span></span></div></div></td>
    <td style="width:5%">
        <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7</span></span></div></td></tr>
  <tr>
    <td style="width:95%">
        <div>&#160;</div></td>
    <td style="width:5%">
        <div>&#160;</div></td></tr>
  <tr>
    <td style="width:95%">
        <div>
        <div style="text-align:left;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#FINANCIALSTATEMENTS_integixAnchor">Notes
        to the Condensed Consolidated Interim Financial Statements</a></span></span></div></div></td>
    <td style="width:5%;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8-9</span></span></td></tr>
  </table></div>

<div style="line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-weight:normal;font-style:normal">2</span></span></span></div>

<div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div></div>

<div>

<div>

<div>

<div style="text-align:right;line-height:1.25;margin-top:14px">&#160;</div>

<div style="text-align:right;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">Chemomab
Therapeutics Ltd.</span></span></span></span></div>

<div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>and
its subsidiaries</span></span></span></span></div>

<div style="text-align:right;line-height:1.25">&#160;</div>

<div style="line-height:1.25">

<div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span id="BalanceSheets_integixAnchor"></span>
<span><span>Condensed Consolidated Balance Sheets</span></span></span></span> <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center;margin-bottom:5pt;margin-top:5pt" />
</div> </div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In USD thousands
(except for share amounts)</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%" width="100%">
  <tr>
    <td rowspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td rowspan="1" style="vertical-align:top" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:top" valign="bottom">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>March
        31,</span></span></span></span></div> </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:top" valign="bottom">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December&#160;31,</span></span></span></span></div>
        </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td rowspan="1" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Note</span></span></span></span></div>
        </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div>
        </div> </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div>
        </div> </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom" valign="bottom">
        <div style="line-height:1.25;font-weight:bold">&#160;</div> </td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td style="vertical-align:top" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top" valign="bottom">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Unaudited</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top" valign="bottom">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Audited</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Assets</span></span></span></span></div>
        </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td rowspan="1" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Current
        assets</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cash and
        cash equivalents</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_30" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,765</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_31" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,519</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Short term
        bank deposits</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_32" name="us-gaap:DepositsAssetsCurrent" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,941</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_33" name="us-gaap:DepositsAssetsCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,374</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Restricted cash</p> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><ix:nonFraction id="Fxbrl_20230501160610892_Fact_30" name="us-gaap:RestrictedCashCurrent" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">77</ix:nonFraction></strong></p>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="Fxbrl_20230501160610892_Fact_31" name="us-gaap:RestrictedCashCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">77</ix:nonFraction></p>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;padding-bottom:2px;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Other receivables
        and prepaid expenses</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_34" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">995</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_35" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,766</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;padding-bottom:2px;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total
        current assets</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_36" name="us-gaap:AssetsCurrent" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,778</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_37" name="us-gaap:AssetsCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,736</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Non-current
        assets</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Long term
        prepaid expenses</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220504175928392" name="us-gaap:PrepaidExpenseNoncurrent" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">690</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_40" name="us-gaap:PrepaidExpenseNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">733</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:top;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Property
        and equipment, net</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_42" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">352</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_43" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">367</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;padding-bottom:2px;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Operating
        lease right-of-use assets</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_46" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">193</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_47" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">227</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;padding-bottom:2px;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total
        non-current assets</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_48" name="us-gaap:AssetsNoncurrent" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,235</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_49" name="us-gaap:AssetsNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,327</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;padding-bottom:4px;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total
        assets</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:4px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_50" name="us-gaap:Assets" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,013</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:4px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_51" name="us-gaap:Assets" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,063</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Current
        liabilities</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trade payables</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_52" name="us-gaap:AccountsPayableTradeCurrent" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,217</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_53" name="us-gaap:AccountsPayableTradeCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,688</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Accrued expenses</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_54" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,164</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_55" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,378</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Employee
        and related expenses</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_56" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,501</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_57" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,560</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;padding-bottom:2px;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Operating
        lease liabilities</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_58" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">115</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_59" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">123</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;padding-bottom:2px;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total
        current liabilities</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_60" name="us-gaap:LiabilitiesCurrent" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,997</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_61" name="us-gaap:LiabilitiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,749</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Non-current
        liabilities</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;padding-bottom:2px;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Operating
        lease liabilities - long term</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_62" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_63" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">91</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;padding-bottom:2px;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total
        non-current liabilities</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_64" name="us-gaap:LiabilitiesNoncurrent" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_65" name="us-gaap:LiabilitiesNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">91</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Commitments
        and contingent liabilities</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20221108051943260_Fact_64" name="us-gaap:CommitmentsAndContingencies" contextRef="C_20230331" unitRef="USD" xsi:nil="true"></ix:nonFraction></span></span></td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20221108051943260_Fact_65" name="us-gaap:CommitmentsAndContingencies" contextRef="C_20221231" unitRef="USD" xsi:nil="true"></ix:nonFraction></span></span></td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;padding-bottom:4px;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total
        liabilities</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:4px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_66" name="us-gaap:Liabilities" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,059</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:4px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_67" name="us-gaap:Liabilities" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,840</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td style="vertical-align:top;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shareholders'
        equity</span></span></span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(255, 255, 255)">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td rowspan="1" style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td rowspan="1" style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Ordinary
        shares <ix:nonFraction id="Fxbrl_20220505092446513" name="us-gaap:CommonStockNoParValue" contextRef="C_20221231" unitRef="USD_per_share" scale="0" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="Fxbrl_20220719155003261" name="us-gaap:CommonStockNoParValue" contextRef="C_20230331" unitRef="USD_per_share" scale="0" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction>
        par value - Authorized: <ix:nonFraction id="Fxbrl_20220505092709497" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220719155025581" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_20230331" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">650,000,000</ix:nonFraction></ix:nonFraction>
        shares as of &#160;March 31, 2023 and&#160;December 31, 2022;&#160;</span></span></span></span></div> </td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td rowspan="1" style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Issued and
        outstanding: <ix:nonFraction id="Fxbrl_20230501162335964" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230501162324131" name="us-gaap:CommonStockSharesIssued" contextRef="C_20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230501162302866" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20230331" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230501162254717" name="us-gaap:CommonStockSharesIssued" contextRef="C_20230331" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">232,636,700</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;Ordinary
        shares as of March 31, 2023 and &#160;December 31, 2022;&#160;</span></span></span></span></div> </td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220505093047469" name="us-gaap:CommonStockValue" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220505093055381" name="us-gaap:CommonStockValue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td rowspan="1" style="vertical-align:bottom;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Treasury
        share at cost (<ix:nonFraction id="Fxbrl_20230501130301925" name="us-gaap:TreasuryStockShares" contextRef="C_20221231" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230501130254826" name="us-gaap:TreasuryStockShares" contextRef="C_20230331" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">11,640,460</ix:nonFraction></ix:nonFraction>&#160;Ordinary
        shares as of March 31, 2023 and December 31, 2022)</span></span></span></p> </td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span style="color:black">(<ix:nonFraction id="Fxbrl_20230501130942230" name="us-gaap:TreasuryStockValue" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,218</ix:nonFraction></span></strong></span></span></p>
        </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:black">(<ix:nonFraction id="Fxbrl_20230501131017943" name="us-gaap:TreasuryStockValue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,218</ix:nonFraction></span></span></span></p>
        </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additional
        paid in capital</span></span></span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_78" name="us-gaap:AdditionalPaidInCapital" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">101,744</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_79" name="us-gaap:AdditionalPaidInCapital" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">101,260</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;padding-bottom:2px;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Accumulated
        deficit</span></span></span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;padding-bottom:2px;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="FFact_80" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">72,572</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="FFact_81" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">63,819</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </div> </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;padding-bottom:2px;width:65%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total
        shareholders&#8217; equity</span></span></span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;padding-bottom:2px;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220719200901554_Fact_84" name="us-gaap:StockholdersEquity" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,954</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220719200901554_Fact_85" name="us-gaap:StockholdersEquity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,223</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;padding-bottom:4px;width:65%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total
        liabilities and shareholders&#8217; equity</span></span></span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:4px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;padding-bottom:4px;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:4px;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double black;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double black;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_84" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,013</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double black;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double black;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20221108131652038" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,063</ix:nonFraction></span></span></span></p>
        </div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  </table>

<div style="line-height:1.25">&#160;</div> </div> </div>

<div>

<div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The accompanying
notes are an integral part of the condensed consolidated interim financial statements.</span></span></span></span></div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:normal;font-style:normal">3</span></span></span></span></span></div>

<div style="page-break-after:always"> <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
</div> </div> </div> </div> </div>

<div>

<div>

<div>

<div style="text-align:right;line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>

<div style="text-align:right;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Chemomab
Therapeutics Ltd.</span></span></div>

<div style="text-align:right;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">and
its subsidiaries</span></span></div>

<div style="line-height:1.25">

<div style="line-height:1.25;font-weight:bold">

<p style="margin-top:0pt;margin-bottom:0pt"><span id="StatementsofOperations_integixAnchor"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Condensed
Consolidated Interim Statements of Operations (Unaudited)</span></span></span></p> <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center;margin-bottom:5pt;margin-top:5pt" />
</div> </div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In USD thousands&#160;</span></span>(except
for share and per share amounts)</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="width:100%">
  <tr>
    <td style="vertical-align:top" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:top" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top" valign="bottom">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Three&#160;months</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top" valign="bottom">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Three&#160;months</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:top" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top" valign="bottom">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ended</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top" valign="bottom">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ended</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:top" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top" valign="bottom">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">March&#160;
        31</span>,</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top" valign="bottom">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">March
        31</span>,</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:center" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</div> </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="line-height:1.25">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="line-height:1.25">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating
        expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:top" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development</span></span></div>
        </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_88" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,887</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_89" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,745</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:65%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);padding-bottom:2px;width:65%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative</span></span></div>
        </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;padding-bottom:2px;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_92" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,162</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_93" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,575</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:65%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total
        operating expenses</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_96" name="us-gaap:OperatingExpenses" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,049</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_97" name="us-gaap:OperatingExpenses" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,320</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:65%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);padding-bottom:2px;width:65%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financing income, net</span></span></div>
        </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;padding-bottom:2px;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20221026182150611" name="cmmb:FinanceIncomeExpensesNet" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">317</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20230501164940410" name="cmmb:FinanceIncomeExpensesNet" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">216</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:65%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);padding-bottom:2px;width:65%" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss
        before taxes</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;padding-bottom:2px;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220808224756229" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,732</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220808224804527" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,104</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:65%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);padding-bottom:2px;width:65%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Taxes on income</span></span></div>
        </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;padding-bottom:2px;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220728231430174" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);width:9%" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_101" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;padding-bottom:2px;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:65%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);padding-bottom:4px;width:65%" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        loss for the year</span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;padding-bottom:4px;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);width:9%" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_104" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,753</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);width:9%" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_105" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,104</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;padding-bottom:4px;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td rowspan="1" style="vertical-align:bottom;width:65%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic and diluted loss
        per Ordinary Share (*)</span></span></div> </td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20221108042029242" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20230101to20230331" unitRef="USD_per_share" scale="0" decimals="3" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220801220211119" name="us-gaap:EarningsPerShareBasic" contextRef="C_20230101to20230331" unitRef="USD_per_share" scale="0" decimals="3" format="ixt:num-dot-decimal">0.040</ix:nonFraction></ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" rowspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20221108042048740" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20220101to20220331" unitRef="USD_per_share" scale="0" decimals="3" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220801220307005" name="us-gaap:EarningsPerShareBasic" contextRef="C_20220101to20220331" unitRef="USD_per_share" scale="0" decimals="3" format="ixt:num-dot-decimal">0.022</ix:nonFraction></ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" rowspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td rowspan="1" style="vertical-align:bottom;width:65%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted average number
        of Ordinary Shares outstanding, basic, and diluted (*)</span></span></div> </td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230501140837133" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20230101to20230331" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230501140723514" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20230101to20230331" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">220,996,240</ix:nonFraction></ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" rowspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230501141120971" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20220101to20220331" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230501141042185" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20220101to20220331" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">228,090,300</ix:nonFraction></ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" rowspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
        </tr>
  </table>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(*)
20 Ordinary Shares are equal to 1 American Depositary Share (ADS).</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of
the condensed consolidated interim financial statements.</span></span>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">4</span></span></span></div>

<div style="page-break-after:always"> <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
</div> </div> </div> </div> </div> </div>

<div>

<div>

<div>

<div style="text-align:right;line-height:1.25">&#160;</div>

<div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Chemomab
Therapeutics Ltd.</span></span></div>

<div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and
its subsidiaries</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25">

<div style="line-height:1.25;font-weight:bold"><span id="ChangesinEquity_integixAnchor"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Condensed
Consolidated Interim Statements of Changes in Equity (Unaudited)</span></span></span> <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center;margin-bottom:5pt;margin-top:5pt" />
</div> </div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In USD thousands (except
share amounts)</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%">
  <tr style="background-color:rgb(255, 255, 255)">
    <td rowspan="1" style="vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:left" valign="bottom">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);text-align:center;font-weight:bold;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;padding:0px">
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span><span>Ordinary</span></span></strong></span></span></span></span></div>
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span><span>Share</span></span></strong></span></span></span></span></div>
        </div> </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td colspan="6" rowspan="1" style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;vertical-align:bottom;border-bottom:2px solid black">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Treasury<br />share</strong></span></span></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);text-align:center;font-weight:bold;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;padding:0px">
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span><span>Additional</span></span></strong></span></span></span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span><span>paid
        in</span></span></strong></span></span></span></span></div>
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span><span>capital</span></span></strong></span></span></span></span></div>
        </div> </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;border-bottom:2px solid rgb(0, 0, 0)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);text-align:center;font-weight:bold;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;padding:0px">
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span><span>Accumulated</span></span></strong></span></span></span></span></div>
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span><span>Deficit</span></span></strong></span></span></span></span></div>
        </div> </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);text-align:center;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;padding:0px">
        <div style="line-height:1.25;font-weight:bold;border-top:0px">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span><span>Total
        </span></span></strong></span></span></span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span><span>Shareholders&#8217;
        </span></span></strong></span></span></span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span><span>equity</span></span></strong></span></span></span></span></div>
        </div> </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td rowspan="1" style="vertical-align:bottom;padding:0px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:left" valign="bottom">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);text-align:center;font-weight:bold;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;padding:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span><span>Number</span></span></strong></span></span></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;border-bottom:2px solid rgb(0, 0, 0)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);text-align:center;font-weight:bold;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;padding:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span><span>USD</span></span></strong></span></span></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;border-bottom:2px solid rgb(0, 0, 0)">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span>Number</span></strong></span></span></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;border-bottom:2px solid rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>USD</strong></span></span></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);text-align:center;font-weight:bold;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;padding:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span><span>USD</span></span></strong></span></span></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px;border-bottom:2px solid rgb(0, 0, 0)">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);text-align:center;font-weight:bold;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;padding:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span><span>USD</span></span></strong></span></span></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);text-align:center;font-weight:bold;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;padding:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span><span>USD</span></span></strong></span></span></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;padding:0px">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255);height:15px">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px" valign="bottom">
        <div style="line-height:1.25;font-weight:bold;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>For
        the three-month period ended on March 31, 2023</span></span></span></span></div> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px">&#160;</td>
    <td colspan="2" style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td colspan="2" style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td colspan="2" style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255);height:15px">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px" valign="bottom">
        <div style="line-height:1.25;font-weight:bold;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance
        as of January 1, 2023</span></span></span></span></div> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px" valign="bottom">
        <div style="line-height:1.25;font-weight:bold;text-align:right;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-align:right"><span><ix:nonFraction id="Fxbrl_20220719171142064_xbrl_20220504161436664" name="us-gaap:SharesOutstanding" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">232,636,700
        </ix:nonFraction></span></span></span></span></div> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px" valign="bottom">
        <div style="line-height:1.25;font-weight:bold;text-align:right;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-align:right"><span><ix:nonFraction id="Fxbrl_20220719171142064_xbrl_20220505093740414" name="us-gaap:StockholdersEquity" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px" valign="bottom">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0px;margin-bottom:0pt;text-align:right;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong style="text-align:right"><span>(<ix:nonFraction id="Fxbrl_20230501151602018" name="us-gaap:SharesOutstanding" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal" sign="-">11,640,460</ix:nonFraction></span></strong></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin:0px;text-align:left;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong style="text-align:left;margin:0px"><span>)</span></strong></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px" valign="bottom">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0px;margin-bottom:0pt;text-align:right;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong style="text-align:right"><span>(<ix:nonFraction id="Fxbrl_20230501151611321" name="us-gaap:StockholdersEquity" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,218</ix:nonFraction></span></strong></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin:0px;text-align:left;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong style="text-align:left;margin:0px"><span>)</span></strong></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px" valign="bottom">
        <div style="line-height:1.25;font-weight:bold;text-align:right;border-top:0px">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><ix:nonFraction id="Fxbrl_20230501151742804" name="us-gaap:StockholdersEquity" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">101,260</ix:nonFraction></span></strong></span></span></p>
        </div> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px">
        <div style="line-height:1.25;font-weight:bold;text-align:left;margin:0px;border-top:0px;border-bottom:0px">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin:0px;text-align:left;padding-top:0px">&#160;</p> </div> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px" valign="bottom">
        <div style="line-height:1.25;font-weight:bold;text-align:right;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-align:right"><span>(</span></span><span><ix:nonFraction id="Fxbrl_20230501152649480" name="us-gaap:StockholdersEquity" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">63,819</ix:nonFraction></span></span></span></div>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px" valign="bottom">
        <div style="line-height:1.25;font-weight:bold;text-align:right;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-align:right"><span><ix:nonFraction id="Fxbrl_20230501152914617" name="us-gaap:StockholdersEquity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,223</ix:nonFraction></span></span></span></span></div>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255);height:15px">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:30%" valign="bottom">
        <div style="line-height:1.25;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Share-based
        compensation</span></span></span></span></div> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:7%" valign="bottom">
        <div style="line-height:1.25;text-align:right;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-align:right"><span>-</span></span></span></span></div>
        </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:7%" valign="bottom">
        <div style="line-height:1.25;text-align:right;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-align:right"><span><ix:nonFraction id="Fxbrl_20220719171155021_xbrl_20220505093821193" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:7%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:7%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230501153041825" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:7%" valign="bottom">
        <div style="line-height:1.25;text-align:right;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-align:right"><span><ix:nonFraction id="Fxbrl_20220719171155021_xbrl_20220504161917493" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">484</ix:nonFraction></span></span></span></span></div>
        </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:7%" valign="bottom">
        <div style="line-height:1.25;text-align:right;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-align:right"><span><ix:nonFraction id="Fxbrl_20220719171155021_xbrl_20220505093815054" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:7%" valign="bottom">
        <div style="line-height:1.25;text-align:right;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-align:right"><span><ix:nonFraction id="Fxbrl_20220719171155021_xbrl_20220504161939600" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">484</ix:nonFraction></span></span></span></span></div>
        </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255);height:15px">
    <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:30%" valign="bottom">
        <div style="line-height:1.25;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Net
        loss for the year</span></span></span></span></div> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:2px solid rgb(0, 0, 0);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:7%" valign="bottom">
        <div style="line-height:1.25;text-align:right;border-top:0px">
        <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </div> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:2px solid rgb(0, 0, 0);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:7%" valign="bottom">
        <div style="line-height:1.25;text-align:right;border-top:0px">
        <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220719171210751_xbrl_20220505093843525" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:2px solid rgb(0, 0, 0);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:7%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:2px solid rgb(0, 0, 0);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:7%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230501153100009" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:2px solid rgb(0, 0, 0);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:7%" valign="bottom">
        <div style="line-height:1.25;text-align:right;border-top:0px">
        <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220719171210751_xbrl_20220505093847704" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:2px solid rgb(0, 0, 0);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:7%" valign="bottom">
        <div style="line-height:1.25;text-align:right;border-top:0px">
        <div style="line-height:1.25;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20230501152819814" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,753</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px 0px 1pt;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;border-bottom:2px solid rgb(0, 0, 0);width:1%">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-width:2px;border-bottom-style:solid;border-bottom-color:rgb(0, 0, 0);background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:7%" valign="bottom">
        <div style="line-height:1.25;text-align:right;border-top:0px">
        <div style="line-height:1.25;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20230501152925490" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,753</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px 0px 1pt;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255);height:15px">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:30%" valign="bottom">
        <div style="line-height:1.25;font-weight:bold;border-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance
        as of March 31, 2023</span></span></span></span></div> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%;border-bottom:4px double black">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:7%;border-bottom:4px double black" valign="bottom">
        <div style="line-height:1.25;text-align:right;border-top:0px">
        <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230501152450068" name="us-gaap:SharesOutstanding" contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">232,636,700</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%;border-bottom:4px double black">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:7%;border-bottom:4px double black" valign="bottom">
        <div style="line-height:1.25;text-align:right;border-top:0px">
        <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220719171143948_xbrl_20220505093740414" name="us-gaap:StockholdersEquity" contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%;border-bottom:4px double black">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:7%;border-bottom:4px double black" valign="bottom">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0px;margin-bottom:0pt;text-align:right;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong style="text-align:right"><span>(<ix:nonFraction id="Fxbrl_20230501152541868" name="us-gaap:SharesOutstanding" contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal" sign="-">11,640,460</ix:nonFraction></span></strong></span></span></p>
        </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px 0px 2.5pt;width:1%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin:0px;text-align:left;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong style="text-align:left;margin:0px"><span>)</span></strong></span></span></p>
        </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%;border-bottom:4px double black">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:7%;border-bottom:4px double black" valign="bottom">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0px;margin-bottom:0pt;text-align:right;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong style="text-align:right"><span>(<ix:nonFraction id="Fxbrl_20230501152556917" name="us-gaap:StockholdersEquity" contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,218</ix:nonFraction></span></strong></span></span></p>
        </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;padding:0px 0px 2.5pt;width:1%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin:0px;text-align:left;padding-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong style="text-align:left;margin:0px"><span>)</span></strong></span></span></p>
        </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%;border-bottom:4px double black">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:7%;border-bottom:4px double black" valign="bottom">
        <div style="line-height:1.25;text-align:right;border-top:0px">
        <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230501152618776" name="us-gaap:StockholdersEquity" contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">101,744</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%;border-bottom:4px double black">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:7%;border-bottom:4px double black" valign="bottom">
        <div style="line-height:1.25;text-align:right;border-top:0px">
        <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20230501152728382" name="us-gaap:StockholdersEquity" contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">72,572</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;vertical-align:bottom;padding:0px 0px 2.5pt;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%;border-bottom:4px double black">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;padding:0px;width:7%;border-bottom:4px double black" valign="bottom">
        <div style="line-height:1.25;text-align:right;border-top:0px">
        <div style="line-height:1.25;font-weight:bold;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20230501152949713" name="us-gaap:StockholdersEquity" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,954
        </ix:nonFraction></span></span></span></span></div> </div> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;height:15px;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;padding:0px;width:1%">&#160;</td>
        </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">5</span></span></span></div>

<div style="page-break-after:always"> <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
</div> </div>

<div style="text-align:right;line-height:1.25">&#160;</div>

<div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Chemomab
Therapeutics Ltd.</span></span></div>

<div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and
its subsidiaries</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25">

<div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Condensed
Consolidated Interim Statements of Changes in Equity (Unaudited)</span></span> <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center;margin-bottom:5pt;margin-top:5pt" />
</div> </div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In USD thousands (except
share amounts)</span></span></div>

<div style="line-height:1.25">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">
  <tr>
    <td rowspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="6" rowspan="1" style="vertical-align:bottom;text-align:center;font-weight:bold;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Ordinary</span></span></span></span></div>
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shares</span></span></span></span></div>
        </div> </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;font-weight:bold;padding-bottom:2px;white-space:nowrap;text-align:center">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;font-weight:bold;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;text-align:center;font-weight:bold;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Additional</span></span></span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>paid
        in</span></span></span></span></div>
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>capital</span></span></span></span></div>
        </div> </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;font-weight:bold;padding-bottom:2px;white-space:nowrap;text-align:center">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;font-weight:bold;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;text-align:center;font-weight:bold;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Accumulated</span></span></span></span></div>
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Deficit</span></span></span></span></div>
        </div> </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;font-weight:bold;padding-bottom:2px;white-space:nowrap;text-align:center">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;font-weight:bold;padding-bottom:2px;text-align:center">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-weight:bold">
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total
        </span></span></span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Shareholders&#8217;
        </span></span></span></span></div>
        <div style="line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>equity</span></span></span></span></div>
        </div> </td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td> </tr>
  <tr>
    <td rowspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25;font-weight:bold">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Number</span></span></span></span></div>
        </div> </td>
    <td colspan="1" rowspan="1" style="text-align:center;vertical-align:bottom;font-weight:bold;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:center;font-weight:bold;padding-bottom:2px">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;text-align:center;font-weight:bold;border-bottom:2px solid rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>USD</span></span></span></span></td>
    <td colspan="1" rowspan="1" style="text-align:center;vertical-align:bottom;font-weight:bold;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:center;font-weight:bold;padding-bottom:2px">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;text-align:center;font-weight:bold;border-bottom:2px solid rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>USD</span></span></span></span></td>
    <td colspan="1" rowspan="1" style="text-align:center;vertical-align:bottom;font-weight:bold;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:center;font-weight:bold;padding-bottom:2px">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;text-align:center;font-weight:bold;border-bottom:2px solid rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>USD</span></span></span></span></td>
    <td colspan="1" rowspan="1" style="text-align:center;vertical-align:bottom;font-weight:bold;padding-bottom:2px;white-space:nowrap">&#160;</td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;text-align:center;font-weight:bold;padding-bottom:2px">&#160;</td>
    <td colspan="2" rowspan="1" style="vertical-align:bottom;text-align:center;font-weight:bold;border-bottom:2px solid rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>USD</span></span></span></span></td>
    <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>For
        the three-month period ended on March 31, 2022</span></span></span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;width:40%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance
        as of January 1, 2022</span></span></span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220504161436664" name="us-gaap:SharesOutstanding" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">228,090,300</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220505093740414" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220504161607482" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">97,639</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20220504161812745" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">36,173</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220504161847247" name="us-gaap:StockholdersEquity" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,466</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Share-based
        compensation</span></span></span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220505093821193" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220504161917493" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">874</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220505093815054" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220504161939600" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">874</ix:nonFraction></span></span></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;width:40%;padding-bottom:2px;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Net loss
        for the period</span></span></span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220505093843525" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220505093847704" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20220504162015389" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,104</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20220504162029289" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,104</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </div> </td> </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Balance
        as of March 31, 2022</span></span></span></span></div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220504162054050" name="us-gaap:SharesOutstanding" contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">228,090,300</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220505093917037" name="us-gaap:StockholdersEquity" contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220504162134224" name="us-gaap:StockholdersEquity" contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">98,513</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20220504162140381" name="us-gaap:StockholdersEquity" contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">41,277</ix:nonFraction></span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
        </div> </td>
    <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220504162145961" name="us-gaap:StockholdersEquity" contextRef="C_20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">57,236</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
        </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes
are an integral part of the condensed consolidated interim financial statements.</span></span></div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">6</span></span></span></div>

<div style="page-break-after:always"> <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
</div> </div> </div> </div>

<div>

<div>

<div>

<div style="text-align:right;line-height:1.25">&#160;</div>

<div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Chemomab
Therapeutics Ltd.</span></span></div>

<div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and
its subsidiaries</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25">

<div style="line-height:1.25;font-weight:bold"><span id="Cashflows_integixAnchor"></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Condensed
Consolidated Interim Statements of Cash flows (Unaudited)</span></span> <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center;margin-bottom:5pt;margin-top:5pt" />
</div> </div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In USD thousands</span></span></div>

<div>

<div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25">

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">
  <tr>
    <td style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Three
        months</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Three
        months</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ended</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ended</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March
        31,</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March
        31,</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25">
        <div style="text-align:right;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        flows from operating activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        loss for the period</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_193" name="us-gaap:ProfitLoss" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,753</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_194" name="us-gaap:ProfitLoss" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,104</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments
        for operating activities:</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_195" name="us-gaap:Depreciation" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_196" name="us-gaap:Depreciation" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based
        compensation</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_205" name="us-gaap:ShareBasedCompensation" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">484</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_206" name="us-gaap:ShareBasedCompensation" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">874</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Change
        in other receivables and prepaid expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_197" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">814</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220719185926153" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">363</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:top;width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Change
        in operating lease liability</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220719190053059" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220504154924941" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Change
        in trade payables</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_199" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">529</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_200" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">151</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Change
        in accrued expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230501141051534" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">214</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_202" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">693</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:top;width:76%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Change
        in employees and related expenses</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230501141057759" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">59</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_204" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_207" name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,567</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220719185858022" name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,393</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash used in operating activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_209" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,186</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_210" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3,711</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        flows from investing activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Decrease
        in bank deposits</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_211" name="cmmb:ProceedsFromSaleOfDeposits" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,433</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220719190124821" name="cmmb:ProceedsFromSaleOfDeposits" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,396</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchase
        of property and equipment</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_215" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_216" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </div> </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash provided by investing activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_217" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,432</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_218" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,382</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash
        flows from financing activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net
        cash provided by financing activities</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_229" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_230" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Change
        in cash, cash equivalents and restricted cash</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_231" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,246</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230501141209877" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,329</ix:nonFraction></span></span></div>
        </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
        </td> </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash,
        cash equivalents and restricted cash at beginning of period</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_233" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,596</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_234" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,241</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash,
        cash equivalents and restricted cash at end of period</span></span></div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_235" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,842</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_236" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,912</ix:nonFraction></span></span></div>
        </div> </td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes
are an integral part of the condensed consolidated interim financial statements.</span></span></div> </div> </div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">7</span></span></span></div>

<div style="page-break-after:always"> <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
</div> </div> </div> </div> </div>

<div style="line-height:1.25">&#160;</div>

<div>

<div>

<div>

<div style="text-align:center;line-height:1.25;font-weight:bold;margin-top:0px"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span style="text-decoration:underline">CHEMOMAB
THERAPEUTICS LTD AND ITS SUBSIDIARIES</span></span></span></span></span></span></span></span></span></span></span></div>

<div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span>&#160;<span style="font-weight:bold;text-decoration:underline">(FORMERLY
ANCHIANO THERAPEUTICS LTD.)</span></span></span></span></span></span></span></span></span></span></span></div>

<div style="text-align:center;line-height:1.25;font-weight:bold"><span id="FINANCIALSTATEMENTS_integixAnchor"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span><span style="text-decoration:underline">NOTES
TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS</span></span></span></span></span></span></span></span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20221108050710796" name="us-gaap:NatureOfOperations" contextRef="C_20230101to20230331" escape="true">

<div>

<div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span>Note
1 - General.</span></span></span></span></span></span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:36pt">&#160;</td>
    <td style="width:36pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span>A.</span></span></span></span></span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify">Chemomab Therapeutics
        Ltd. (the &#8220;Company") is an Israeli-based company incorporated under the laws of the State of Israel in September 2011. The Company&#8217;s
        registered office is located in Kiryat Atidim, Tel Aviv, Israel. The Company is a clinical-stage biotech company discovering and developing
        innovative therapeutics for conditions with high-unmet medical need that involve inflammation and fibrosis.&#160;</p> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:36pt">&#160;</td>
    <td style="width:36pt;vertical-align:top;font-weight:bold">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">B.</span></p>
        </td>
    <td style="width:auto;vertical-align:top">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify">The Company currently
        has no products approved for sale. The Company&#8217;s operations are funded primarily by its Shareholders. The Company has incurred operating
        losses in each year since its inception and does not expect to generate significant revenue unless and until it obtains marketing approval
        for its products. Continuation of the Company&#8217;s development programs depend on its future ability to raise sources of financing.
        The Company believes that its existing liquidity resources as of March 31, 2023 will enable it to fund its operations through June 30,
        2024 with the ability to perform cost reductions in order to extend the operations even further, if required to do so.</p> </td> </tr>
  <tr>
    <td style="width:36pt">&#160;</td>
    <td style="width:36pt;vertical-align:top;font-weight:bold">&#160;</td>
    <td style="width:auto;vertical-align:top">&#160;</td> </tr>
  <tr>
    <td style="width:36pt">&#160;</td>
    <td style="width:36pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span>C.</span></span></span></span></span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify">On April 30, 2021,
        the Company entered into an At the Market Offering Agreement (the "ATM Agreement") with Cantor Fitzgerald &#38; Co., ("Cantor"). According
        to the ATM Agreement, the Company may offer and sell, from time to time, its ADSs having an aggregate offering price of up to $<ix:nonFraction id="Fxbrl_20230504064019754" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">75</ix:nonFraction>
        million through Cantor or the ATM Agreement. From April 30, 2021, through March 31, 2023 the Company issued <ix:nonFraction id="Fxbrl_20230504064033619" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">699,806</ix:nonFraction>
        ADSs at an average price of $<ix:nonFraction id="Fxbrl_20230504064050529" name="us-gaap:SaleOfStockPricePerShare" contextRef="C_20230331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">22.75</ix:nonFraction>
        per ADS under the ATM Agreement, resulting in gross proceeds of $<ix:nonFraction id="Fxbrl_20230504064101257" name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,917</ix:nonFraction>
        thousand.</p> </td> </tr>
  </table>

<div style="text-align:justify;margin-left:72pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25">

<table border="0" cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;text-align:justify">
  <tr>
    <td style="font-size:10pt;vertical-align:top;width:36pt">&#160;</td>
    <td style="font-size:10pt;vertical-align:top;width:36pt"><strong>D.</strong></td>
    <td style="font-size:10pt;vertical-align:top;width:auto;margin-top:0pt;margin-bottom:0pt">
        <p style="margin-top:0pt;margin-bottom:0pt">On April 25, 2022, the Company filed a prospectus supplement with the SEC for the issuance
        and sale of up to&#160; $<ix:nonFraction id="Fxbrl_20230504064130218" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="C_20220401to20220425_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,125,000</ix:nonFraction>
        of its ADSs in connection with the reactivation of the ATM Facility and pursuant to General Instruction I.B.6 of Form S-3, which, subject
        to certain exceptions, limits the amount of securities the Company is able to offer and sell under such registration statement to one-third
        of our unaffiliated public float. During the year ended December 31, 2022, the Company issued <ix:nonFraction id="Fxbrl_20230504064138848" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">130,505</ix:nonFraction>
        ADSs at an average price of $<ix:nonFraction id="Fxbrl_20230504064151056" name="us-gaap:SaleOfStockPricePerShare" contextRef="C_20221231_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" unitRef="USD_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.11</ix:nonFraction>
        per ADS under the ATM Agreement, resulting in gross proceeds of $<ix:nonFraction id="Fxbrl_20230504064202553" name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">275</ix:nonFraction>
        thousand.</p>
        <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">On March 22, 2023 the Company filed
        with the SEC an amendment to registration statement on form S-1/A for the issuance and sale of up to&#160; $<ix:nonFraction id="Fxbrl_20230504064230261" name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="C_20230301to20230322_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember" unitRef="USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">10</ix:nonFraction>
        million of its ADSs.</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><br />On March 27, 2020 and December
        27, 2020, the President of the United States signed and enacted into law the Coronavirus Aid, Relief, and Economic Security Act (CARES
        Act) and the Consolidated Appropriations Act, 2021 (CAA). Among other provisions, the CARES Act and the CAA provide relief to U.S. federal
        corporate taxpayers through temporary adjustments to net operating loss rules, changes to limitations on interest expense deductibility,
        and the acceleration of available refunds for minimum tax credit carryforwards. The CARES Act also includes provisions for a carryback
        of any net operating loss (NOL) arising in a taxable year beginning after December 31, 2017, and before January 1, 2021, to each of the
        five taxable years preceding the taxable year in which the loss arises (carryback period).</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">Chemomab Therapeutics Inc., a wholly
        owned subsidiary of the Company, filed an application with the US Internal Revenue Service to carryback net operating losses. The Company
        received $<ix:nonFraction id="Fxbrl_20230504064257425" name="cmmb:CarrybackNetOperatingLosses" contextRef="C_20220101to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">351</ix:nonFraction>
        thousand in 2022 and $<ix:nonFraction id="Fxbrl_20230504064307409" name="cmmb:CarrybackNetOperatingLosses" contextRef="C_20230101to20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">187</ix:nonFraction>
        thousand in March 2023.</p> </td> </tr>
  </table> </div> </div> </ix:nonNumeric>

<p style="margin:0pt">&#160;</p>

<p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:5pt;margin-bottom:5px;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">8</span></span></p>

<div style="clear:both"><hr style="page-break-after:always;border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:5pt;margin-bottom:10pt" /></div>

<p style="margin:0px 0pt 0pt;text-align:center">&#160;</p>

<p style="margin:0px 0pt 0pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="text-decoration:underline"><strong>CHEMOMAB
THERAPEUTICS LTD AND ITS SUBSIDIARIES<br />(FORMERLY ANCHIANO THERAPEUTICS LTD)<br />NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL
STATEMENTS</strong></span></span></span></p> </div> </div> </div>

<div>

<div>

<div>

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right">&#160;</p> </div>
</div> </div>

<div> <ix:nonNumeric id="Fxbrl_20220505134338955" name="us-gaap:SignificantAccountingPoliciesTextBlock" contextRef="C_20230101to20230331" escape="true">

<div>

<div>

<div>

<div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note
2 - Basis of Presentation and Significant Accounting Policies</span></span></div>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20221108051936803" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" contextRef="C_20230101to20230331" escape="true">

<div>

<div>

<table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">
  <tr style="vertical-align:top">
    <td style="width:36pt">&#160;</td>
    <td style="vertical-align:top;width:36pt">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">A.</span></span></span></div>
        </td>
    <td style="vertical-align:top;width:auto">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Basis
        of Preparation</span></span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:35.45pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The
condensed interim consolidated financial statements included in this quarterly report are unaudited. These financial statements have been
prepared in accordance with U.S. GAAP and applicable rules and regulations of the SEC regarding interim financial reporting and reflect,
in the opinion of management, all adjustments of a normal and recurring nature that are necessary for a fair statement of the Company&#8217;s
financial position as of March 31, 2023, and its results of operations for the three ended March 31, 2023, and 2022, changes in shareholders&#8217;
equity for the three months ended March 31, 2023 and 2022, and cash flows for the three months ended March 31, 2023 and 2022. The results
of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the year ending
December 31, 2023 or for any other future annual or interim period. These financial statements should be read in conjunction with the
audited financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022 and Form
10-Q for the three months ended March 31, 2023 filed with the SEC. The Company&#8217;s significant accounting policies are disclosed in
the audited financial statements for the year ended December 31, 2022 included in the Company&#8217;s Annual Report on Form 10-K. Since
the date of such financial statements, there have been no changes to the Company&#8217;s significant accounting policies.</span></span></span></div>
</div> </ix:nonNumeric>

<div style="line-height:1.25">&#160;</div> <ix:nonNumeric id="Fxbrl_20221108051959534" name="us-gaap:UseOfEstimates" contextRef="C_20230101to20230331" escape="true">

<div>

<div>

<table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">
  <tr style="vertical-align:top">
    <td style="width:36pt">&#160;</td>
    <td style="vertical-align:top;width:36pt">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">B.</span></span></span></div>
        </td>
    <td style="vertical-align:top;width:auto">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Use
        of estimates</span></span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:-0.55pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and
liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual
results could differ materially from those estimates.</span></span></div> </div> </ix:nonNumeric> </div> </div> </div> </ix:nonNumeric>
</div>

<div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">

<p style="margin:0pt">&#160;</p> </div> <ix:nonNumeric id="Fxbrl_20220728222325384" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextRef="C_20230101to20230331" escape="true">

<div>

<div>

<div>

<div>

<div>

<div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note
3 - Contingencies</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-family:Times New Roman, Times, serif;font-size:10pt">During 2022, the
Israeli tax authority ("ITA&#8221;) notified the Company that it had initiated a routine VAT audit to include tax years 2017 through 2020.
The ITA raised several claims, mainly in respect with the recoverability of VAT with respect to Merger Agreement related expenses and
the classification of the Company as a holding company. On July 2022, the ITA proposed a settlement, which the Company rejected. As a
result, the ITA issued an assessment. The Company plans to appeal the ITA&#8217;s assessment. The Company has recorded a provision in
2022 which is inherently subjective due to the inherent uncertainty of these matters and the judicial process. Therefore, the outcome
may differ from the estimated liability recorded by the Company during the period.</span></div> </div> </div> </div> </div> </div> </ix:nonNumeric>

<div style="text-align:center"><br /><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal;color:rgb(0, 0, 0)">9</span></span></span></div>

<div style="clear:both;margin-top:0pt;margin-bottom:10pt"> <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;margin-bottom:10pt;page-break-after:always" />
</div>

<div>

<div style="line-height:1.25">

<div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</div>

<div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Item
2.<span id="Item2_integixAnchor"></span> MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </span></span></span></span></div>

<div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</div></div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-style:italic">You
should read the following discussion and analysis of our financial condition and results of operations together with our condensed consolidated
financial statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q, as well as our audited consolidated
financial statements and related notes for the year ended December 31, 2022, as filed in our Annual Report on Form 10-K for the year ended
December 31, 2022 (the &#8220;2022 Annual Report&#8221;). Some of the information contained in this discussion and analysis, particularly
with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks
and uncertainties. You should read &#8220;Risk Factors&#8221; in Item 1A of our 2022 Annual Report for a discussion of important factors
that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained
in the following discussion and analysis.</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Overview</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>We
are a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory
diseases with high unmet needs. Based on the unique and pivotal role of the soluble protein CCL24 in promoting fibrosis and inflammation,
We developed CM-101, a monoclonal antibody designed to bind and block CCL24 activity. We believe CM-101 has demonstrated the potential
to treat multiple severe and life-threatening fibrotic and inflammatory diseases.</span></span></span></span></div></div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>We
have pioneered the therapeutic targeting of CCL24, a chemokine that promotes various types of cellular processes that regulate inflammatory
and fibrotic activities through the CCR3 receptor. CCL24 is expressed in various types of cells, including immune cells, endothelial cells
and epithelial cells. We have developed a novel CCL24-inhibiting product candidate with dual anti-fibrotic and anti-inflammatory activity
that modulates the complex interplay of both of these inflammatory and fibrotic mechanisms, which drives abnormal states of fibrosis and
clinical fibrotic diseases. This innovative approach is being developed for difficult-to-treat rare diseases, also known as orphan indications
or diseases, such as primary sclerosing cholangitis, or PSC, and systemic sclerosis, or SSc, for which patients have no established disease
modifying standard of care treatment options. We estimate that there are approximately 77 thousand patients suffering from PSC in the
U.S., EU and Japan, representing an estimated $1 billion market opportunity, and approximately 170 thousand patients suffering from SSc
in those same markets, representing an estimated $1.5 billion market opportunity.</span></span></span></span></div></div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>CM-101,
our lead clinical product candidate, is a first-in-class humanized monoclonal antibody that attenuates the basic function of CCL24, also
known as eotaxin-2, as a regulator of major inflammatory and fibrotic pathways. We have demonstrated that CM-101 interferes with the underlying
biology of inflammation and fibrosis through a novel and differentiated mechanism of action. Based on these findings, we are actively
advancing CM-101 in Phase 2 clinical studies directed toward two distinct clinical indications that include patients with liver or skin,
and/or lung fibrosis. We are currently conducting a Phase 2 clinical study in PSC, a rare obstructive and cholestatic liver disease. The
study is actively recruiting patients in the U.S., Europe and Israel and includes two dose arms (10 and 20mg/kg) as well as an open label
extension.</span></span></span></span></div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-weight:normal;font-style:normal">10</span></span></span></span></span></div>

<div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></div>

<div style="line-height:1.25">

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>We
are also planning to open a Phase 2 clinical trial in SSc about midyear 2023. The trial in SSc, a rare autoimmune rheumatic disease characterized
by fibrosis in the skin and lung and other organs, will focus on establishing biological and clinical proof of concept in this patient
population. Although our primary focus is on these two rare indications, as we noted, an additional Phase 2 clinical study in patients
with liver fibrosis due to non-alcoholic steatohepatitis, or NASH was completed late last year. &#160;This trial provided safety and pharmacokinetic
(PK) data on CM-101 in this patient population and was informative for determining whether the company advances the development of its
current subcutaneous formulation of CM-101. Additionally, the trial measured a number of biomarkers that may be relevant to the potential
activity of CM-101 in NASH and in other fibro-inflammatory conditions. We reported results from this trial in January 2023 that showed
that the trial met its primary endpoint of safety and tolerability, and that CM-101 demonstrated encouraging activity in secondary endpoints
that include a range of liver fibrosis biomarkers and physiologic assessments.</span></span></span></span></span></span></div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div></div>

<div style="line-height:1.25">

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fibrosis
is the abnormal and excessive accumulation of collagen and extracellular matrix, the non-cellular component in all tissues and organs,
which provides structural and biochemical support to surrounding cells. When present in excessive amounts, collagen and extracellular
matrix lead to scarring and thickening of connective tissues, affecting tissue properties and potentially leading to organ dysfunction
and failure. Fibrosis can occur in many different tissues, including lung, liver, kidney, muscle, skin, and the gastrointestinal tract,
resulting in a wide array of progressive fibrotic conditions. Fibrosis and inflammation are intrinsically linked. While a healthy inflammatory
response is necessary for efficient tissue repair; after disease or injury, an excessive, uncontrolled inflammatory response can lead
to tissue fibrosis that in turn can further stimulate inflammatory processes in a fibro-inflammatory vicious cycle.</span></span></span></span></div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div></div>

<div style="text-align:justify;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Recent
Developments</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0);font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>FDA
Clearance of our IND Application to Study CM-101 in a Phase 2 Trial in SSc Patients</span></span></span></span></div></div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On
February 21, 2023, we reported U.S. Food and Drug Administration (FDA) clearance of our Investigational New Drug (IND) Application to
evaluate CM-101 in a Phase 2 trial in adults with systemic sclerosis (SSc). The Phase 2 ABATE trial is a multicenter, randomized, double-blind,
proof-of-biology study to evaluate the sAfety, toleraBility, and Activity of CM-101 in patients with sysTEmic sclerosis. It expects to
enroll 45 patients with clinically active dermatologic, vascular or pulmonary SSc. The study population is expected to be roughly split
between patients with diffuse SSc and patients with limited SSc. The primary outcome measure is safety. Secondary endpoints include multiple
serum-based biological markers and a variety of exploratory biological and clinical outcomes, including the American College of Rheumatology
Composite Response Index in Systemic Sclerosis (ACR-CRISS) score and its revisions (rCRISS). The trial includes a 24-week double blind
period during which active treatment patients will receive 10 mg/kg of CM-101 by intravenous infusion every three weeks, followed by a
24-week open label extension, where all patients will receive a 10 mg/kg dose. The trial includes multiple clinical assessments of the
skin, vasculature and pulmonary function. It is expected to generate additional information about disease mechanisms, provide data relevant
to future patient stratification strategies and inform the selection of appropriate endpoints for future studies. The trial is expected
to begin enrolling patients around midyear 2023. A data read-out is targeted for the second half of 2024.</span></span></span></span></div></div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0);font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Report
Topline Results from CM-101 Phase 2a Liver Fibrosis Biomarker Trial in NASH Patients</span></span></span></span></div></div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On
January 3, 2023, we reported positive topline results from our Phase 2a liver fibrosis biomarker trial of CM-101 in NASH patients. This
trial was primarily designed to assess a subcutaneous formulation of CM-101 and to evaluate the drug&#8217;s impact on liver fibrosis
biomarkers relevant to both NASH and the fibro-inflammatory conditions that represent the focus for the company, such as PSC and SSc.
The trial met its primary endpoint of safety and tolerability, and CM-101 demonstrated encouraging activity in secondary endpoints that
include a range of liver fibrosis biomarkers and physiologic assessments measured at baseline and at week 20.</span></span></span></span></div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-weight:normal;font-style:normal">11</span></span></span></span></span></div>

<div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
randomized, placebo-controlled trial enrolled 23 NASH patients with stage F1c, F2 and F3 disease who were randomized to receive either
CM-101 or placebo. Patients received a dose of 5 mg/kg of study drug administered by subcutaneous (SC) injection once every two weeks,
for a treatment period of 16 weeks. Key findings of the CM-101 Phase 2a trial included the following.</span></span></span></span></div></div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:5%;vertical-align:middle;font-family:'Times New Roman',Times,serif">&#160;</td>
    <td style="width:3%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#8226;</span></span></span></span></div></td>
    <td style="width:92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>CM-101
        appeared to be safe when administered subcutaneously. Most reported adverse events observed were mild, with one unrelated serious adverse
        event reported. No significant injection site reactions were reported and no anti-drug antibodies were detected.</span></span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:5%;vertical-align:middle;font-family:'Times New Roman',Times,serif">&#160;</td>
    <td style="width:3%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#8226;</span></span></span></span></div></td>
    <td style="width:92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>CM-101
        administered subcutaneously demonstrated favorable pharmacokinetics and target engagement profiles as expected, and were similar to what
        the company has previously reported.</span></span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:5%;vertical-align:middle;font-family:'Times New Roman',Times,serif">&#160;</td>
    <td style="width:3%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#8226;</span></span></span></span></div></td>
    <td style="width:92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>CM-101-treated
        patients showed greater improvements than the placebo group in a number of liver fibrosis-related biomarkers, including ProC-3, ProC-4,
        ProC-18, TIMP-1 and ELF.</span></span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:5%;vertical-align:middle;font-family:'Times New Roman',Times,serif">&#160;</td>
    <td style="width:3%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#8226;</span></span></span></span></div></td>
    <td style="width:92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A
        majority of CM-101-treated patients showed improvements in multiple liver fibrosis-related biomarkers&#8212;almost 60% of CM-101 patients
        were &#8220;multiple responders&#8221;, responding in at least three biomarkers at week 20, compared to no patients in the placebo group.</span></span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25">

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div></div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:5%;vertical-align:middle;font-family:'Times New Roman',Times,serif">&#160;</td>
    <td style="width:3%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#8226;</span></span></span></span></div></td>
    <td style="width:92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>CM-101-treated
        patients with higher CCL24 levels at baseline showed greater reductions in fibrosis-related biomarkers than patients with lower levels
        of CCL24 at baseline. More CM-101-treated patients with higher CCL24 levels also were &#8220;multiple responders&#8221;, responding in
        three or more of the fibrosis-related biomarkers, compared to patients with lower CCL24 levels at baseline. These findings further add
        to the growing body of evidence validating the role of CCL24 in the pathophysiology of fibrotic liver disease.</span></span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25">

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div></div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:5%;vertical-align:middle;font-family:'Times New Roman',Times,serif">&#160;</td>
    <td style="width:3%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#8226;</span></span></span></span></div></td>
    <td style="width:92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>A
        higher proportion of patients in the CM-101-treated group showed improvement in a physiologic measure of liver stiffness as compared to
        placebo (reduction of at least one grade of fibrosis score as assessed by the non-invasive elastography method known as FibroScan<sup style="vertical-align:text-top;line-height:1;font-size:smaller">&#174;</sup>).</span></span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25">

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div></div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:5%;vertical-align:middle;font-family:'Times New Roman',Times,serif">&#160;</td>
    <td style="width:3%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#8226;</span></span></span></span></div></td>
    <td style="width:92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>After
        completion of the study, the unblinded data showed that patients in the CM-101-treated group had higher baseline levels of fibrosis compared
        to placebo patients. The impact of this difference on the results, if any, is unknown.</span></span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25">

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div></div>

<div style="line-height:1.25">

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>We
believe that the data from this trial provide important insights in support of the CM-101 development program, including the favorable
safety and tolerability of CM-101 in patients with serious liver disease, confirmation of early signs of biomarker activity that are relevant
for a number of fibro-inflammatory disorders, and support for the tolerability and pharmacokinetic data needed to assess next steps in
the development of our SC formulation<span style="font-style:italic">.</span></span></span></span></span></div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:#000000;font-weight:normal;font-style:normal">12</span></span></span></span></span></div>

<div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div></div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Corporate
Information</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>We
were incorporated on September 22, 2011, under the laws of the State of Israel. In March 2021, in connection with the Merger, we changed
our name from Anchiano Therapeutics Ltd. to Chemomab Therapeutics Ltd. Our principal executive offices are located at Kiryat Atidim, Building
7, Tel Aviv, Israel 6158002, and our phone number is +972-77-331-0156. Our website is: www.chemomab.com. The information contained on,
or that can be accessed through, our website is not incorporated by reference into this Quarterly Report on Form 10-Q. We have included
our website address as an inactive textual reference only. &#160;</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Components
of Operating Results</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold;font-style:italic">References
to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and &#8220;Chemomab&#8221; in this &#8220;Components of Operating Results&#8221;
and in the &#8220;Results of Operations&#8221; below refer to the Company after the Merger, and, with respect to historical periods preceding
the Merger, refer to Chemomab Ltd., whose business became the business of the Company upon consummation of the Merger.</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold;font-style:italic">Revenues</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>To
date, we have not generated any revenue. We do not expect to generate revenue unless and until we obtain regulatory approval and commercialize
a product candidate, or until we receive revenue from a collaboration such as a co-development or out-licensing agreement. There can be
no assurance that we will receive such regulatory approvals, and if any product candidate is approved, that we will be successful in commercializing
it.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold;font-style:italic">Research
and Development Expenses</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Research
and development expenses consist primarily of costs incurred in connection with the development of our product candidates. These expenses
include:</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:5%;vertical-align:middle;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:3%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#8226;</span></span></span></span></div></td>
    <td style="width:92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>expenses
        incurred under agreements with contract research organizations or contract manufacturing organizations, as well as investigative sites
        and consultants that conduct our clinical trials, preclinical studies and other scientific development services;</span></span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:5%;vertical-align:middle;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:3%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#8226;</span></span></span></span></div></td>
    <td style="width:92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>manufacturing
        scale-up expenses and the cost of acquiring and manufacturing preclinical and clinical trial materials;</span></span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:5%;vertical-align:middle;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:3%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#8226;</span></span></span></span></div></td>
    <td style="width:92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>employee-related
        expenses, including salaries, related benefits, travel and share-based compensation expenses for employees engaged in research and development
        functions, as well as external costs, such as fees paid to outside consultants engaged in such activities;</span></span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:5%;vertical-align:middle;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:3%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#8226;</span></span></span></span></div></td>
    <td style="width:92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>license
        maintenance fees and milestone fees incurred in connection with various license agreements;</span></span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:5%;vertical-align:middle;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:3%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#8226;</span></span></span></span></div></td>
    <td style="width:92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>costs
        related to compliance with regulatory requirements; and</span></span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:5%;vertical-align:middle;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:3%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>&#8226;</span></span></span></span></div></td>
    <td style="width:92%;vertical-align:top;font-family:'Times New Roman',Times,serif">
        <div style="text-align:justify;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>depreciation
        and other expenses.</span></span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>We
recognize external development costs based on an evaluation of the progress to completion of specific tasks using information provided
to us by our service providers.</span></span></span></span></div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:#000000;font-weight:normal;font-style:normal">13</span></span></span></span></span></div>

<div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>We
do not allocate employee costs or facility expenses, including depreciation or other indirect costs, to specific programs because these
costs are deployed across multiple programs and, as such, are not separately classified. We use our internal resources primarily to oversee
research, as well as for managing our preclinical development, process development, manufacturing and clinical development activities.
Our employees work across multiple programs and, therefore, we do not track costs by program.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Research
and development activities are fundamental to our business. Product candidates in later stages of clinical development generally have
higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage
clinical trials. As a result, we expect that our research and development expenses will increase substantially over the next several quarters
and years as we continue to advance the development of our product candidates. We also expect to incur additional expenses related to
milestone and royalty payments payable to third parties with whom we have entered into license agreements to acquire the rights to its
product candidates.</span></span></span></span></div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold;font-style:italic">General
and Administrative Expenses</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>General
and administrative expenses consist primarily of salaries, related benefits and share-based compensation expenses for personnel in executive
and administrative functions. General and administrative expenses also include professional fees for legal, consulting, accounting and
audit services.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>We
anticipate that our general and administrative expenses will increase in the future as we increase headcount and general activities to
support our continued research activities and development of our product candidates as well as expanding our presence in the United States.
We also anticipate that we will incur increased headcount, accounting, audit, legal, regulatory, compliance, director and officer insurance
costs, as well as investor and public relations expenses associated with being a public company. We expect that the additional costs for
these services will substantially increase our general and administrative expenses. Additionally, if and when we believe that regulatory
approval of a product candidate appears likely, we expect to incur an increase in payroll and related expenses as a result of our preparation
for commercial operations, especially as it relates to the sales and marketing of any product candidate. </span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Results
of Operations</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold;font-style:italic">Three
Months Ended March 31, 2023 Compared to the Three Months Ended March 31, 2022</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Below
is a summary of our results of operations for the periods indicated:</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">
  <tr>
    <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Three
        months ended</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;padding-bottom:2px" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>March
        31,</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Increase/(decrease)</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;padding-bottom:2px" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;border-bottom:2px solid rgb(0, 0, 0);text-align:center;font-weight:bold" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(in
        thousands)</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Operating
        expenses:</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:52%" valign="bottom">
        <div style="text-align:justify;text-indent:10pt;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Research
        and development</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,887</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,745</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,142</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>151</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></div></td></tr>
  <tr>
    <td style="vertical-align:middle;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;width:52%" valign="bottom">
        <div style="text-indent:10pt;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>General
        and administrative</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,162</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,575</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(413</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(16</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)%</span></span></span></span></div></td></tr>
  <tr>
    <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:52%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Operating
        loss</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9,049</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5,320</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,729</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>70</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></div></td></tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;width:52%" valign="bottom">
        <div style="text-indent:10pt;line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financing
        income, net</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(317</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(216</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(101</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>47</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></div></td></tr>
  <tr>
    <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:52%" valign="bottom">
        <div style="text-indent:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Loss
        before taxes</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,732</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5,104</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,628</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>71</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></div></td></tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;width:52%;padding-bottom:2px" valign="bottom">
        <div style="text-indent:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Taxes
        on income</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>21</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>21</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>100</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></div></td></tr>
  <tr>
    <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:52%;padding-bottom:4px" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Net
        loss</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,753</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5,104</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,649</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>71</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Our
results of operations have varied in the past and can be expected to vary in the future due to numerous factors. We believe that period-to-period
comparisons of our operating results are not necessarily meaningful and should not be relied upon as indications of future performance.</span></span></span></span></div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:#000000;font-weight:normal;font-style:normal">14</span></span></span></span></span></div>

<div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-style:italic">Research
and development expenses</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Research
and development expenses increased by approximately $4.1 million, or 151%, for the three months ended March 31, 2023, as compared to the
same period of 2022. The increase was primarily due to increased clinical and preclinical activities.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-style:italic">General
and administrative expenses</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>General
and administrative expenses decreased by approximately $0.4 million, or 16%, for the three months ended March 31, 2023, as compared to
the same period of 2022. The decrease was primarily due to a decrease in non-cash share-based expenses and decrease in insurance expenses.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-style:italic">Financing
income, net&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Financing
income, net for the three months ended March 31, 2023 was $317 thousand. Financing income, net for the three months ended March 31, 2022
was $216 thousand. This reflects an increase in finance income, net of $101 thousand, or 47%, for the three months ended March 31, 2023
from the comparable period of 2022. The increase was primarily related to interest earned on bank deposits and to foreign currency exchange
rate gains.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Liquidity
and Capital Resources</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Since
inception, we have not generated any revenue and have incurred significant operating losses and negative cash flows from our operations,
resulting in an accumulated deficit at March 31, 2023 of $73.0 million. We have funded our operations to date primarily with proceeds
from the sale of our ADSs, and, prior to the Merger, other equity securities. Cash in excess of immediate requirements is invested primarily
in bank deposits with a view to liquidity and capital preservation.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On
April 30, 2021,&#160;</span></span></span></span><span style="font-size:10pt;text-indent:36pt">the Company entered into an At the Market
Offering Agreement (the "ATM Agreement") with Cantor Fitzgerald &#38; Co., ("Cantor"). Pursuant to the ATM Agreement, the Company may
offer and sell, from time to time, its ADSs having an aggregate offering price of up to $75 million through Cantor or the ATM Agreement.
From April 30, 2021, through December 31, 2022 the Company issued 699,806 ADSs at an average price of $22.75 per ADS under the ATM Agreement,
resulting in gross proceeds of $15,917 thousand.</span>

<p style="margin:0pt">&#160;</p>

<p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On
April 25, 2022, the Company filed a prospectus supplement with the SEC for the issuance and sale of up to $18,125,000 of its ADSs in connection
with the reactivation of the ATM Facility and pursuant to General Instruction I.B.6 of Form S-3, which, subject to certain exceptions,
limits the amount of securities the Company is able to offer and sell under such registration statement to one-third of our unaffiliated
public float. During the year ended December 31, 2022, the Company issued 130,505 ADSs at an average price of $2.11 per ADS under the
ATM Agreement, resulting in gross proceeds of $275 thousand.</span></span></p></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Developing
product candidates, conducting clinical trials and commercializing products are expensive, and we will need to raise substantial additional
funds to achieve our strategic objectives. We believe that our existing cash resources, including from the ADSs sold pursuant to the Sales
Agreement, will be sufficient to fund our projected cash requirements through June 30, 2024. Nevertheless, we will require significant
additional financing in the future to fund our operations, including if and when we progress into additional clinical trials, obtain regulatory
approval for any of our product candidates and commercialize the same. We believe that we will need to raise significant additional funds
before we have any cash flow from operations, if at all. Our future capital requirements will depend on many factors, including:</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;line-height:1.25;color:rgb(33, 37, 41);font-family:Times New Roman, Times, serif">

<table border="0" cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%">
  <tr>
    <td style="font-size:10pt;vertical-align:top;width:40pt">&#160;</td>
    <td style="font-size:10pt;vertical-align:top;width:30pt">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></p></td>
    <td style="font-size:10pt;width:auto"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>the progress
        and costs of our preclinical studies, clinical trials and other research and development activities;</span></span></span></td></tr>
  <tr>
    <td style="width:40pt">&#160;</td>
    <td style="width:30pt">&#160;</td>
    <td style="width:auto">&#160;</td></tr>
  <tr>
    <td style="font-size:10pt;vertical-align:top;width:40pt">&#160;</td>
    <td style="font-size:10pt;vertical-align:top;width:30pt">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></p></td>
    <td style="font-size:10pt;width:auto"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>the scope,
        prioritization and number of our clinical trials and other research and development programs;</span></span></span></td></tr>
  <tr>
    <td style="width:40pt">&#160;</td>
    <td style="width:30pt">&#160;</td>
    <td style="width:auto">&#160;</td></tr>
  <tr>
    <td style="font-size:10pt;vertical-align:top;width:40pt">&#160;</td>
    <td style="font-size:10pt;vertical-align:top;width:30pt">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></p></td>
    <td style="font-size:10pt;width:auto"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>the amount
        of revenues and contributions we receive under future licensing, development and commercialization arrangements with respect to our product
        candidates;</span></span></span></td></tr>
  <tr>
    <td style="width:40pt">&#160;</td>
    <td style="width:30pt">&#160;</td>
    <td style="width:auto">&#160;</td></tr>
  <tr>
    <td style="font-size:10pt;vertical-align:top;width:40pt">&#160;</td>
    <td style="font-size:10pt;vertical-align:top;width:30pt">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></p></td>
    <td style="font-size:10pt;width:auto"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>the costs of
        the development and expansion of our operational infrastructure;</span></span></span></td></tr>
  <tr>
    <td style="width:40pt">&#160;</td>
    <td style="width:30pt">&#160;</td>
    <td style="width:auto">&#160;</td></tr>
  <tr>
    <td style="font-size:10pt;vertical-align:top;width:40pt">&#160;</td>
    <td style="font-size:10pt;vertical-align:top;width:30pt">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></p></td>
    <td style="font-size:10pt;width:auto"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>the costs and
        timing of obtaining regulatory approval for our product candidates;</span></span></span></td></tr>
  </table></div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:#000000;font-weight:normal;font-style:normal">15</span></span></span></span></span></div>

<div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;line-height:1.25;color:rgb(33, 37, 41);font-family:Times New Roman, Times, serif">

<table border="0" cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%">
  <tr>
    <td style="font-size:10pt;vertical-align:top;width:40pt">&#160;</td>
    <td style="font-size:10pt;vertical-align:top;width:30pt">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></p></td>
    <td style="font-size:10pt;width:auto"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>the costs of
        filing, prosecuting, enforcing and defending patent claims and other intellectual property rights;</span></span></span></td></tr>
  <tr>
    <td style="width:40pt">&#160;</td>
    <td style="width:30pt">&#160;</td>
    <td style="width:auto">&#160;</td></tr>
  <tr>
    <td style="font-size:10pt;vertical-align:top;width:40pt">&#160;</td>
    <td style="font-size:10pt;vertical-align:top;width:30pt">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></p></td>
    <td style="font-size:10pt;width:auto"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>the costs and
        timing of securing manufacturing arrangements for clinical or commercial production;</span></span></span></td></tr>
  <tr>
    <td style="width:40pt">&#160;</td>
    <td style="width:30pt">&#160;</td>
    <td style="width:auto">&#160;</td></tr>
  <tr>
    <td style="font-size:10pt;vertical-align:top;width:40pt">&#160;</td>
    <td style="font-size:10pt;vertical-align:top;width:30pt">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></p></td>
    <td style="font-size:10pt;width:auto"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>the costs of
        contracting with third parties to provide sales and marketing capabilities for us;</span></span></span></td></tr>
  <tr>
    <td style="width:40pt">&#160;</td>
    <td style="width:30pt">&#160;</td>
    <td style="width:auto">&#160;</td></tr>
  <tr>
    <td style="font-size:10pt;vertical-align:top;width:40pt">&#160;</td>
    <td style="font-size:10pt;vertical-align:top;width:30pt">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></p></td>
    <td style="font-size:10pt;width:auto"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>the costs of
        acquiring or undertaking development and commercialization efforts for any future products, product candidates or platforms;</span></span></span></td></tr>
  <tr>
    <td style="width:40pt">&#160;</td>
    <td style="width:30pt">&#160;</td>
    <td style="width:auto">&#160;</td></tr>
  <tr>
    <td style="font-size:10pt;vertical-align:top;width:40pt">&#160;</td>
    <td style="font-size:10pt;vertical-align:top;width:30pt">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></p></td>
    <td style="font-size:10pt;width:auto"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>the magnitude
        of our general and administrative expenses; and</span></span></span></td></tr>
  <tr>
    <td style="width:40pt">&#160;</td>
    <td style="width:30pt">&#160;</td>
    <td style="width:auto">&#160;</td></tr>
  <tr>
    <td style="font-size:10pt;vertical-align:top;width:40pt">&#160;</td>
    <td style="font-size:10pt;vertical-align:top;width:30pt">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></p></td>
    <td style="font-size:10pt;width:auto"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>any cost that
        we may incur under future in- and out-licensing arrangements relating to our product candidates.</span></span></span></td></tr>
  </table></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>We
currently do not have any commitments for future external funding. In the future, we will need to raise additional funds, and we may decide
to raise additional funds even before we need such funds if the conditions for raising capital are feasible. Until we can generate significant
recurring revenues, we expect to satisfy our future cash needs through debt or equity financings, credit facilities or by out-licensing
applications of our product candidates. The sale of equity or convertible debt securities may result in dilution to our existing shareholders.
The incurrence of indebtedness would result in increased fixed obligations and could also subject us to covenants that restrict our operations.
We cannot be certain that additional funding, whether through grants from the Israel Innovation Authority, financings, credit facilities
or out-licensing arrangements, will be available to us on acceptable terms, if at all. If sufficient funds are not available, we may be
required to delay, reduce the scope of or eliminate research or development plans for, or commercialization efforts with respect to, one
or more applications of our product candidates, or obtain funds through arrangements with collaborators or others that may require us
to relinquish rights to certain potential products that we might otherwise seek to develop or commercialize independently.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold;font-style:italic">Cash
Flows</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
table below shows a summary of our cash flow activities for the periods indicated:</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">
  <tr>
    <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Three
        months ended</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;padding-bottom:2px" valign="bottom">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>March
        31,</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Change</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;padding-bottom:2px" valign="bottom">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2023</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2022</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;border-bottom:2px solid rgb(0, 0, 0);text-align:center;font-weight:bold" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;text-align:right;vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="2" rowspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">
        <div style="text-align:center;line-height:1.25;color:rgb(0, 0, 0);font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(in
        thousands)</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;text-align:right;vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;width:52%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Net
        cash used in operating activities</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(7,186</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(3,711</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(3,475</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(94</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)%</span></span></span></span></div></td></tr>
  <tr>
    <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:52%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Net
        cash provided by investing activities</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,432</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,382</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>12,050</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>506</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></div></td></tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;width:52%;padding-bottom:2px" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Net
        cash used in financing activities</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>%</span></span></span></span></div></td></tr>
  <tr>
    <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:52%;padding-bottom:4px" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Net
        increase (decrease) in cash, cash equivalents and restricted cash</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>7,246</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(1,329</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>8,575</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(645</span></span></span></span></div></td>
    <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)%</span></span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-style:italic">Operating
activities</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Net
cash used in operating activities increased by $3.5 million, or 94%, for the three months ended March 31, 2023, compared to the same period
of 2022. The increase is primarily related to the increase in net loss of $3.6 million.</span></span></span></span></div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:#000000;font-weight:normal;font-style:normal">16</span></span></span></span></span></div>

<div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-style:italic">Investing
activities</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Net
cash provided in investing activities for the three months ended March 31, 2023 increased by approximately $12 million, as compared to
the same period of 2022. The increase is primarily related to withdrawal of bank deposits.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Contractual
Commitments</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
Company&#8217;s contractual commitments are as follows at March 31, 2023 (in thousands):</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Remainder
        of 2023</span></span></span></span></div></td>
    <td colspan="1" style="font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div></td>
    <td colspan="1" style="font-family:Times New Roman, Times, serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,361</span></span></span></span></div></td>
    <td colspan="1" style="font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td></tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:88%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2024</span></span></span></span></div></td>
    <td colspan="1" style="font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:Times New Roman, Times, serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,676</span></span></span></span></div></td>
    <td colspan="1" style="font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2025</span></span></span></span></div></td>
    <td colspan="1" style="font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:Times New Roman, Times, serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,060</span></span></span></span></div></td>
    <td colspan="1" style="font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td></tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:88%;padding-bottom:4px;background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total</span></span></span></span></div></td>
    <td colspan="1" style="font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>$</span></span></span></span></div></td>
    <td colspan="1" style="font-family:Times New Roman, Times, serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(255, 255, 255)" valign="bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>9,097</span></span></span></span></div></td>
    <td colspan="1" style="font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td></tr>
  </table>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Critical
Accounting Estimates</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The
Company&#8217;s financial statements are prepared in accordance with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;).
The preparation of the Company&#8217;s financial statements and related disclosures in accordance with GAAP requires it to make estimates
and judgments that affect the reported amounts of assets, liabilities, revenue, costs and expenses, and the disclosure of contingent assets
and liabilities in the Company&#8217;s financial statements. The Company bases its estimates on historical experience, known trends and
events and various other factors that it believes are reasonable under the circumstances, the results of which form the basis for making
judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company evaluates
its estimates and assumptions on an ongoing basis. The Company&#8217;s actual results may differ from these estimates under different
assumptions or conditions.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>While
the Company&#8217;s significant accounting policies are described in more detail in Note 2 to the Company&#8217;s consolidated financial
statements included in our 2022 Annual Report, the Company believes that the following accounting estimates are those that include a higher
degree of judgment or complexity and are reasonably likely to have a material impact on our financial condition or results of operations
and are therefore considered critical accounting estimates.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Share-Based
Compensation</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>We
apply Accounting Standard Codification (ASC) 718-10, &#8220;Share-Based Payment,&#8221; which requires the measurement and recognition
of compensation expenses for all share-based payment awards made to employees and directors, including employee options under the Company&#8217;s
option plans based on estimated fair values.</span></span></span></span></div>

<div style="text-align:justify;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>ASC
718-10 requires that we estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The
fair value of the award is recognized as an expense over the requisite service periods in the Company&#8217;s statements of comprehensive
loss. The Company recognizes share-based award forfeitures as they occur, rather than estimate by applying a forfeiture rate.</span></span></span></span></div>

<div style="text-align:justify;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>In
June 2018, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2018-07,
&#8220;Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting&#8221;, which simplifies
the accounting for nonemployee share-based payment transactions by aligning the measurement and classification guidance, with certain
exceptions, to that for share-based payment awards to employees. The amendments expand the scope of the accounting standard for share-based
payment awards to include share-based payment awards granted to non-employees in exchange for goods or services used or consumed in an
entity&#8217;s own operations and supersedes the guidance related to equity-based payments to non-employees. We adopted these amendments
on January 1, 2019.</span></span></span></span></div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:#000000;font-weight:normal;font-style:normal">17</span></span></span></span></span></div>

<div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>We
recognize compensation expenses for the fair value of non-employee awards over the requisite service period of each award.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>We
estimate the fair value of options granted as equity awards using a Black-Scholes options pricing model. The option-pricing model requires
a number of assumptions, of which the most significant are share price, expected volatility and the expected option term (the time from
the grant date until the options are exercised or expire). The Company determines the fair value per share of the underlying stock by
taking into consideration its most recent sales of stock, as well as additional factors that the Company deems relevant. The Company&#8217;s
board determined the fair value of ordinary shares based on valuations performed using the Option Pricing Method subject to relevant facts
and circumstances. The Company has historically been a private company and lacks company-specific historical and implied volatility information
of its stock. Expected volatility is estimated based on volatility of similar companies in the biotechnology sector. The Company has historically
not paid dividends and has no foreseeable plans to issue dividends. The risk-free interest rate is based on the yield from governmental
zero-coupon bonds with an equivalent term. The expected option term is calculated for options granted to employees and directors using
the &#8220;simplified&#8221; method. Grants to non-employees are based on the contractual term. Changes in the determination of each of
the inputs can affect the fair value of the options granted and the results of operations of the Company.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Recently-Issued
Accounting Pronouncements</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Certain
recently-issued accounting pronouncements are discussed in Note 2, Summary of Significant Accounting Policies, to the audited consolidated
financial statements in our 2022 Annual Report.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Item
3. <span id="Item3_integixAnchor"></span>Quantitative and Qualitative Disclosures About Market Risk.</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:37.5pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>We
are an emerging growth company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;),
and are not required to provide the information under this item.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Item
4<span id="Item4_integixAnchor"></span>. Controls and Procedures.</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Evaluation
of Disclosure Controls and Procedures</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Disclosure
controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded,
processed, summarized, and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is
accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing
similar functions, as appropriate to allow timely decisions regarding required disclosure.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Under
the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting
officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures, as such term is defined in Rules 13a-15(e)
and 15d-15(e) under the Exchange Act, as of March 31, 2023. Based on such evaluation, our principal executive officer and principal financial
officer have concluded that that our disclosure controls and procedures were effective as of March 31, 2023.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Changes
in Internal Control over Financial Reporting</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>There
have been no changes in our internal control over financial reporting that occurred during the last fiscal quarter that have materially
affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></span></span></span></div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:#000000;font-weight:normal;font-style:normal">18</span></span></span></span></span></div>

<div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:center;line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">PART
II<span id="PARTII_integixAnchor"></span>. &#8211; OTHER INFORMATION</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span id="Item1LegalProceedings_integixAnchor"><span><span><span style="font-weight:bold">Item
1.</span><span>&#160;<span style="font-weight:bold">Legal Proceedings</span>&#160;</span></span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>From
time to time, we may become involved in legal proceedings relating to claims arising from the ordinary course of business. Our management
believes that there are currently no claims or actions pending against us, the ultimate disposition of which could have a material adverse
effect on our results of operations, financial condition or cash flows.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Item
1A.</span><span>&#160;<span style="font-weight:bold"><span id="Item1A_integixAnchor"></span>Risk Factors</span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>There
have been no material changes from the information set forth in &#8220;Item 1A. Risk Factors&#8221; in our 2022&#160;Annual Report.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Item
2. <span id="Item22_integixAnchor"></span>Unregistered Sales of Equity Securities and Use of Proceeds.</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>None.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Item
3.</span><span>&#160;<span id="tem3_integixAnchor"></span><span style="font-weight:bold">Defaults Upon Senior Securities.</span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Not
applicable.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Item
4.</span><span><span id="Item4._integixAnchor"></span>&#160;<span style="font-weight:bold">Mine Safety Disclosures.</span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Not
applicable.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Item
5<span id="Item5_integixAnchor"></span>.</span><span>&#160;<span style="font-weight:bold">Other Information.</span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>None.</span></span></span></span></div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:#000000;font-weight:normal;font-style:normal">19</span></span></span></span></span></div>

<div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div>

<div style="text-indent:36pt;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Item
6<span id="Item6_integixAnchor"></span>.</span><span>&#160;<span style="font-weight:bold">Exhibits.</span></span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(a)
The following documents are filed as exhibits to this Quarterly Report or incorporated by reference herein.</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:10%;vertical-align:bottom;border-bottom:#000000 2px solid">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Exhibit</span></span></span></span></div>
        <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Number</span><span>&#160;</span></span></span></span></span></div></td>
    <td style="width:1%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:89%;vertical-align:bottom;border-bottom:#000000 2px solid">
        <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Description</span><span>&#160;</span></span></span></span></span></div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 255);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="exhibit_31-1.htm">31.1*</a></span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 255);font-family:'Times New Roman',Times,serif">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">&#160;</td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 255);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="exhibit_31-1.htm">Certification
        of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act</a></span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 255);font-family:'Times New Roman',Times,serif">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 255);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="exhibit_31-2.htm">31.2*</a></span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 255);font-family:'Times New Roman',Times,serif">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">&#160;</td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 255);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="exhibit_31-2.htm">Certification
        of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act</a></span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 255);font-family:'Times New Roman',Times,serif">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:top">
        <div style="line-height:1.25;color:rgb(0, 0, 255);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="exhibit_32-1.htm">32.1**</a></span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 255);font-family:'Times New Roman',Times,serif">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">&#160;</td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 255);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="exhibit_32-1.htm">Certification
        of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 255);font-family:'Times New Roman',Times,serif">&#160;</div></td></tr>
  <tr>
    <td rowspan="1" style="width:10%;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="exhibit_32-2.htm">32.2**</a></span></span></span></span></td>
    <td rowspan="1" style="width:1%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">&#160;</td>
    <td rowspan="1" style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 255);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="exhibit_32-2.htm">Certification
        of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></span></span></span></div></td></tr>
  <tr>
    <td rowspan="1" style="width:10%;vertical-align:bottom">&#160;</td>
    <td rowspan="1" style="width:1%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">&#160;</td>
    <td rowspan="1" style="width:89%;vertical-align:bottom">&#160;</td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>101.
        INS</span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Inline
        XBRL Instance Document</span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>101.
        SCH</span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Inline
        XBRL Taxonomy Extension Schema Document</span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>101.
        CAL</span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Inline
        XBRL Taxonomy Extension Calculation Linkbase Document</span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>101.
        DEF</span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Inline
        XBRL Taxonomy Extension Definition Linkbase Document</span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>101.
        LAB</span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Inline
        XBRL Taxonomy Extension Label Linkbase Document</span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>101.
        PRE</span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Inline
        XBRL Taxonomy Extension Presentation Linkbase Document</span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>104</span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cover
        Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>*</span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Filed
        herewith.</span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>**</span></span></span></span></div></td>
    <td style="width:1%;vertical-align:bottom;font-family:'Times New Roman',Times,serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Furnished
        herewith.</span></span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:#000000;font-weight:normal;font-style:normal">20</span></span></span></span></span></div>

<div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div>

<div style="text-align:center;line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span id="SIGNATURES_integixAnchor"></span>SIGNATURES</span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<div style="text-align:justify;line-height:1.25;color:#212529;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.</span><span>&#160;</span></span></span></span></span></div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:'Times New Roman',Times,serif">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%">
  <tr>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td colspan="2" style="vertical-align:bottom">
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>CHEMOMAB
        THERAPEUTICS LTD.</span></span></span></span></div>
        <div style="line-height:1.25;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif">&#160;</div></td>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td></tr>
  <tr>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:50%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Date:
        May 11, 2023</span></span></span></span></div></td>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:4%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>By:</span></span></span></span></div></td>
    <td style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);width:35%">
        <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-style:italic">/s/
        Dale Pfost</span><span>&#160;</span></span></span></span></span></div></td>
    <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:11%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td></tr>
  <tr>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:50%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:4%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Name:</span></span></span></span></div></td>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:35%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Dale
        Pfost</span></span></span></span></div></td>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:11%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td></tr>
  <tr>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:50%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:4%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Title:</span></span></span></span></div></td>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:35%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Chief
        Executive Officer</span></span></span></span></div></td>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:11%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td></tr>
  <tr>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:50%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:4%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:35%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:11%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td></tr>
  <tr>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:50%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Date:
        May 11, 2023</span></span></span></span></div></td>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:4%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>By:</span></span></span></span></div></td>
    <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:35%">
        <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-style:italic">/s/
        Donald Marvin</span><span>&#160;</span></span></span></span></span></div></td>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:11%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td></tr>
  <tr>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:50%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:4%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Name:</span></span></span></span></div></td>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:35%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Donald
        Marvin</span></span></span></span></div></td>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:11%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td></tr>
  <tr>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:50%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:4%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Title:</span></span></span></span></div></td>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:35%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Chief
        Financial Officer</span></span></span></span></div></td>
    <td style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:11%">
        <div style="line-height:1.25;color:rgb(0, 0, 0)">&#160;</div></td></tr>
  </table>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</div>

<div style="line-height:1.25;color:rgb(33, 37, 41);font-family:Times New Roman, Times, serif;text-align:center;margin-top:0pt;margin-bottom:0pt">

<p style="margin-top:0pt;margin-bottom:4pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="color:rgb(0, 0, 0);font-weight:normal;font-style:normal;margin-top:0pt;margin-bottom:0pt">21</span></span></span></span></span></p><hr style="border-right:none;border-left:none;border-image:initial;border-bottom:4px solid black;border-top:1px solid black;height:10px;width:100%;color:rgb(255, 255, 255);background-color:rgb(255, 255, 255);text-align:center;margin:0pt auto;text-align:center" /></div></div></div>

</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit_31-1.htm
<DESCRIPTION>CERTIFICATION PURSUANT TO
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.3.1.5138
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u>Exhibit 31.1</u></div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">CERTIFICATION PURSUANT TO</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">AS ADOPTED PURSUANT TO</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">I, Dale Pfost, certify that:</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">1.</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 of Chemomab Therapeutics Ltd.;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">2.</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
              light of the circumstances under which such statements were made, not misleading with respect to the period end covered by this report;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">3.</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
              results of operations and cash flows of the registrant as of, and for, the period end presented in this report;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">4.</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules
              13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 7.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">&#160;&#160;&#160; a.</div>
          </td>
          <td style="width: 92.01%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
              information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period end in which this report is being prepared;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 92.01%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">&#160;&#160;&#160; b.</div>
          </td>
          <td style="width: 92.01%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
              reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 92.01%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">&#160;&#160;&#160; c.</div>
          </td>
          <td style="width: 92.01%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure
              controls and procedures, as of the end of the period end covered by this report based on such evaluation; and</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 92.01%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">&#160;&#160;&#160; d.</div>
          </td>
          <td style="width: 92.01%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the
              registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">5.</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s
              auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 7.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">&#160;&#160;&#160; a.</div>
          </td>
          <td style="width: 92.01%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
              affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 92.01%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">&#160;&#160;&#160; b.</div>
          </td>
          <td style="width: 92.01%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 40%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">
              <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',serif;">Date: May 11, 2023</div>
            </div>
          </td>
          <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-style: italic;">/s/ Dale Pfost</div>
          </td>
          <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Dale Pfost</div>
          </td>
          <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Chief Executive Officer</div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(<font style="font-style: italic;">principal executive officer)</font></div>
          </td>
          <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit_31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.3.1.5138
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="line-height: 1.25;">
      <div style="text-align: right; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Exhibit 31.2</u></font><font style="font-family: 'Times New Roman',Times,serif;"><u>&#160;</u></font></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">CERTIFICATION PURSUANT TO</div>
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</div>
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">AS ADOPTED PURSUANT TO</div>
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</div>
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">I, Donald Marvin, certify that:</div>
      <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">1.</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 of Chemomab Therapeutics Ltd.;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">2.</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
              light of the circumstances under which such statements were made, not misleading with respect to the period end covered by this report;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">3.</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
              results of operations and cash flows of the registrant as of, and for, the period end presented in this report;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">4.</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules
              13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 7.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">&#160;&#160;&#160; a.</div>
          </td>
          <td style="width: 92.01%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
              information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period end in which this report is being prepared;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 92.01%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">&#160;&#160;&#160; b.</div>
          </td>
          <td style="width: 92.01%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
              reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 92.01%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">&#160;&#160;&#160; c.</div>
          </td>
          <td style="width: 92.01%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure
              controls and procedures, as of the end of the period end covered by this report based on such evaluation; and</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 92.01%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">&#160;&#160;&#160; d.</div>
          </td>
          <td style="width: 92.01%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the
              registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">5.</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s
              auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 7.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">&#160;&#160;&#160; a.</div>
          </td>
          <td style="width: 92.01%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
              affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 92.01%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0);">&#160;&#160;&#160; b.</div>
          </td>
          <td style="width: 92.01%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 40%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">
              <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',serif;">Date: May 11, 2023</div>
            </div>
          </td>
          <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-style: italic;">/s/ Donald Marvin</div>
          </td>
          <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Donald Marvin</div>
          </td>
          <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Chief Financial Officer</div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(<font style="font-style: italic;">principal financial and accounting officer)</font></div>
          </td>
          <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit_32-1.htm
<DESCRIPTION>CERTIFICATION PURSUANT TO
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.3.1.5138
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u>Exhibit 32.1</u></div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">CERTIFICATION PURSUANT TO</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">18 U.S.C. SECTION 1350,</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">AS ADOPTED PURSUANT TO</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">In connection with the Quarterly Report of Chemomab Therapeutics Ltd. (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended March 31, 2023, as filed with the
      Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Dale Pfost, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to
      the best of my knowledge:</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">(1)</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">(2)</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-style: italic;">/s/ Dale Pfost</div>
          </td>
          <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Dale Pfost</div>
          </td>
          <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Chief Executive Officer</div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(<font style="font-style: italic;">principal executive officer)</font></div>
          </td>
          <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Chemomab Therapeutics Ltd.</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">
              <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',serif;">May 11, 2023</div>
            </div>
          </td>
          <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exhibit_32-2.htm
<DESCRIPTION>CERTIFICATION PURSUANT TO
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.3.1.5138
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u>Exhibit 32.2</u></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">CERTIFICATION PURSUANT TO</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">18 U.S.C. SECTION 1350,</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">AS ADOPTED PURSUANT TO</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">In connection with the Quarterly Report of Chemomab Therapeutics Ltd. (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended March 31, 2023, as filed with the
      Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Donald Marvin, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to
      the best of my knowledge:</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">(1)</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">(2)</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-style: italic;">/s/ Donald Marvin</div>
          </td>
          <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Donald Marvin</div>
          </td>
          <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Chief Financial Officer</div>
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(<font style="font-style: italic;">principal financial and accounting officer)</font></div>
          </td>
          <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Chemomab Therapeutics Ltd.</div>
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">
              <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',serif;">May 11, 2023</div>
            </div>
          </td>
          <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>cmmb-20230331.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<schema xmlns:cmmb="http://www.anchiano.com/20230331" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" targetNamespace="http://www.anchiano.com/20230331" elementFormDefault="qualified">
  <!-- INTEGIX by Ez-XBRL -->
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"/>
  <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd"/>
  <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd"/>
  <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://www.anchiano.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>0001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets" id="StatementCondensedConsolidatedBalanceSheets">
        <link:definition>0002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
        <link:definition>0003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations" id="StatementUnauditedCondensedConsolidatedStatementsOfOperations">
        <link:definition>0004 - Statement - Condensed Consolidated Interim Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/InterimStatementsOfChangesInEquity" id="InterimStatementsOfChangesInEquity">
        <link:definition>0005 - Statement - Condensed Consolidated Interim Statements of Changes in Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows" id="StatementUnauditedCondensedConsolidatedStatementsOfCashFlows">
        <link:definition>0006 - Statement - Condensed Consolidated Interim Statements of Cash flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/General." id="General.">
        <link:definition>0007 - Disclosure - General</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPolicies" id="BasisOfPresentationAndSignificantAccountingPolicies">
        <link:definition>0008 - Disclosure - Basis of Presentation and Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/Contingencies" id="Contingencies">
        <link:definition>0009 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" id="BasisOfPresentationAndSignificantAccountingPoliciesPolicies">
        <link:definition>0011 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/General.Details" id="General.Details">
        <link:definition>0013 - Disclosure - General (Detail Textuals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
    </appinfo>
  </annotation>
  <element name="AccountReceivableDueToExerciseOfOptions" id="cmmb_AccountReceivableDueToExerciseOfOptions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AccruedShareIssuanceExpenses" id="cmmb_AccruedShareIssuanceExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmericanDepositarySharesMember" id="cmmb_AmericanDepositarySharesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmericanDepositorySharesMember" id="cmmb_AmericanDepositorySharesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid" id="cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" id="cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" id="cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" id="cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CarrybackNetOperatingLosses" id="cmmb_CarrybackNetOperatingLosses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CashAcquiredInReverseRecapitalization" id="cmmb_CashAcquiredInReverseRecapitalization" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="EffectOfReverseCapitalizationTransaction" id="cmmb_EffectOfReverseCapitalizationTransaction" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EffectOfReverseCapitalizationTransactionShares" id="cmmb_EffectOfReverseCapitalizationTransactionShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EstimatedFairValueOfNetAssetsAcquired" id="cmmb_EstimatedFairValueOfNetAssetsAcquired" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FinanceIncomeExpensesNet" id="cmmb_FinanceIncomeExpensesNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FormerChemomabSecurityHoldersMember" id="cmmb_FormerChemomabSecurityHoldersMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfSharesNetOfIssuanceCosts" id="cmmb_IssuanceOfSharesNetOfIssuanceCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger" id="cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember" id="cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NatureOfOperationsDisclosureAbstract" id="cmmb_NatureOfOperationsDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfAdsIssuedAndOutstandingAfterMerger" id="cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfOrdinarySharesConsistedInDS" id="cmmb_NumberOfOrdinarySharesConsistedInDS" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger" id="cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesDilutedAfterMerger" id="cmmb_NumberOfSharesDilutedAfterMerger" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OneEmployeeOneOfficerConsultantAndSixBoardMember" id="cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OrdinarySharesMember" id="cmmb_OrdinarySharesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OrdinarySharesNoParValuePerShareMember" id="cmmb_OrdinarySharesNoParValuePerShareMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PaymentsToPurchaseOfDeposits" id="cmmb_PaymentsToPurchaseOfDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ProceedsFromSaleOfDeposits" id="cmmb_ProceedsFromSaleOfDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RepurchaseArrangementMember" id="cmmb_RepurchaseArrangementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RepurchaseOfAmericanDepositaryReceipts" id="cmmb_RepurchaseOfAmericanDepositaryReceipts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RetainedEarningsAccumulatedDeficits" id="cmmb_RetainedEarningsAccumulatedDeficits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" id="cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareholdingPercentageImmediatelyFollowingMerger" id="cmmb_ShareholdingPercentageImmediatelyFollowingMerger" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharesConvertiblePerShareOfAcquireeEntity" id="cmmb_SharesConvertiblePerShareOfAcquireeEntity" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockAndWarrantIssuedDuringPeriodNewIssues" id="cmmb_StockAndWarrantIssuedDuringPeriodNewIssues" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockAndWarrantsIssuedDuringPeriodValueNewIssues" id="cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="TwoThousandFifteenPlanMember" id="cmmb_TwoThousandFifteenPlanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsExercisablePeriod" id="cmmb_WarrantsExercisablePeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>cmmb-20230331_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="cmmb-20230331.xsd#StatementCondensedConsolidatedBalanceSheets" roleURI="http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230331.xsd#StatementUnauditedCondensedConsolidatedStatementsOfOperations" roleURI="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230331.xsd#StatementUnauditedCondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_25"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0" xlink:to="loc_us-gaap_AssetsCurrent_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_DepositsAssetsCurrent_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_RestrictedCashCurrent_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0" xlink:to="loc_us-gaap_AssetsNoncurrent_6" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_6" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_6" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_6" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_7" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_6" xlink:to="loc_us-gaap_PrepaidExpenseNoncurrent_9" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_10" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_12" xlink:to="loc_us-gaap_Liabilities_13" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_13" xlink:to="loc_us-gaap_LiabilitiesCurrent_13" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_13" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_13" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_13" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_14" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_13" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_15" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_13" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_16" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_13" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_18" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_18" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_18" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_12" xlink:to="loc_us-gaap_CommitmentsAndContingencies_21" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_12" xlink:to="loc_us-gaap_StockholdersEquity_22" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_22" xlink:to="loc_us-gaap_CommonStockValue_22" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_22" xlink:to="loc_us-gaap_TreasuryStockValue_23" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_22" xlink:to="loc_us-gaap_AdditionalPaidInCapital_24" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_22" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_25" order="30" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="loc_cmmb_FinanceIncomeExpensesNet_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" xlink:to="loc_cmmb_FinanceIncomeExpensesNet_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" xlink:to="loc_us-gaap_OperatingExpenses_2" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_2" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_3" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6" order="10" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_12"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_ProceedsFromSaleOfDeposits" xlink:label="loc_cmmb_ProceedsFromSaleOfDeposits_13"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_PaymentsToPurchaseOfDeposits" xlink:label="loc_cmmb_PaymentsToPurchaseOfDeposits_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_16"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_CashAcquiredInReverseRecapitalization" xlink:label="loc_cmmb_CashAcquiredInReverseRecapitalization_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_18"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_IssuanceOfSharesNetOfIssuanceCosts" xlink:label="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_19"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_ProfitLoss_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" xlink:to="loc_us-gaap_Depreciation_2" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_4" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_5" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_6" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_7" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" xlink:to="loc_us-gaap_ShareBasedCompensation_8" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_11" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_11" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_11" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_11" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_12" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_11" xlink:to="loc_cmmb_ProceedsFromSaleOfDeposits_13" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_11" xlink:to="loc_cmmb_PaymentsToPurchaseOfDeposits_14" order="30" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_16" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_16" xlink:to="loc_cmmb_CashAcquiredInReverseRecapitalization_16" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_16" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_17" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_16" xlink:to="loc_us-gaap_ProceedsFromOtherEquity_18" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_16" xlink:to="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_19" order="30" use="optional" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>cmmb-20230331_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="cmmb-20230331.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230331.xsd#InterimStatementsOfChangesInEquity" roleURI="http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230331.xsd#General.Details" roleURI="http://www.anchiano.com/role/General.Details"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/DocumentDocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AmericanDepositarySharesMember" xlink:label="loc_cmmb_AmericanDepositarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="loc_cmmb_OrdinarySharesNoParValuePerShareMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_dei_DocumentQuarterlyReport_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_dei_EntityInformationFormerLegalOrRegisteredName_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_dei_NoTradingSymbolFlag_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_39"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1" xlink:to="loc_us-gaap_ClassOfStockDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1" xlink:to="loc_cmmb_AmericanDepositarySharesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1" xlink:to="loc_cmmb_OrdinarySharesNoParValuePerShareMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1" xlink:to="loc_us-gaap_ClassOfStockDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentType_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityCentralIndexKey_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentPeriodEndDate_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_CurrentFiscalYearEndDate_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentFiscalYearFocus_11" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_12" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_AmendmentFlag_13" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentQuarterlyReport_14" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentTransitionReport_15" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityFileNumber_16" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityRegistrantName_17" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_18" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityTaxIdentificationNumber_19" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityAddressAddressLine1_20" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityAddressAddressLine2_21" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityAddressCityOrTown_22" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityAddressPostalZipCode_23" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityAddressCountry_24" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_CityAreaCode_25" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_LocalPhoneNumber_26" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityInformationFormerLegalOrRegisteredName_27" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_Security12bTitle_28" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_TradingSymbol_29" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_NoTradingSymbolFlag_30" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_SecurityExchangeName_31" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityCurrentReportingStatus_32" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityInteractiveDataCurrent_33" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityFilerCategory_34" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntitySmallBusiness_35" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityEmergingGrowthCompany_36" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityExTransitionPeriod_37" order="310" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityShellCompany_38" order="320" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_39" order="330" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/InterimStatementsOfChangesInEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_CommonStockMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_TreasuryStockMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_RetainedEarningsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockholdersEquity_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_SharesOutstanding_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_11" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_NetIncomeLoss_12" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/General.Details">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember" xlink:label="loc_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_FormerChemomabSecurityHoldersMember" xlink:label="loc_cmmb_FormerChemomabSecurityHoldersMember_5"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember" xlink:label="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_6"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" xlink:label="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_11"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_TwoThousandFifteenPlanMember" xlink:label="loc_cmmb_TwoThousandFifteenPlanMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_15"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AmericanDepositorySharesMember" xlink:label="loc_cmmb_AmericanDepositorySharesMember_15"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_OrdinarySharesMember" xlink:label="loc_cmmb_OrdinarySharesMember_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_25"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" xlink:label="loc_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_ShareholdingPercentageImmediatelyFollowingMerger" xlink:label="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_30"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger" xlink:label="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_32"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NumberOfOrdinarySharesConsistedInDS" xlink:label="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_33"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" xlink:label="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_34"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NumberOfSharesDilutedAfterMerger" xlink:label="loc_cmmb_NumberOfSharesDilutedAfterMerger_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Capital" xlink:label="loc_us-gaap_Capital_36"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_SharesConvertiblePerShareOfAcquireeEntity" xlink:label="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_37"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_RetainedEarningsAccumulatedDeficits" xlink:label="loc_cmmb_RetainedEarningsAccumulatedDeficits_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_45"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_47"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_48"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_WarrantsExercisablePeriod" xlink:label="loc_cmmb_WarrantsExercisablePeriod_49"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_50"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid" xlink:label="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_51"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_CarrybackNetOperatingLosses" xlink:label="loc_cmmb_CarrybackNetOperatingLosses_52"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" xlink:to="loc_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_srt_TitleOfIndividualAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_5" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" xlink:to="loc_cmmb_FormerChemomabSecurityHoldersMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" xlink:to="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" xlink:to="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_5" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_PlanNameAxis_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_11" xlink:to="loc_us-gaap_PlanNameDomain_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_11" xlink:to="loc_cmmb_TwoThousandFifteenPlanMember_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_11" xlink:to="loc_us-gaap_PlanNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_15" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_15" xlink:to="loc_us-gaap_ClassOfStockDomain_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_15" xlink:to="loc_cmmb_AmericanDepositorySharesMember_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_15" xlink:to="loc_cmmb_OrdinarySharesMember_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_15" xlink:to="loc_us-gaap_ClassOfStockDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_srt_RangeAxis_20" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_20" xlink:to="loc_srt_RangeMember_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_20" xlink:to="loc_srt_MinimumMember_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_20" xlink:to="loc_srt_MaximumMember_21" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_20" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_25" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_25" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_25" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_25" xlink:to="loc_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_25" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_25" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_30" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_31" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_32" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_33" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_34" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_NumberOfSharesDilutedAfterMerger_35" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_Capital_36" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_37" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_RetainedEarningsAccumulatedDeficits_38" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_39" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_40" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_41" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_42" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_43" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_44" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_45" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_46" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_47" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_48" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_WarrantsExercisablePeriod_49" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_50" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_51" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_CarrybackNetOperatingLosses_52" order="230" use="optional"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>cmmb-20230331_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AccountReceivableDueToExerciseOfOptions" xlink:label="loc_cmmb_AccountReceivableDueToExerciseOfOptions_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AccountReceivableDueToExerciseOfOptions" xlink:label="loc_cmmb_AccountReceivableDueToExerciseOfOptions_2"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AccountReceivableDueToExerciseOfOptions" xlink:label="loc_cmmb_AccountReceivableDueToExerciseOfOptions_3"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AccountReceivableDueToExerciseOfOptions" xlink:label="loc_cmmb_AccountReceivableDueToExerciseOfOptions_4"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AccruedShareIssuanceExpenses" xlink:label="loc_cmmb_AccruedShareIssuanceExpenses_5"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AccruedShareIssuanceExpenses" xlink:label="loc_cmmb_AccruedShareIssuanceExpenses_6"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AmericanDepositarySharesMember" xlink:label="loc_cmmb_AmericanDepositarySharesMember_7"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AmericanDepositarySharesMember" xlink:label="loc_cmmb_AmericanDepositarySharesMember_8"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AmericanDepositorySharesMember" xlink:label="loc_cmmb_AmericanDepositorySharesMember_9"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AmericanDepositorySharesMember" xlink:label="loc_cmmb_AmericanDepositorySharesMember_10"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AmericanDepositorySharesMember" xlink:label="loc_cmmb_AmericanDepositorySharesMember_11"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid" xlink:label="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_12"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid" xlink:label="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_13"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid" xlink:label="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_14"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" xlink:label="loc_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_15"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" xlink:label="loc_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_16"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" xlink:label="loc_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_17"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_18"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_19"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_21"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_22"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_23"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_CarrybackNetOperatingLosses" xlink:label="loc_cmmb_CarrybackNetOperatingLosses_24"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_CarrybackNetOperatingLosses" xlink:label="loc_cmmb_CarrybackNetOperatingLosses_25"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_CarrybackNetOperatingLosses" xlink:label="loc_cmmb_CarrybackNetOperatingLosses_26"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_CashAcquiredInReverseRecapitalization" xlink:label="loc_cmmb_CashAcquiredInReverseRecapitalization_27"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_CashAcquiredInReverseRecapitalization" xlink:label="loc_cmmb_CashAcquiredInReverseRecapitalization_28"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_CashAcquiredInReverseRecapitalization" xlink:label="loc_cmmb_CashAcquiredInReverseRecapitalization_29"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_EffectOfReverseCapitalizationTransaction" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransaction_30"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_EffectOfReverseCapitalizationTransaction" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransaction_31"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_EffectOfReverseCapitalizationTransactionShares" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_32"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_EffectOfReverseCapitalizationTransactionShares" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_33"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_EffectOfReverseCapitalizationTransactionShares" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_34"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_EstimatedFairValueOfNetAssetsAcquired" xlink:label="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_35"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_EstimatedFairValueOfNetAssetsAcquired" xlink:label="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_36"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_EstimatedFairValueOfNetAssetsAcquired" xlink:label="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_37"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="loc_cmmb_FinanceIncomeExpensesNet_38"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="loc_cmmb_FinanceIncomeExpensesNet_39"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="loc_cmmb_FinanceIncomeExpensesNet_40"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="loc_cmmb_FinanceIncomeExpensesNet_41"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_FormerChemomabSecurityHoldersMember" xlink:label="loc_cmmb_FormerChemomabSecurityHoldersMember_42"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_FormerChemomabSecurityHoldersMember" xlink:label="loc_cmmb_FormerChemomabSecurityHoldersMember_43"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_IssuanceOfSharesNetOfIssuanceCosts" xlink:label="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_44"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_IssuanceOfSharesNetOfIssuanceCosts" xlink:label="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_45"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_IssuanceOfSharesNetOfIssuanceCosts" xlink:label="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_46"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_IssuanceOfSharesNetOfIssuanceCosts" xlink:label="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_47"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger" xlink:label="loc_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_48"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger" xlink:label="loc_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_49"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger" xlink:label="loc_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_50"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember" xlink:label="loc_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_51"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember" xlink:label="loc_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_52"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember" xlink:label="loc_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_53"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="loc_cmmb_NatureOfOperationsDisclosureAbstract_54"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="loc_cmmb_NatureOfOperationsDisclosureAbstract_55"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" xlink:label="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_56"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" xlink:label="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_57"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NumberOfOrdinarySharesConsistedInDS" xlink:label="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_58"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NumberOfOrdinarySharesConsistedInDS" xlink:label="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_59"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NumberOfOrdinarySharesConsistedInDS" xlink:label="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_60"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger" xlink:label="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_61"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger" xlink:label="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_62"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger" xlink:label="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_63"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NumberOfSharesDilutedAfterMerger" xlink:label="loc_cmmb_NumberOfSharesDilutedAfterMerger_64"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NumberOfSharesDilutedAfterMerger" xlink:label="loc_cmmb_NumberOfSharesDilutedAfterMerger_65"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember" xlink:label="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_66"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember" xlink:label="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_67"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember" xlink:label="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_68"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_OrdinarySharesMember" xlink:label="loc_cmmb_OrdinarySharesMember_69"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_OrdinarySharesMember" xlink:label="loc_cmmb_OrdinarySharesMember_70"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="loc_cmmb_OrdinarySharesNoParValuePerShareMember_71"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="loc_cmmb_OrdinarySharesNoParValuePerShareMember_72"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_PaymentsToPurchaseOfDeposits" xlink:label="loc_cmmb_PaymentsToPurchaseOfDeposits_73"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_PaymentsToPurchaseOfDeposits" xlink:label="loc_cmmb_PaymentsToPurchaseOfDeposits_74"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_PaymentsToPurchaseOfDeposits" xlink:label="loc_cmmb_PaymentsToPurchaseOfDeposits_75"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_ProceedsFromSaleOfDeposits" xlink:label="loc_cmmb_ProceedsFromSaleOfDeposits_76"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_ProceedsFromSaleOfDeposits" xlink:label="loc_cmmb_ProceedsFromSaleOfDeposits_77"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_ProceedsFromSaleOfDeposits" xlink:label="loc_cmmb_ProceedsFromSaleOfDeposits_78"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_RepurchaseArrangementMember" xlink:label="loc_cmmb_RepurchaseArrangementMember_79"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_RepurchaseArrangementMember" xlink:label="loc_cmmb_RepurchaseArrangementMember_80"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_RepurchaseArrangementMember" xlink:label="loc_cmmb_RepurchaseArrangementMember_81"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_RepurchaseOfAmericanDepositaryReceipts" xlink:label="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_82"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_RepurchaseOfAmericanDepositaryReceipts" xlink:label="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_83"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_RepurchaseOfAmericanDepositaryReceipts" xlink:label="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_84"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_RetainedEarningsAccumulatedDeficits" xlink:label="loc_cmmb_RetainedEarningsAccumulatedDeficits_85"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_RetainedEarningsAccumulatedDeficits" xlink:label="loc_cmmb_RetainedEarningsAccumulatedDeficits_86"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_RetainedEarningsAccumulatedDeficits" xlink:label="loc_cmmb_RetainedEarningsAccumulatedDeficits_87"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" xlink:label="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_88"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" xlink:label="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_89"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" xlink:label="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_90"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_ShareholdingPercentageImmediatelyFollowingMerger" xlink:label="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_91"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_ShareholdingPercentageImmediatelyFollowingMerger" xlink:label="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_92"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_SharesConvertiblePerShareOfAcquireeEntity" xlink:label="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_93"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_SharesConvertiblePerShareOfAcquireeEntity" xlink:label="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_94"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_SharesConvertiblePerShareOfAcquireeEntity" xlink:label="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_95"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_StockAndWarrantIssuedDuringPeriodNewIssues" xlink:label="loc_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_96"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_StockAndWarrantIssuedDuringPeriodNewIssues" xlink:label="loc_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_97"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_StockAndWarrantIssuedDuringPeriodNewIssues" xlink:label="loc_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_98"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_99"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_100"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_101"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_TwoThousandFifteenPlanMember" xlink:label="loc_cmmb_TwoThousandFifteenPlanMember_102"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_TwoThousandFifteenPlanMember" xlink:label="loc_cmmb_TwoThousandFifteenPlanMember_103"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_TwoThousandFifteenPlanMember" xlink:label="loc_cmmb_TwoThousandFifteenPlanMember_104"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_WarrantsExercisablePeriod" xlink:label="loc_cmmb_WarrantsExercisablePeriod_105"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_WarrantsExercisablePeriod" xlink:label="loc_cmmb_WarrantsExercisablePeriod_106"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_WarrantsExercisablePeriod" xlink:label="loc_cmmb_WarrantsExercisablePeriod_107"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_108"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_109"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_110"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_111"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_112"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_113"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_114"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_115"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_116"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_117"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_118"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_119"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_120"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_121"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_122"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_123"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_124"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_125"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_126"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_127"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_128"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_129"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_130"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_131"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_132"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_133"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_134"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_135"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_136"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_137"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_138"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_139"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_140"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_141"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_142"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_143"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_144"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_dei_DocumentQuarterlyReport_145"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_146"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_147"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_148"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_149"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_150"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_151"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_152"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_153"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_154"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_155"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_156"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_157"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_158"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_159"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_160"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_dei_EntityInformationFormerLegalOrRegisteredName_161"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_162"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_163"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_164"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_165"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_166"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_167"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_dei_NoTradingSymbolFlag_168"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_169"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_170"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_171"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_172"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_173"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_174"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_175"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_176"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_177"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_178"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_179"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_180"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_181"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_182"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_183"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_184"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_185"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_186"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_187"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_188"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_189"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_190"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_191"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_192"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_193"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_194"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_195"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_196"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_197"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Capital" xlink:label="loc_us-gaap_Capital_198"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_199"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_201"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_202"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_203"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_204"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_205"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_206"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_207"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_208"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_209"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_210"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNoParValue" xlink:label="loc_us-gaap_CommonStockNoParValue_211"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_212"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_213"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_214"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_215"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_216"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_217"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_218"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_219"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_220"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_221"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_222"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_223"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_224"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_225"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_226"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_227"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_228"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_229"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_230"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_231"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_232"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_233"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_234"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_235"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_236"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_237"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_238"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_239"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_240"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_241"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_242"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_243"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_244"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_245"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_246"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_247"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_248"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_249"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_250"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_251"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_252"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_253"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_254"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_255"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_256"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_257"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_258"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_259"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_260"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_261"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent_262"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_263"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_264"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_265"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_266"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_267"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_268"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_269"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_270"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_271"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_272"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_273"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_274"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_275"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_276"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_277"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_278"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_279"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_280"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_281"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_282"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_283"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_284"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_285"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_286"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_287"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_288"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_289"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_290"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_291"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_292"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_293"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_294"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_295"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_296"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_297"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_298"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_299"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_300"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_301"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_302"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_303"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_304"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_305"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_306"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_307"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_308"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_309"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_310"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_311"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_312"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_313"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_314"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_315"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_316"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_317"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_318"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_319"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_320"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_321"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_322"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_323"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AccountReceivableDueToExerciseOfOptions_0" xml:lang="en-US">Represent the amount of account receivable due to exercise of options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AccountReceivableDueToExerciseOfOptions_1" xml:lang="en-US">Account Receivable Due To Exercise Of Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_AccountReceivableDueToExerciseOfOptions_2" xml:lang="en-US">Account receivable Due to Exercise of Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_AccountReceivableDueToExerciseOfOptions_3" xml:lang="en-US">Receivable related to exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AccruedShareIssuanceExpenses_0" xml:lang="en-US">The amount of accrued issuance expenses non-cash investing and financing activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AccruedShareIssuanceExpenses_1" xml:lang="en-US">Accrued share issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AmericanDepositarySharesMember_0" xml:lang="en-US">American Depositary Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AmericanDepositarySharesMember_1" xml:lang="en-US">American Depositary Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AmericanDepositorySharesMember_0" xml:lang="en-US">This member stands for American Depository Shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AmericanDepositorySharesMember_1" xml:lang="en-US">American Depository Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_AmericanDepositorySharesMember_2" xml:lang="en-US">American Depositary Share ("ADS") [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_0" xml:lang="en-US">Represents the amount of total sale and transfer of compounds and products kestrel paid.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_1" xml:lang="en-US">Amount Of Total Sale And Transfer Of Compounds And Products Kestrel Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_2" xml:lang="en-US">Amount of total sale and transfer of compounds and products kestrel paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_0" xml:lang="en-US">This member stands for At the Market Offering Agreement with Cantor Fitzgerald &amp; Co.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_1" xml:lang="en-US">At Market Offering Agreement With Cantor Fitzgerald And Co [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_2" xml:lang="en-US">At The Market Offering Agreement With Cantor Fitzgerald &amp; Co. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_0" xml:lang="en-US">The amount of of asset held for sale recogized prior to the completion of merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_1" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Asset Held For Sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_2" xml:lang="en-US">Asset held for sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_0" xml:lang="en-US">Amount of accrued liabilities to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_1" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_2" xml:lang="en-US">Accrued liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_CarrybackNetOperatingLosses_0" xml:lang="en-US">The amount of carryback net operating losses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_CarrybackNetOperatingLosses_1" xml:lang="en-US">Carryback Net Operating Losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_CarrybackNetOperatingLosses_2" xml:lang="en-US">Carryback net operating losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_CashAcquiredInReverseRecapitalization_0" xml:lang="en-US">represents cash acquired from acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_CashAcquiredInReverseRecapitalization_1" xml:lang="en-US">Cash acquired in reverse recapitalization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_CashAcquiredInReverseRecapitalization_2" xml:lang="en-US">Cash acquired in reverse recapitalization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_EffectOfReverseCapitalizationTransaction_0" xml:lang="en-US">The amount of effect due reverse capitalization transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_EffectOfReverseCapitalizationTransaction_1" xml:lang="en-US">Effect of reverse capitalization transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_0" xml:lang="en-US">The number of shares isued due to effect of reverse capitalization transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_1" xml:lang="en-US">Effect Of Reverse Capitalization Transaction Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_2" xml:lang="en-US">Effect of reverse capitalization transaction (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_0" xml:lang="en-US">The amount of estimated fair value of the net assets acquired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_1" xml:lang="en-US">Estimated Fair Value Of Net Assets Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_2" xml:lang="en-US">Net acquired assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_FinanceIncomeExpensesNet_0" xml:lang="en-US">The net amount of finance income earned and finance expenses incurred during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_cmmb_FinanceIncomeExpensesNet_1" xml:lang="en-US">Financing income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_FinanceIncomeExpensesNet_2" xml:lang="en-US">Finance Income Expenses Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_FinanceIncomeExpensesNet_3" xml:lang="en-US">Financing expense, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_FormerChemomabSecurityHoldersMember_0" xml:lang="en-US">This represents former Chemomab security holders.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_FormerChemomabSecurityHoldersMember_1" xml:lang="en-US">Former Chemomab Security Holders [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_IssuanceOfSharesNetOfIssuanceCosts_0" xml:lang="en-US">Issuance of shares net, of issuance costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_IssuanceOfSharesNetOfIssuanceCosts_1" xml:lang="en-US">Issuance Of Shares Net Of Issuance Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_IssuanceOfSharesNetOfIssuanceCosts_2" xml:lang="en-US">Issuance of shares net, of issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_IssuanceOfSharesNetOfIssuanceCosts_3" xml:lang="en-US">Issuance of shares, net of issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_0" xml:lang="en-US">The amount of liabilities assumed, net of non-cash assets received in reverse merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_1" xml:lang="en-US">Liabilities Assumed Net Of Non Cash Assets Received In Reverse Merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_2" xml:lang="en-US">Liabilities assumed, net of non-cash assets received in reverse merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_0" xml:lang="en-US">This represents Merger Agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company inclued proposed merger of CMB Acquisition Ltd, wholly owned subsidiary of our company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_1" xml:lang="en-US">Merger Agreement With Chemomab Israeli Limited Company And Clinical Stage Biotech Company [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_2" xml:lang="en-US">Merger agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NatureOfOperationsDisclosureAbstract_0" xml:lang="en-US">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NatureOfOperationsDisclosureAbstract_1" xml:lang="en-US">Nature Of Operations Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_0" xml:lang="en-US">Number of ADS issued and outstanding after the merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_1" xml:lang="en-US">Number of ADS issued and outstanding after the merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfOrdinarySharesConsistedInDS_0" xml:lang="en-US">Represent the number of ordinary shares consisted in one American depository share (ADS).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfOrdinarySharesConsistedInDS_1" xml:lang="en-US">Number Of Ordinary Shares Consisted In D S</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_NumberOfOrdinarySharesConsistedInDS_2" xml:lang="en-US">Number of ordinary shares represented by each ADS (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_0" xml:lang="en-US">Number of shares of common stock for each preferred share converted before merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_1" xml:lang="en-US">Number Of Ordinary Shares For Each Preferred Share Converted Prior To Date Of Merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_2" xml:lang="en-US">Number of common shares for each preferred share converted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfSharesDilutedAfterMerger_0" xml:lang="en-US">The number of shares diluted after the merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfSharesDilutedAfterMerger_1" xml:lang="en-US">Number of shares diluted after the merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_0" xml:lang="en-US">One employee one officer consultant and six Board [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_1" xml:lang="en-US">One Employee One Officer Consultant And Six Board [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_2" xml:lang="en-US">One employee one officer consultant and six Board [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_OrdinarySharesMember_0" xml:lang="en-US">Ordinary Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_OrdinarySharesMember_1" xml:lang="en-US">Ordinary Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_OrdinarySharesNoParValuePerShareMember_0" xml:lang="en-US">Ordinary Shares, No Par Value Per Share [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_OrdinarySharesNoParValuePerShareMember_1" xml:lang="en-US">Ordinary Shares, No Par Value Per Share [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_PaymentsToPurchaseOfDeposits_0" xml:lang="en-US">The cash outflow to purchase of deposits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_cmmb_PaymentsToPurchaseOfDeposits_1" xml:lang="en-US">Increase in deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_PaymentsToPurchaseOfDeposits_2" xml:lang="en-US">Payments To Purchase Of Deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ProceedsFromSaleOfDeposits_0" xml:lang="en-US">The cash inflow from the sale of deposits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ProceedsFromSaleOfDeposits_1" xml:lang="en-US">Proceeds From Sale Of Deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_ProceedsFromSaleOfDeposits_2" xml:lang="en-US">Decrease in bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_RepurchaseArrangementMember_0" xml:lang="en-US">The member represents repurchase arrangement member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_RepurchaseArrangementMember_1" xml:lang="en-US">Repurchase Arrangement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_RepurchaseArrangementMember_2" xml:lang="en-US">Repurchase Arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_RepurchaseOfAmericanDepositaryReceipts_0" xml:lang="en-US">Represents the amount of repurchase of american depositary receipts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_RepurchaseOfAmericanDepositaryReceipts_1" xml:lang="en-US">Repurchase Of American Depositary Receipts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_RepurchaseOfAmericanDepositaryReceipts_2" xml:lang="en-US">Repurchase of ADSs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_RetainedEarningsAccumulatedDeficits_0" xml:lang="en-US">The cumulative amount of the reporting entity's undistributed earnings or deficits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_cmmb_RetainedEarningsAccumulatedDeficits_1" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_RetainedEarningsAccumulatedDeficits_2" xml:lang="en-US">Retained Earnings Accumulated Deficits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_0" xml:lang="en-US">This member stands for Security holders of anchiano as of immediately prior to merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_1" xml:lang="en-US">Security Holders Of Anchiano As Of Immediately Prior To Merger [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_2" xml:lang="en-US">Security holders of Anchiano as of immediately prior to the merger [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_0" xml:lang="en-US">shareholding percentage immediately following the merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_1" xml:lang="en-US">Shareholding percentage immediately following the merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_SharesConvertiblePerShareOfAcquireeEntity_0" xml:lang="en-US">Represents the shares convertible in merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_SharesConvertiblePerShareOfAcquireeEntity_1" xml:lang="en-US">Shares Convertible Per Share Of Acquiree Entity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_SharesConvertiblePerShareOfAcquireeEntity_2" xml:lang="en-US">Number of shares after merger for each share of Chemomab</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_0" xml:lang="en-US">it represents number of shares and warrants issued during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_1" xml:lang="en-US">Stock And Warrant Issued During Period New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_2" xml:lang="en-US">Issuance of shares and warrants, net of issuance costs (In shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_0" xml:lang="en-US">Value of stock issued in lieu contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_1" xml:lang="en-US">Stock And Warrants Issued During Period Value New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_2" xml:lang="en-US">Issuance of shares and warrants, net of issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_TwoThousandFifteenPlanMember_0" xml:lang="en-US">2015 Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_TwoThousandFifteenPlanMember_1" xml:lang="en-US">Two Thousand Fifteen Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_TwoThousandFifteenPlanMember_2" xml:lang="en-US">2015 Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_WarrantsExercisablePeriod_0" xml:lang="en-US">Represent the warrants exercisable period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_WarrantsExercisablePeriod_1" xml:lang="en-US">Warrants exercisable period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_WarrantsExercisablePeriod_2" xml:lang="en-US">Warrants exercisable period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_0" xml:lang="en-US">Taxes on income (benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_1" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_2" xml:lang="en-US">Taxes Expenses (Income)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_3" xml:lang="en-US">Taxes on income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0" xml:lang="en-US">Change in other receivables and prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0" xml:lang="en-US">Purchase of property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_TreasuryStockValue_0" xml:lang="en-US">Treasury share at cost (11,640,460 Ordinary shares as of March 31, 2023 and December 31, 2022)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TreasuryStockValue_1" xml:lang="en-US">Treasury Stock, Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TreasuryStockValue_2" xml:lang="en-US">Treasury share at cost (11,640,460 ordinary shares as of March 31, 2023 and December 31, 2022)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0" xml:lang="en-US">Loss before taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2" xml:lang="en-US">Loss before taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_us-gaap_NetIncomeLoss_0" xml:lang="en-US">Net loss for the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_us-gaap_NetIncomeLoss_1" xml:lang="en-US">Net loss for the period/year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLoss_2" xml:lang="en-US">Net loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetIncomeLoss_3" xml:lang="en-US">Net loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_us-gaap_OperatingExpenses_0" xml:lang="en-US">Total operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpenses_1" xml:lang="en-US">Operating Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingExpenses_2" xml:lang="en-US">Total operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_SharesOutstanding_0" xml:lang="en-US">Ending balance (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_SharesOutstanding_1" xml:lang="en-US">Beginning balance (In shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesOutstanding_2" xml:lang="en-US">Shares, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_StockholdersEquity_0" xml:lang="en-US">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_StockholdersEquity_1" xml:lang="en-US">Beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquity_2" xml:lang="en-US">Stockholders' Equity Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_StockholdersEquity_3" xml:lang="en-US">Total shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag_0" xml:lang="en-US">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CityAreaCode_0" xml:lang="en-US">City Area Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CurrentFiscalYearEndDate_0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalPeriodFocus_0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalYearFocus_0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentPeriodEndDate_0" xml:lang="en-US">Document Period End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentQuarterlyReport_0" xml:lang="en-US">Document Quarterly Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentTransitionReport_0" xml:lang="en-US">Document Transition Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType_0" xml:lang="en-US">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine1_0" xml:lang="en-US">Entity Address, Address Line One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine2_0" xml:lang="en-US">Entity Address, Address Line Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCityOrTown_0" xml:lang="en-US">Entity Address, City or Town</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCountry_0" xml:lang="en-US">Entity Address, Country</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressPostalZipCode_0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey_0" xml:lang="en-US">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCurrentReportingStatus_0" xml:lang="en-US">Entity Current Reporting Status</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityEmergingGrowthCompany_0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityExTransitionPeriod_0" xml:lang="en-US">Entity Ex Transition Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFileNumber_0" xml:lang="en-US">Entity File Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFilerCategory_0" xml:lang="en-US">Entity Filer Category</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityIncorporationStateCountryCode_0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityInformationFormerLegalOrRegisteredName_0" xml:lang="en-US">Entity Information, Former Legal or Registered Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityInteractiveDataCurrent_0" xml:lang="en-US">Entity Interactive Data Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName_0" xml:lang="en-US">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityShellCompany_0" xml:lang="en-US">Entity Shell Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntitySmallBusiness_0" xml:lang="en-US">Entity Small Business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityTaxIdentificationNumber_0" xml:lang="en-US">Entity Tax Identification Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LocalPhoneNumber_0" xml:lang="en-US">Local Phone Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_NoTradingSymbolFlag_0" xml:lang="en-US">No Trading Symbol Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_Security12bTitle_0" xml:lang="en-US">Title of 12(b) Security</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_SecurityExchangeName_0" xml:lang="en-US">Name of Exchange on which Security is Registered</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_TradingSymbol_0" xml:lang="en-US">Trading Symbol</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MaximumMember_0" xml:lang="en-US">Maximum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MinimumMember_0" xml:lang="en-US">Minimum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeAxis_0" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_TitleOfIndividualAxis_0" xml:lang="en-US">Title of Individual [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountingPoliciesAbstract_0" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent_0" xml:lang="en-US">Trade payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent_0" xml:lang="en-US">Accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapital_0" xml:lang="en-US">Additional paid in capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember_0" xml:lang="en-US">Additional paid in capital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_0" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_1" xml:lang="en-US">Adjustments for operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">Adjustments for operating activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Assets_0" xml:lang="en-US">Assets [Default Label]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Assets_1" xml:lang="en-US">Total assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsAbstract_0" xml:lang="en-US">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrent_0" xml:lang="en-US">Assets, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsCurrent_1" xml:lang="en-US">Total current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrentAbstract_0" xml:lang="en-US">Current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsNoncurrent_0" xml:lang="en-US">Assets, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsNoncurrent_1" xml:lang="en-US">Total non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract_0" xml:lang="en-US">Non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0" xml:lang="en-US">Basis of Preparation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_0" xml:lang="en-US">Business Acquisition [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0" xml:lang="en-US">Prepaid and other assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Capital_0" xml:lang="en-US">Market capitalization amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1" xml:lang="en-US">Change in cash, cash equivalents and restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1" xml:lang="en-US">Warrant exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingencies_0" xml:lang="en-US">Commitments and contingent liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1" xml:lang="en-US">Contingencies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockMember_0" xml:lang="en-US">Ordinary shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockMember_1" xml:lang="en-US">Ordinary Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockNoParValue_0" xml:lang="en-US">Common Stock, No Par Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_0" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesIssued_0" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_0" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockValue_0" xml:lang="en-US">Ordinary shares no par value - Authorized: 650,000,000 shares as of September 30, 2021 and 500,000,000 shares as of December 31, 2020; Issued and outstanding: 227,956,060 ordinary shares at September 30, 2021 and 9,274,838 ordinary shares at December 31, 2020</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockValue_1" xml:lang="en-US">Ordinary shares no par value - Authorized: 650,000,000 shares as of March 31, 2022 and as of December 31, 2021; Issued and outstanding: 228,090,300 ordinary shares at March 31, 2022 as of December 31, 2021</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockValue_2" xml:lang="en-US">Ordinary shares no par value - Authorized: 650,000,000 shares as of March 31, 2023 and December 31, 2022; Issued and outstanding: 232,636,700 Ordinary shares as of March 31, 2023 and December 31, 2022;</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DepositsAssetsCurrent_0" xml:lang="en-US">Short term bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Depreciation_0" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareBasic_0" xml:lang="en-US">Basic and diluted loss per Ordinary Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareBasic_1" xml:lang="en-US">Basic loss per Ordinary Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareDiluted_0" xml:lang="en-US">Earnings Per Share, Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareDiluted_1" xml:lang="en-US">Diluted loss per Ordinary Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_0" xml:lang="en-US">Employee and related expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquityComponentDomain_0" xml:lang="en-US">Equity Component [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense_0" xml:lang="en-US">General and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementAbstract_0" xml:lang="en-US">Income Statement [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_0" xml:lang="en-US">Change in trade payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_0" xml:lang="en-US">Change in accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_0" xml:lang="en-US">Change in employees and related expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_0" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_1" xml:lang="en-US">Change in operating lease liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_2" xml:lang="en-US">Change in operating lease liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Liabilities_0" xml:lang="en-US">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Liabilities_1" xml:lang="en-US">Total liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_0" xml:lang="en-US">Liabilities and Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_1" xml:lang="en-US">Total liabilities and shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' EQUITY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrent_0" xml:lang="en-US">Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesCurrent_1" xml:lang="en-US">Total current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_0" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesNoncurrent_0" xml:lang="en-US">Liabilities, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesNoncurrent_1" xml:lang="en-US">Total non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract_0" xml:lang="en-US">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NatureOfOperations_0" xml:lang="en-US">Nature of Operations [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NatureOfOperations_1" xml:lang="en-US">General</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1" xml:lang="en-US">Net cash provided by financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0" xml:lang="en-US">Cash flows from financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1" xml:lang="en-US">Net cash provided by investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0" xml:lang="en-US">Cash flows from investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xml:lang="en-US">Net cash used in operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">Cash flows from operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpensesAbstract_0" xml:lang="en-US">Operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_0" xml:lang="en-US">Operating lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0" xml:lang="en-US">Operating lease liabilities - long term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_0" xml:lang="en-US">Operating lease right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PlanNameAxis_0" xml:lang="en-US">Plan Name [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0" xml:lang="en-US">Other receivables and prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseNoncurrent_0" xml:lang="en-US">Long term prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromOtherEquity_0" xml:lang="en-US">Proceeds from Other Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromOtherEquity_1" xml:lang="en-US">Issuance of shares and warrants, net of issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_0" xml:lang="en-US">Proceeds from Sale of Property Held-for-sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_1" xml:lang="en-US">Sale of asset held for sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised_0" xml:lang="en-US">Exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised_1" xml:lang="en-US">Exercise of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised_2" xml:lang="en-US">Exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises_0" xml:lang="en-US">Proceeds from Warrant Exercises</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises_1" xml:lang="en-US">Proceeds from exercise of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProfitLoss_0" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProfitLoss_1" xml:lang="en-US">Net loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_0" xml:lang="en-US">Property and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis_0" xml:lang="en-US">Related Party Transaction [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain_0" xml:lang="en-US">Related Party Transaction [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems_0" xml:lang="en-US">Related Party Transaction [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract_0" xml:lang="en-US">Related Party Transactions [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_0" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1" xml:lang="en-US">Transaction with related parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_0" xml:lang="en-US">Research and development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedCashCurrent_0" xml:lang="en-US">Restricted Cash, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RestrictedCashCurrent_1" xml:lang="en-US">Restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems_0" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsMember_0" xml:lang="en-US">Accumulated deficit [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RetainedEarningsMember_1" xml:lang="en-US">Accumulated Deficit [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_0" xml:lang="en-US">Aggregate offering price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_0" xml:lang="en-US">Gross proceeds from sale under agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_0" xml:lang="en-US">Shares issued under agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockPricePerShare_0" xml:lang="en-US">Average price of shares issued under agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_0" xml:lang="en-US">Schedule of net assets acquired based on their estimated fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensation_0" xml:lang="en-US">Share-based compensation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensation_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0" xml:lang="en-US">Share based payment options vesting period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_0" xml:lang="en-US">Number of shares authorized, increase</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0" xml:lang="en-US">Options to purchase ADs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0" xml:lang="en-US">Exercise price per ADs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1" xml:lang="en-US">Value of ADS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementClassOfStockAxis_0" xml:lang="en-US">Class of Stock [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_0" xml:lang="en-US">Equity Components [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementLineItems_0" xml:lang="en-US">Statement [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract_0" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract_0" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementTable_0" xml:lang="en-US">Statement [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_0" xml:lang="en-US">Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_1" xml:lang="en-US">Isuuance and sale value of ADSs and warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0" xml:lang="en-US">Shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_0" xml:lang="en-US">Reverse stock split conversion ratio</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_0" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis_0" xml:lang="en-US">Sale of Stock [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TreasuryStockMember_0" xml:lang="en-US">Treasury Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TreasuryStockMember_1" xml:lang="en-US">Treasury share [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TreasuryStockShares_0" xml:lang="en-US">Treasury Stock, Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TreasuryStockShares_1" xml:lang="en-US">Treasury Stock, Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UseOfEstimates_0" xml:lang="en-US">Use of estimates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1" xml:lang="en-US">Weighted average number of Ordinary Shares outstanding, diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0" xml:lang="en-US">Weighted average number of Ordinary Shares outstanding, basic, and diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1" xml:lang="en-US">Weighted average number of Ordinary Shares outstanding, basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AccountReceivableDueToExerciseOfOptions_1" xlink:to="lab_cmmb_AccountReceivableDueToExerciseOfOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AccountReceivableDueToExerciseOfOptions_2" xlink:to="lab_cmmb_AccountReceivableDueToExerciseOfOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AccountReceivableDueToExerciseOfOptions_3" xlink:to="lab_cmmb_AccountReceivableDueToExerciseOfOptions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AccountReceivableDueToExerciseOfOptions_4" xlink:to="lab_cmmb_AccountReceivableDueToExerciseOfOptions_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AccruedShareIssuanceExpenses_5" xlink:to="lab_cmmb_AccruedShareIssuanceExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AccruedShareIssuanceExpenses_6" xlink:to="lab_cmmb_AccruedShareIssuanceExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmericanDepositarySharesMember_7" xlink:to="lab_cmmb_AmericanDepositarySharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmericanDepositarySharesMember_8" xlink:to="lab_cmmb_AmericanDepositarySharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmericanDepositorySharesMember_9" xlink:to="lab_cmmb_AmericanDepositorySharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmericanDepositorySharesMember_10" xlink:to="lab_cmmb_AmericanDepositorySharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmericanDepositorySharesMember_11" xlink:to="lab_cmmb_AmericanDepositorySharesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_12" xlink:to="lab_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_13" xlink:to="lab_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_14" xlink:to="lab_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_15" xlink:to="lab_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_16" xlink:to="lab_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_17" xlink:to="lab_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_18" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_19" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_20" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_21" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_22" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_23" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CarrybackNetOperatingLosses_24" xlink:to="lab_cmmb_CarrybackNetOperatingLosses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CarrybackNetOperatingLosses_25" xlink:to="lab_cmmb_CarrybackNetOperatingLosses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CarrybackNetOperatingLosses_26" xlink:to="lab_cmmb_CarrybackNetOperatingLosses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CashAcquiredInReverseRecapitalization_27" xlink:to="lab_cmmb_CashAcquiredInReverseRecapitalization_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CashAcquiredInReverseRecapitalization_28" xlink:to="lab_cmmb_CashAcquiredInReverseRecapitalization_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CashAcquiredInReverseRecapitalization_29" xlink:to="lab_cmmb_CashAcquiredInReverseRecapitalization_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EffectOfReverseCapitalizationTransaction_30" xlink:to="lab_cmmb_EffectOfReverseCapitalizationTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EffectOfReverseCapitalizationTransaction_31" xlink:to="lab_cmmb_EffectOfReverseCapitalizationTransaction_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_32" xlink:to="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_33" xlink:to="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_34" xlink:to="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_35" xlink:to="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_36" xlink:to="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_37" xlink:to="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FinanceIncomeExpensesNet_38" xlink:to="lab_cmmb_FinanceIncomeExpensesNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FinanceIncomeExpensesNet_39" xlink:to="lab_cmmb_FinanceIncomeExpensesNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FinanceIncomeExpensesNet_40" xlink:to="lab_cmmb_FinanceIncomeExpensesNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FinanceIncomeExpensesNet_41" xlink:to="lab_cmmb_FinanceIncomeExpensesNet_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FormerChemomabSecurityHoldersMember_42" xlink:to="lab_cmmb_FormerChemomabSecurityHoldersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FormerChemomabSecurityHoldersMember_43" xlink:to="lab_cmmb_FormerChemomabSecurityHoldersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_44" xlink:to="lab_cmmb_IssuanceOfSharesNetOfIssuanceCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_45" xlink:to="lab_cmmb_IssuanceOfSharesNetOfIssuanceCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_46" xlink:to="lab_cmmb_IssuanceOfSharesNetOfIssuanceCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_47" xlink:to="lab_cmmb_IssuanceOfSharesNetOfIssuanceCosts_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_48" xlink:to="lab_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_49" xlink:to="lab_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_50" xlink:to="lab_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_51" xlink:to="lab_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_52" xlink:to="lab_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_53" xlink:to="lab_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_54" xlink:to="lab_cmmb_NatureOfOperationsDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_55" xlink:to="lab_cmmb_NatureOfOperationsDisclosureAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_56" xlink:to="lab_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_57" xlink:to="lab_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_58" xlink:to="lab_cmmb_NumberOfOrdinarySharesConsistedInDS_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_59" xlink:to="lab_cmmb_NumberOfOrdinarySharesConsistedInDS_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_60" xlink:to="lab_cmmb_NumberOfOrdinarySharesConsistedInDS_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_61" xlink:to="lab_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_62" xlink:to="lab_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_63" xlink:to="lab_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfSharesDilutedAfterMerger_64" xlink:to="lab_cmmb_NumberOfSharesDilutedAfterMerger_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfSharesDilutedAfterMerger_65" xlink:to="lab_cmmb_NumberOfSharesDilutedAfterMerger_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_66" xlink:to="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_67" xlink:to="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_68" xlink:to="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OrdinarySharesMember_69" xlink:to="lab_cmmb_OrdinarySharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OrdinarySharesMember_70" xlink:to="lab_cmmb_OrdinarySharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OrdinarySharesNoParValuePerShareMember_71" xlink:to="lab_cmmb_OrdinarySharesNoParValuePerShareMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OrdinarySharesNoParValuePerShareMember_72" xlink:to="lab_cmmb_OrdinarySharesNoParValuePerShareMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_PaymentsToPurchaseOfDeposits_73" xlink:to="lab_cmmb_PaymentsToPurchaseOfDeposits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_PaymentsToPurchaseOfDeposits_74" xlink:to="lab_cmmb_PaymentsToPurchaseOfDeposits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_PaymentsToPurchaseOfDeposits_75" xlink:to="lab_cmmb_PaymentsToPurchaseOfDeposits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ProceedsFromSaleOfDeposits_76" xlink:to="lab_cmmb_ProceedsFromSaleOfDeposits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ProceedsFromSaleOfDeposits_77" xlink:to="lab_cmmb_ProceedsFromSaleOfDeposits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ProceedsFromSaleOfDeposits_78" xlink:to="lab_cmmb_ProceedsFromSaleOfDeposits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RepurchaseArrangementMember_79" xlink:to="lab_cmmb_RepurchaseArrangementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RepurchaseArrangementMember_80" xlink:to="lab_cmmb_RepurchaseArrangementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RepurchaseArrangementMember_81" xlink:to="lab_cmmb_RepurchaseArrangementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_82" xlink:to="lab_cmmb_RepurchaseOfAmericanDepositaryReceipts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_83" xlink:to="lab_cmmb_RepurchaseOfAmericanDepositaryReceipts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RepurchaseOfAmericanDepositaryReceipts_84" xlink:to="lab_cmmb_RepurchaseOfAmericanDepositaryReceipts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RetainedEarningsAccumulatedDeficits_85" xlink:to="lab_cmmb_RetainedEarningsAccumulatedDeficits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RetainedEarningsAccumulatedDeficits_86" xlink:to="lab_cmmb_RetainedEarningsAccumulatedDeficits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RetainedEarningsAccumulatedDeficits_87" xlink:to="lab_cmmb_RetainedEarningsAccumulatedDeficits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_88" xlink:to="lab_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_89" xlink:to="lab_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_90" xlink:to="lab_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_91" xlink:to="lab_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_92" xlink:to="lab_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_93" xlink:to="lab_cmmb_SharesConvertiblePerShareOfAcquireeEntity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_94" xlink:to="lab_cmmb_SharesConvertiblePerShareOfAcquireeEntity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_95" xlink:to="lab_cmmb_SharesConvertiblePerShareOfAcquireeEntity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_96" xlink:to="lab_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_97" xlink:to="lab_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_98" xlink:to="lab_cmmb_StockAndWarrantIssuedDuringPeriodNewIssues_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_99" xlink:to="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_100" xlink:to="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_101" xlink:to="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_TwoThousandFifteenPlanMember_102" xlink:to="lab_cmmb_TwoThousandFifteenPlanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_TwoThousandFifteenPlanMember_103" xlink:to="lab_cmmb_TwoThousandFifteenPlanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_TwoThousandFifteenPlanMember_104" xlink:to="lab_cmmb_TwoThousandFifteenPlanMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_WarrantsExercisablePeriod_105" xlink:to="lab_cmmb_WarrantsExercisablePeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_WarrantsExercisablePeriod_106" xlink:to="lab_cmmb_WarrantsExercisablePeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_WarrantsExercisablePeriod_107" xlink:to="lab_cmmb_WarrantsExercisablePeriod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_108" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_109" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_110" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_111" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_112" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_113" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_114" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_115" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_116" xlink:to="lab_us-gaap_TreasuryStockValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_117" xlink:to="lab_us-gaap_TreasuryStockValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_118" xlink:to="lab_us-gaap_TreasuryStockValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_119" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_120" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_121" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_122" xlink:to="lab_us-gaap_NetIncomeLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_123" xlink:to="lab_us-gaap_NetIncomeLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_124" xlink:to="lab_us-gaap_NetIncomeLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_125" xlink:to="lab_us-gaap_NetIncomeLoss_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_126" xlink:to="lab_us-gaap_OperatingExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_127" xlink:to="lab_us-gaap_OperatingExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_128" xlink:to="lab_us-gaap_OperatingExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_129" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_130" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_131" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_132" xlink:to="lab_us-gaap_SharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_133" xlink:to="lab_us-gaap_SharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_134" xlink:to="lab_us-gaap_SharesOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_135" xlink:to="lab_us-gaap_StockholdersEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_136" xlink:to="lab_us-gaap_StockholdersEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_137" xlink:to="lab_us-gaap_StockholdersEquity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_138" xlink:to="lab_us-gaap_StockholdersEquity_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_139" xlink:to="lab_dei_AmendmentFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_140" xlink:to="lab_dei_CityAreaCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_141" xlink:to="lab_dei_CurrentFiscalYearEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_142" xlink:to="lab_dei_DocumentFiscalPeriodFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_143" xlink:to="lab_dei_DocumentFiscalYearFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_144" xlink:to="lab_dei_DocumentPeriodEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport_145" xlink:to="lab_dei_DocumentQuarterlyReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport_146" xlink:to="lab_dei_DocumentTransitionReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_147" xlink:to="lab_dei_DocumentType_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_148" xlink:to="lab_dei_EntityAddressAddressLine1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2_149" xlink:to="lab_dei_EntityAddressAddressLine2_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_150" xlink:to="lab_dei_EntityAddressCityOrTown_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry_151" xlink:to="lab_dei_EntityAddressCountry_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_152" xlink:to="lab_dei_EntityAddressPostalZipCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_153" xlink:to="lab_dei_EntityCentralIndexKey_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_154" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_155" xlink:to="lab_dei_EntityCurrentReportingStatus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_156" xlink:to="lab_dei_EntityEmergingGrowthCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod_157" xlink:to="lab_dei_EntityExTransitionPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_158" xlink:to="lab_dei_EntityFileNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_159" xlink:to="lab_dei_EntityFilerCategory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_160" xlink:to="lab_dei_EntityIncorporationStateCountryCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationFormerLegalOrRegisteredName_161" xlink:to="lab_dei_EntityInformationFormerLegalOrRegisteredName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent_162" xlink:to="lab_dei_EntityInteractiveDataCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_163" xlink:to="lab_dei_EntityRegistrantName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany_164" xlink:to="lab_dei_EntityShellCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness_165" xlink:to="lab_dei_EntitySmallBusiness_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber_166" xlink:to="lab_dei_EntityTaxIdentificationNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_167" xlink:to="lab_dei_LocalPhoneNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_NoTradingSymbolFlag_168" xlink:to="lab_dei_NoTradingSymbolFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_169" xlink:to="lab_dei_Security12bTitle_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_170" xlink:to="lab_dei_SecurityExchangeName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_171" xlink:to="lab_dei_TradingSymbol_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_172" xlink:to="lab_srt_MaximumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_173" xlink:to="lab_srt_MinimumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_174" xlink:to="lab_srt_RangeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis_175" xlink:to="lab_srt_TitleOfIndividualAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_176" xlink:to="lab_us-gaap_AccountingPoliciesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent_177" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_178" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital_179" xlink:to="lab_us-gaap_AdditionalPaidInCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember_180" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_181" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_182" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_183" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_184" xlink:to="lab_us-gaap_Assets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_185" xlink:to="lab_us-gaap_Assets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract_186" xlink:to="lab_us-gaap_AssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_187" xlink:to="lab_us-gaap_AssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_188" xlink:to="lab_us-gaap_AssetsCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract_189" xlink:to="lab_us-gaap_AssetsCurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent_190" xlink:to="lab_us-gaap_AssetsNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent_191" xlink:to="lab_us-gaap_AssetsNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_192" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_193" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_194" xlink:to="lab_us-gaap_BusinessAcquisitionAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_195" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_196" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_197" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Capital_198" xlink:to="lab_us-gaap_Capital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_199" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_200" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_201" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_202" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_203" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_204" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies_205" xlink:to="lab_us-gaap_CommitmentsAndContingencies_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_206" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_207" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_208" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_209" xlink:to="lab_us-gaap_CommonStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_210" xlink:to="lab_us-gaap_CommonStockMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockNoParValue_211" xlink:to="lab_us-gaap_CommonStockNoParValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_212" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_213" xlink:to="lab_us-gaap_CommonStockSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding_214" xlink:to="lab_us-gaap_CommonStockSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_215" xlink:to="lab_us-gaap_CommonStockValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_216" xlink:to="lab_us-gaap_CommonStockValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_217" xlink:to="lab_us-gaap_CommonStockValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssetsCurrent_218" xlink:to="lab_us-gaap_DepositsAssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation_219" xlink:to="lab_us-gaap_Depreciation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_220" xlink:to="lab_us-gaap_EarningsPerShareBasic_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_221" xlink:to="lab_us-gaap_EarningsPerShareBasic_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_222" xlink:to="lab_us-gaap_EarningsPerShareDiluted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_223" xlink:to="lab_us-gaap_EarningsPerShareDiluted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_224" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain_225" xlink:to="lab_us-gaap_EquityComponentDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_226" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract_227" xlink:to="lab_us-gaap_IncomeStatementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_228" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_229" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_230" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_231" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_232" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_233" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_234" xlink:to="lab_us-gaap_Liabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_235" xlink:to="lab_us-gaap_Liabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_236" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_237" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_238" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_239" xlink:to="lab_us-gaap_LiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_240" xlink:to="lab_us-gaap_LiabilitiesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_241" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_242" xlink:to="lab_us-gaap_LiabilitiesNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_243" xlink:to="lab_us-gaap_LiabilitiesNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_244" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations_245" xlink:to="lab_us-gaap_NatureOfOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations_246" xlink:to="lab_us-gaap_NatureOfOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_247" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_248" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_249" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_250" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_251" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_252" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_253" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_254" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_255" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract_256" xlink:to="lab_us-gaap_OperatingExpensesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent_257" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_258" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_259" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis_260" xlink:to="lab_us-gaap_PlanNameAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_261" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseNoncurrent_262" xlink:to="lab_us-gaap_PrepaidExpenseNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromOtherEquity_263" xlink:to="lab_us-gaap_ProceedsFromOtherEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromOtherEquity_264" xlink:to="lab_us-gaap_ProceedsFromOtherEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_265" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_266" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised_267" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised_268" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised_269" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises_270" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises_271" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_272" xlink:to="lab_us-gaap_ProfitLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_273" xlink:to="lab_us-gaap_ProfitLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_274" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_275" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_276" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_277" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_278" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_279" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_280" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_281" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent_282" xlink:to="lab_us-gaap_RestrictedCashCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent_283" xlink:to="lab_us-gaap_RestrictedCashCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_284" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_285" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_286" xlink:to="lab_us-gaap_RetainedEarningsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_287" xlink:to="lab_us-gaap_RetainedEarningsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_288" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_289" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_290" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare_291" xlink:to="lab_us-gaap_SaleOfStockPricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_292" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_293" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_294" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_295" xlink:to="lab_us-gaap_ShareBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_296" xlink:to="lab_us-gaap_ShareBasedCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_297" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_298" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_299" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_300" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_301" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock_302" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis_303" xlink:to="lab_us-gaap_StatementClassOfStockAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_304" xlink:to="lab_us-gaap_StatementEquityComponentsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems_305" xlink:to="lab_us-gaap_StatementLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_306" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_307" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable_308" xlink:to="lab_us-gaap_StatementTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_309" xlink:to="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_310" xlink:to="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_311" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_312" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_313" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_314" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember_315" xlink:to="lab_us-gaap_TreasuryStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember_316" xlink:to="lab_us-gaap_TreasuryStockMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares_317" xlink:to="lab_us-gaap_TreasuryStockShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares_318" xlink:to="lab_us-gaap_TreasuryStockShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates_319" xlink:to="lab_us-gaap_UseOfEstimates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_320" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_321" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_322" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_323" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>cmmb-20230331_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230331.xsd#BalanceSheetsParenthetical" roleURI="http://www.anchiano.com/role/BalanceSheetsParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230331.xsd#StatementCondensedConsolidatedBalanceSheets" roleURI="http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230331.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230331.xsd#General." roleURI="http://www.anchiano.com/role/General."/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230331.xsd#InterimStatementsOfChangesInEquity" roleURI="http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230331.xsd#StatementUnauditedCondensedConsolidatedStatementsOfOperations" roleURI="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230331.xsd#StatementUnauditedCondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230331.xsd#BasisOfPresentationAndSignificantAccountingPolicies" roleURI="http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230331.xsd#BasisOfPresentationAndSignificantAccountingPoliciesPolicies" roleURI="http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230331.xsd#General.Details" roleURI="http://www.anchiano.com/role/General.Details"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20230331.xsd#Contingencies" roleURI="http://www.anchiano.com/role/Contingencies"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/BalanceSheetsParenthetical">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNoParValue" xlink:label="loc_us-gaap_CommonStockNoParValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockNoParValue_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesIssued_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_TreasuryStockShares_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_31"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_AssetsAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_AssetsCurrentAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_DepositsAssetsCurrent_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_RestrictedCashCurrent_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_AssetsCurrent_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_us-gaap_PrepaidExpenseNoncurrent_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_us-gaap_AssetsNoncurrent_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_Assets_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_14" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_14" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_14" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_14" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_15" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_14" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_16" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_14" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_17" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_14" xlink:to="loc_us-gaap_LiabilitiesCurrent_18" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_20" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_20" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_20" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_20" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_21" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14" xlink:to="loc_us-gaap_CommitmentsAndContingencies_23" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14" xlink:to="loc_us-gaap_Liabilities_24" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_25" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_25" xlink:to="loc_us-gaap_CommonStockValue_25" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_25" xlink:to="loc_us-gaap_TreasuryStockValue_26" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_25" xlink:to="loc_us-gaap_AdditionalPaidInCapital_27" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_25" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_28" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_25" xlink:to="loc_us-gaap_StockholdersEquity_29" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_31" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/DocumentDocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AmericanDepositarySharesMember" xlink:label="loc_cmmb_AmericanDepositarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="loc_cmmb_OrdinarySharesNoParValuePerShareMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_dei_DocumentQuarterlyReport_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_dei_EntityInformationFormerLegalOrRegisteredName_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_dei_NoTradingSymbolFlag_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_37"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1" xlink:to="loc_us-gaap_ClassOfStockDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1" xlink:to="loc_cmmb_AmericanDepositarySharesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1" xlink:to="loc_cmmb_OrdinarySharesNoParValuePerShareMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_DocumentType_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityCentralIndexKey_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_DocumentPeriodEndDate_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_CurrentFiscalYearEndDate_8" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_DocumentFiscalYearFocus_9" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_DocumentFiscalPeriodFocus_10" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_AmendmentFlag_11" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_DocumentQuarterlyReport_12" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_DocumentTransitionReport_13" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityFileNumber_14" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityRegistrantName_15" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityIncorporationStateCountryCode_16" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityTaxIdentificationNumber_17" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityAddressAddressLine1_18" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityAddressAddressLine2_19" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityAddressCityOrTown_20" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityAddressPostalZipCode_21" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityAddressCountry_22" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_CityAreaCode_23" order="180" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_LocalPhoneNumber_24" order="190" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityInformationFormerLegalOrRegisteredName_25" order="200" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_Security12bTitle_26" order="210" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_TradingSymbol_27" order="220" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_NoTradingSymbolFlag_28" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_SecurityExchangeName_29" order="240" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityCurrentReportingStatus_30" order="250" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityInteractiveDataCurrent_31" order="260" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityFilerCategory_32" order="270" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntitySmallBusiness_33" order="280" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityEmergingGrowthCompany_34" order="290" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityExTransitionPeriod_35" order="300" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityShellCompany_36" order="310" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_37" order="320" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/General.">
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="loc_cmmb_NatureOfOperationsDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_0" xlink:to="loc_us-gaap_NatureOfOperations_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/InterimStatementsOfChangesInEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_CommonStockMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_TreasuryStockMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_RetainedEarningsMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockholdersEquity_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_SharesOutstanding_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_NetIncomeLoss_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockholdersEquity_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_SharesOutstanding_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_3"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="loc_cmmb_FinanceIncomeExpensesNet_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_OperatingExpensesAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1" xlink:to="loc_us-gaap_OperatingExpenses_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_cmmb_FinanceIncomeExpensesNet_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_NetIncomeLoss_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareBasic_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareDiluted_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_12" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_PaymentsToPurchaseOfDeposits" xlink:label="loc_cmmb_PaymentsToPurchaseOfDeposits_13"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_ProceedsFromSaleOfDeposits" xlink:label="loc_cmmb_ProceedsFromSaleOfDeposits_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_CashAcquiredInReverseRecapitalization" xlink:label="loc_cmmb_CashAcquiredInReverseRecapitalization_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_IssuanceOfSharesNetOfIssuanceCosts" xlink:label="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_28"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger" xlink:label="loc_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_28"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AccountReceivableDueToExerciseOfOptions" xlink:label="loc_cmmb_AccountReceivableDueToExerciseOfOptions_29"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AccruedShareIssuanceExpenses" xlink:label="loc_cmmb_AccruedShareIssuanceExpenses_30"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_ProfitLoss_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_Depreciation_2" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_ShareBasedCompensation_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_6" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_8" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_9" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_10" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13" xlink:to="loc_cmmb_PaymentsToPurchaseOfDeposits_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13" xlink:to="loc_cmmb_ProceedsFromSaleOfDeposits_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_16" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_17" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19" xlink:to="loc_cmmb_CashAcquiredInReverseRecapitalization_19" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_20" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19" xlink:to="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_21" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19" xlink:to="loc_us-gaap_ProceedsFromOtherEquity_22" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_23" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_25" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_26" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_27" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_28" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_28" xlink:to="loc_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_28" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_28" xlink:to="loc_cmmb_AccountReceivableDueToExerciseOfOptions_29" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_28" xlink:to="loc_cmmb_AccruedShareIssuanceExpenses_30" order="20" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_UseOfEstimates_2" order="10" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/General.Details">
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="loc_cmmb_NatureOfOperationsDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember" xlink:label="loc_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_FormerChemomabSecurityHoldersMember" xlink:label="loc_cmmb_FormerChemomabSecurityHoldersMember_4"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember" xlink:label="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_5"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember" xlink:label="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_9"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_TwoThousandFifteenPlanMember" xlink:label="loc_cmmb_TwoThousandFifteenPlanMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_12"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AmericanDepositorySharesMember" xlink:label="loc_cmmb_AmericanDepositorySharesMember_12"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_OrdinarySharesMember" xlink:label="loc_cmmb_OrdinarySharesMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" xlink:label="loc_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_23"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_ShareholdingPercentageImmediatelyFollowingMerger" xlink:label="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_23"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger" xlink:label="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_25"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NumberOfOrdinarySharesConsistedInDS" xlink:label="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_26"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" xlink:label="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_27"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_NumberOfSharesDilutedAfterMerger" xlink:label="loc_cmmb_NumberOfSharesDilutedAfterMerger_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Capital" xlink:label="loc_us-gaap_Capital_29"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_SharesConvertiblePerShareOfAcquireeEntity" xlink:label="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_30"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_RetainedEarningsAccumulatedDeficits" xlink:label="loc_cmmb_RetainedEarningsAccumulatedDeficits_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_41"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_WarrantsExercisablePeriod" xlink:label="loc_cmmb_WarrantsExercisablePeriod_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_43"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid" xlink:label="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_44"/>
    <loc xlink:type="locator" xlink:href="cmmb-20230331.xsd#cmmb_CarrybackNetOperatingLosses" xlink:label="loc_cmmb_CarrybackNetOperatingLosses_45"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" xlink:to="loc_cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_srt_TitleOfIndividualAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_4" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" xlink:to="loc_cmmb_FormerChemomabSecurityHoldersMember_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" xlink:to="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" xlink:to="loc_cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_PlanNameAxis_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_9" xlink:to="loc_us-gaap_PlanNameDomain_9" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9" xlink:to="loc_cmmb_TwoThousandFifteenPlanMember_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_12" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_12" xlink:to="loc_us-gaap_ClassOfStockDomain_12" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_12" xlink:to="loc_cmmb_AmericanDepositorySharesMember_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_12" xlink:to="loc_cmmb_OrdinarySharesMember_13" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_srt_RangeAxis_16" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_16" xlink:to="loc_srt_RangeMember_16" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_16" xlink:to="loc_srt_MinimumMember_16" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_16" xlink:to="loc_srt_MaximumMember_17" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_20" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_20" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20" xlink:to="loc_cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_20" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_23" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_23" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_24" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_25" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_26" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_27" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_cmmb_NumberOfSharesDilutedAfterMerger_28" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_us-gaap_Capital_29" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_30" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_cmmb_RetainedEarningsAccumulatedDeficits_31" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_32" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_33" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_34" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_35" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_36" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_37" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_38" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_39" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_40" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_41" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_cmmb_WarrantsExercisablePeriod_42" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_43" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_44" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_23" xlink:to="loc_cmmb_CarrybackNetOperatingLosses_45" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/Contingencies">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139714849682928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>May 08, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001534248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Chemomab
Therapeutics Ltd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-3676773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Kiryat
        Atidim<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Building 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tel
        Aviv<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">6158002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">77-331-0156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,049,812<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesMember', window );">American Depositary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American
        Depositary Shares, each representing twenty (20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CMMB<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Name of Exchange on which Security is Registered</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember', window );">Ordinary Shares, No Par Value Per Share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary
        shares, no par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">n/a<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Name of Exchange on which Security is Registered</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139714845225968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 20,765<span></span>
</td>
<td class="nump">$ 13,519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsCurrent', window );">Short term bank deposits</a></td>
<td class="nump">11,941<span></span>
</td>
<td class="nump">26,374<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Other receivables and prepaid expenses</a></td>
<td class="nump">995<span></span>
</td>
<td class="nump">1,766<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">33,778<span></span>
</td>
<td class="nump">41,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseNoncurrent', window );">Long term prepaid expenses</a></td>
<td class="nump">690<span></span>
</td>
<td class="nump">733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">352<span></span>
</td>
<td class="nump">367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">227<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="nump">1,235<span></span>
</td>
<td class="nump">1,327<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">35,013<span></span>
</td>
<td class="nump">43,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Trade payables</a></td>
<td class="nump">2,217<span></span>
</td>
<td class="nump">1,688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">3,164<span></span>
</td>
<td class="nump">3,378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee and related expenses</a></td>
<td class="nump">1,501<span></span>
</td>
<td class="nump">1,560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">6,997<span></span>
</td>
<td class="nump">6,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities - long term</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingent liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">7,059<span></span>
</td>
<td class="nump">6,840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Shareholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares no par value - Authorized: 650,000,000 shares as of March 31, 2023 and December 31, 2022; Issued and outstanding: 232,636,700 Ordinary shares as of March 31, 2023 and December 31, 2022;</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury share at cost (11,640,460 Ordinary shares as of March 31, 2023 and December 31, 2022)</a></td>
<td class="num">(1,218)<span></span>
</td>
<td class="num">(1,218)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="nump">101,744<span></span>
</td>
<td class="nump">101,260<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(72,572)<span></span>
</td>
<td class="num">(63,819)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity</a></td>
<td class="nump">27,954<span></span>
</td>
<td class="nump">36,223<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 35,013<span></span>
</td>
<td class="nump">$ 43,063<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139714849643600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockNoParValue', window );">Common Stock, No Par Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">650,000,000<span></span>
</td>
<td class="nump">650,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">232,636,700<span></span>
</td>
<td class="nump">232,636,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">232,636,700<span></span>
</td>
<td class="nump">232,636,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="nump">11,640,460<span></span>
</td>
<td class="nump">11,640,460<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139714849445856">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Interim Statements of Operations (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 6,887<span></span>
</td>
<td class="nump">$ 2,745<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,162<span></span>
</td>
<td class="nump">2,575<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,049<span></span>
</td>
<td class="nump">5,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_FinanceIncomeExpensesNet', window );">Financing income, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(317)<span></span>
</td>
<td class="num">(216)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,732<span></span>
</td>
<td class="nump">5,104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Taxes on income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">21<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 8,753<span></span>
</td>
<td class="nump">$ 5,104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic loss per Ordinary Share</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted loss per Ordinary Share</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of Ordinary Shares outstanding, basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">220,996,240<span></span>
</td>
<td class="nump">228,090,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of Ordinary Shares outstanding, diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">220,996,240<span></span>
</td>
<td class="nump">228,090,300<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">20 Ordinary Shares are equal to 1 American Depositary Share (ADS).</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_FinanceIncomeExpensesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of finance income earned and finance expenses incurred during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_FinanceIncomeExpensesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139714849500720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Interim Statements of Changes in Equity (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Ordinary Shares [Member]</div></th>
<th class="th"><div>Treasury share [Member]</div></th>
<th class="th"><div>Additional paid in capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97,639<span></span>
</td>
<td class="num">$ (36,173)<span></span>
</td>
<td class="nump">$ 61,466<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (In shares) at Dec. 31, 2021</a></td>
<td class="nump">228,090,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">874<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">874<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period/year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,104)<span></span>
</td>
<td class="num">(5,104)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98,513<span></span>
</td>
<td class="num">(41,277)<span></span>
</td>
<td class="nump">57,236<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="nump">228,090,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1,218)<span></span>
</td>
<td class="nump">101,260<span></span>
</td>
<td class="num">(63,819)<span></span>
</td>
<td class="nump">36,223<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (In shares) at Dec. 31, 2022</a></td>
<td class="nump">232,636,700<span></span>
</td>
<td class="num">(11,640,460)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">484<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">484<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period/year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,753)<span></span>
</td>
<td class="num">(8,753)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1,218)<span></span>
</td>
<td class="nump">$ 101,744<span></span>
</td>
<td class="num">$ (72,572)<span></span>
</td>
<td class="nump">$ 27,954<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2023</a></td>
<td class="nump">232,636,700<span></span>
</td>
<td class="num">(11,640,460)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139714849560080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Interim Statements of Cash flows (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss for the period</a></td>
<td class="num">$ (8,753)<span></span>
</td>
<td class="num">$ (5,104)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments for operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">484<span></span>
</td>
<td class="nump">874<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Change in other receivables and prepaid expenses</a></td>
<td class="nump">814<span></span>
</td>
<td class="num">(363)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Change in operating lease liability</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Change in trade payables</a></td>
<td class="nump">529<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Change in accrued expenses</a></td>
<td class="num">(214)<span></span>
</td>
<td class="nump">693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Change in employees and related expenses</a></td>
<td class="num">(59)<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities', window );">Adjustments for operating activities</a></td>
<td class="nump">1,567<span></span>
</td>
<td class="nump">1,393<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(7,186)<span></span>
</td>
<td class="num">(3,711)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_ProceedsFromSaleOfDeposits', window );">Decrease in bank deposits</a></td>
<td class="nump">14,433<span></span>
</td>
<td class="nump">2,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">14,432<span></span>
</td>
<td class="nump">2,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Change in cash, cash equivalents and restricted cash</a></td>
<td class="nump">7,246<span></span>
</td>
<td class="num">(1,329)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">13,596<span></span>
</td>
<td class="nump">15,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">$ 20,842<span></span>
</td>
<td class="nump">$ 13,912<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ProceedsFromSaleOfDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ProceedsFromSaleOfDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139714847927408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_NatureOfOperationsDisclosureAbstract', window );"><strong>Nature Of Operations Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">General</a></td>
<td class="text">

<div>

<div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span>Note
1 - General.</span></span></span></span></span></span></span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:36pt">&#160;</td>
    <td style="width:36pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span>A.</span></span></span></span></span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify">Chemomab Therapeutics
        Ltd. (the &#8220;Company") is an Israeli-based company incorporated under the laws of the State of Israel in September 2011. The Company&#8217;s
        registered office is located in Kiryat Atidim, Tel Aviv, Israel. The Company is a clinical-stage biotech company discovering and developing
        innovative therapeutics for conditions with high-unmet medical need that involve inflammation and fibrosis.&#160;</p> </td> </tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:36pt">&#160;</td>
    <td style="width:36pt;vertical-align:top;font-weight:bold">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">B.</span></p>
        </td>
    <td style="width:auto;vertical-align:top">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify">The Company currently
        has no products approved for sale. The Company&#8217;s operations are funded primarily by its Shareholders. The Company has incurred operating
        losses in each year since its inception and does not expect to generate significant revenue unless and until it obtains marketing approval
        for its products. Continuation of the Company&#8217;s development programs depend on its future ability to raise sources of financing.
        The Company believes that its existing liquidity resources as of March 31, 2023 will enable it to fund its operations through June 30,
        2024 with the ability to perform cost reductions in order to extend the operations even further, if required to do so.</p> </td> </tr>
  <tr>
    <td style="width:36pt">&#160;</td>
    <td style="width:36pt;vertical-align:top;font-weight:bold">&#160;</td>
    <td style="width:auto;vertical-align:top">&#160;</td> </tr>
  <tr>
    <td style="width:36pt">&#160;</td>
    <td style="width:36pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span>C.</span></span></span></span></span></span></span></span></span></span></td>
    <td style="width:auto;vertical-align:top">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify">On April 30, 2021,
        the Company entered into an At the Market Offering Agreement (the "ATM Agreement") with Cantor Fitzgerald &amp; Co., ("Cantor"). According
        to the ATM Agreement, the Company may offer and sell, from time to time, its ADSs having an aggregate offering price of up to $75
        million through Cantor or the ATM Agreement. From April 30, 2021, through March 31, 2023 the Company issued 699,806
        ADSs at an average price of $22.75
        per ADS under the ATM Agreement, resulting in gross proceeds of $15,917
        thousand.</p> </td> </tr>
  </table>

<div style="text-align:justify;margin-left:72pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25">

<table border="0" cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;text-align:justify">
  <tr>
    <td style="font-size:10pt;vertical-align:top;width:36pt">&#160;</td>
    <td style="font-size:10pt;vertical-align:top;width:36pt"><strong>D.</strong></td>
    <td style="font-size:10pt;vertical-align:top;width:auto;margin-top:0pt;margin-bottom:0pt">
        <p style="margin-top:0pt;margin-bottom:0pt">On April 25, 2022, the Company filed a prospectus supplement with the SEC for the issuance
        and sale of up to&#160; $18,125,000
        of its ADSs in connection with the reactivation of the ATM Facility and pursuant to General Instruction I.B.6 of Form S-3, which, subject
        to certain exceptions, limits the amount of securities the Company is able to offer and sell under such registration statement to one-third
        of our unaffiliated public float. During the year ended December 31, 2022, the Company issued 130,505
        ADSs at an average price of $2.11
        per ADS under the ATM Agreement, resulting in gross proceeds of $275
        thousand.</p>
        <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">On March 22, 2023 the Company filed
        with the SEC an amendment to registration statement on form S-1/A for the issuance and sale of up to&#160; $10
        million of its ADSs.</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><br/>On March 27, 2020 and December
        27, 2020, the President of the United States signed and enacted into law the Coronavirus Aid, Relief, and Economic Security Act (CARES
        Act) and the Consolidated Appropriations Act, 2021 (CAA). Among other provisions, the CARES Act and the CAA provide relief to U.S. federal
        corporate taxpayers through temporary adjustments to net operating loss rules, changes to limitations on interest expense deductibility,
        and the acceleration of available refunds for minimum tax credit carryforwards. The CARES Act also includes provisions for a carryback
        of any net operating loss (NOL) arising in a taxable year beginning after December 31, 2017, and before January 1, 2021, to each of the
        five taxable years preceding the taxable year in which the loss arises (carryback period).</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">Chemomab Therapeutics Inc., a wholly
        owned subsidiary of the Company, filed an application with the US Internal Revenue Service to carryback net operating losses. The Company
        received $351
        thousand in 2022 and $187
        thousand in March 2023.</p> </td> </tr>
  </table> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NatureOfOperationsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NatureOfOperationsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139714847998640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Significant Accounting Policies</a></td>
<td class="text">

<div>

<div>

<div>

<div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note
2 - Basis of Presentation and Significant Accounting Policies</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div>

<div>

<table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">
  <tr style="vertical-align:top">
    <td style="width:36pt">&#160;</td>
    <td style="vertical-align:top;width:36pt">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">A.</span></span></span></div>
        </td>
    <td style="vertical-align:top;width:auto">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Basis
        of Preparation</span></span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:35.45pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The
condensed interim consolidated financial statements included in this quarterly report are unaudited. These financial statements have been
prepared in accordance with U.S. GAAP and applicable rules and regulations of the SEC regarding interim financial reporting and reflect,
in the opinion of management, all adjustments of a normal and recurring nature that are necessary for a fair statement of the Company&#8217;s
financial position as of March 31, 2023, and its results of operations for the three ended March 31, 2023, and 2022, changes in shareholders&#8217;
equity for the three months ended March 31, 2023 and 2022, and cash flows for the three months ended March 31, 2023 and 2022. The results
of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the year ending
December 31, 2023 or for any other future annual or interim period. These financial statements should be read in conjunction with the
audited financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022 and Form
10-Q for the three months ended March 31, 2023 filed with the SEC. The Company&#8217;s significant accounting policies are disclosed in
the audited financial statements for the year ended December 31, 2022 included in the Company&#8217;s Annual Report on Form 10-K. Since
the date of such financial statements, there have been no changes to the Company&#8217;s significant accounting policies.</span></span></span></div>
</div>

<div style="line-height:1.25">&#160;</div>

<div>

<div>

<table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">
  <tr style="vertical-align:top">
    <td style="width:36pt">&#160;</td>
    <td style="vertical-align:top;width:36pt">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">B.</span></span></span></div>
        </td>
    <td style="vertical-align:top;width:auto">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Use
        of estimates</span></span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:-0.55pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and
liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual
results could differ materially from those estimates.</span></span></div> </div>  </div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139714848124224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingencies</a></td>
<td class="text">

<div>

<div>

<div>

<div>

<div>

<div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note
3 - Contingencies</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-family:Times New Roman, Times, serif;font-size:10pt">During 2022, the
Israeli tax authority ("ITA&#8221;) notified the Company that it had initiated a routine VAT audit to include tax years 2017 through 2020.
The ITA raised several claims, mainly in respect with the recoverability of VAT with respect to Merger Agreement related expenses and
the classification of the Company as a holding company. On July 2022, the ITA proposed a settlement, which the Company rejected. As a
result, the ITA issued an assessment. The Company plans to appeal the ITA&#8217;s assessment. The Company has recorded a provision in
2022 which is inherently subjective due to the inherent uncertainty of these matters and the judicial process. Therefore, the outcome
may differ from the estimated liability recorded by the Company during the period.</span></div> </div> </div> </div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139715019381648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Preparation</a></td>
<td class="text">

<div>

<div>

<table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">
  <tr style="vertical-align:top">
    <td style="width:36pt">&#160;</td>
    <td style="vertical-align:top;width:36pt">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">A.</span></span></span></div>
        </td>
    <td style="vertical-align:top;width:auto">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Basis
        of Preparation</span></span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;margin-left:35.45pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The
condensed interim consolidated financial statements included in this quarterly report are unaudited. These financial statements have been
prepared in accordance with U.S. GAAP and applicable rules and regulations of the SEC regarding interim financial reporting and reflect,
in the opinion of management, all adjustments of a normal and recurring nature that are necessary for a fair statement of the Company&#8217;s
financial position as of March 31, 2023, and its results of operations for the three ended March 31, 2023, and 2022, changes in shareholders&#8217;
equity for the three months ended March 31, 2023 and 2022, and cash flows for the three months ended March 31, 2023 and 2022. The results
of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the year ending
December 31, 2023 or for any other future annual or interim period. These financial statements should be read in conjunction with the
audited financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022 and Form
10-Q for the three months ended March 31, 2023 filed with the SEC. The Company&#8217;s significant accounting policies are disclosed in
the audited financial statements for the year ended December 31, 2022 included in the Company&#8217;s Annual Report on Form 10-K. Since
the date of such financial statements, there have been no changes to the Company&#8217;s significant accounting policies.</span></span></span></div>
</div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text">

<div>

<div>

<table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">
  <tr style="vertical-align:top">
    <td style="width:36pt">&#160;</td>
    <td style="vertical-align:top;width:36pt">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">B.</span></span></span></div>
        </td>
    <td style="vertical-align:top;width:auto">
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Use
        of estimates</span></span></span></div> </td> </tr>
  </table> </div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:-0.55pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The
preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and
liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual
results could differ materially from those estimates.</span></span></div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139714849511024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Detail Textuals) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 22, 2023</div></th>
<th class="th"><div>Apr. 25, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cmmb_CarrybackNetOperatingLosses', window );">Carryback net operating losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 187<span></span>
</td>
<td class="nump">$ 351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositorySharesMember', window );">American Depositary Share ("ADS") [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Gross proceeds from sale under agreement</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositorySharesMember', window );">American Depositary Share ("ADS") [Member] | At The Market Offering Agreement With Cantor Fitzgerald &amp; Co. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Aggregate offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,125,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">699,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,505<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Average price of shares issued under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Gross proceeds from sale under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 275<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_CarrybackNetOperatingLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of carryback net operating losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_CarrybackNetOperatingLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositorySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositorySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>zk2329603_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cmmb="http://www.anchiano.com/20230331"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cmmb-20230331.xsd" xlink:type="simple"/>
    <context id="C_20230101to20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_20230508">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2023-05-08</instant>
        </period>
    </context>
    <context id="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_20230331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_20220401to20220425_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-25</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230301to20230322_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-22</endDate>
        </period>
    </context>
    <context id="C_20220101to20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_20230331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <unit id="Share">
        <measure>shares</measure>
    </unit>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="USD_per_share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="C_20230101to20230331" id="FFact_288">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="C_20230101to20230331" id="FFact_289">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="C_20230101to20230331" id="FFact_290">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="C_20230101to20230331" id="FFact_292">0001534248</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="C_20230101to20230331" id="FFact_1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="C_20230101to20230331" id="FFact_2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_20230101to20230331"
      id="Fxbrl_20221026220521273">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_20230101to20230331"
      id="Fxbrl_20221026220738505">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="C_20230101to20230331" id="FFact_4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="C_20230101to20230331" id="FFact_5">001-38807</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="C_20230101to20230331" id="FFact_6">Chemomab Therapeutics Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_20230101to20230331" id="FFact_7">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="C_20230101to20230331" id="FFact_8">81-3676773</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_20230101to20230331" id="FFact_9">Kiryat         Atidim</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="C_20230101to20230331" id="FFact_10">Building 7</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="C_20230101to20230331" id="FFact_11">Tel         Aviv</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="C_20230101to20230331" id="FFact_12">IL</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="C_20230101to20230331" id="FFact_13">6158002</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_20230101to20230331" id="FFact_14">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_20230101to20230331" id="FFact_15">77-331-0156</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember"
      id="FFact_16">American         Depositary Shares, each representing twenty (20)</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember"
      id="FFact_17">CMMB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember"
      id="FFact_18">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember"
      id="FFact_19">Ordinary         shares, no par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember"
      id="Fxbrl_20221108153004455">n/a</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember"
      id="Fxbrl_20220810204332751">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="C_20230101to20230331" id="FFact_22">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="C_20230101to20230331" id="FFact_23">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="C_20230101to20230331" id="FFact_24">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="C_20230101to20230331" id="FFact_25">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="C_20230101to20230331" id="FFact_26">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="C_20230101to20230331" id="FFact_27">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="C_20230101to20230331" id="FFact_28">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_20230508"
      decimals="INF"
      id="Fxbrl_20221026225744475"
      unitRef="Share">11049812</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20230331"
      decimals="-3"
      id="FFact_30"
      unitRef="USD">20765000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_31"
      unitRef="USD">13519000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DepositsAssetsCurrent
      contextRef="C_20230331"
      decimals="-3"
      id="FFact_32"
      unitRef="USD">11941000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:DepositsAssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_33"
      unitRef="USD">26374000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="C_20230331"
      decimals="-3"
      id="Fxbrl_20230501160610892_Fact_30"
      unitRef="USD">77000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230501160610892_Fact_31"
      unitRef="USD">77000</us-gaap:RestrictedCashCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20230331"
      decimals="-3"
      id="FFact_34"
      unitRef="USD">995000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_35"
      unitRef="USD">1766000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_20230331"
      decimals="-3"
      id="FFact_36"
      unitRef="USD">33778000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_37"
      unitRef="USD">41736000</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="C_20230331"
      decimals="-3"
      id="Fxbrl_20220504175928392"
      unitRef="USD">690000</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_40"
      unitRef="USD">733000</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20230331"
      decimals="-3"
      id="FFact_42"
      unitRef="USD">352000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_43"
      unitRef="USD">367000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20230331"
      decimals="-3"
      id="FFact_46"
      unitRef="USD">193000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_47"
      unitRef="USD">227000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AssetsNoncurrent
      contextRef="C_20230331"
      decimals="-3"
      id="FFact_48"
      unitRef="USD">1235000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_49"
      unitRef="USD">1327000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_20230331"
      decimals="-3"
      id="FFact_50"
      unitRef="USD">35013000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_51"
      unitRef="USD">43063000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="C_20230331"
      decimals="-3"
      id="FFact_52"
      unitRef="USD">2217000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_53"
      unitRef="USD">1688000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_20230331"
      decimals="-3"
      id="FFact_54"
      unitRef="USD">3164000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_55"
      unitRef="USD">3378000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_20230331"
      decimals="-3"
      id="FFact_56"
      unitRef="USD">1501000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_57"
      unitRef="USD">1560000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20230331"
      decimals="-3"
      id="FFact_58"
      unitRef="USD">115000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_59"
      unitRef="USD">123000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20230331"
      decimals="-3"
      id="FFact_60"
      unitRef="USD">6997000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_61"
      unitRef="USD">6749000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20230331"
      decimals="-3"
      id="FFact_62"
      unitRef="USD">62000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_63"
      unitRef="USD">91000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_20230331"
      decimals="-3"
      id="FFact_64"
      unitRef="USD">62000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_65"
      unitRef="USD">91000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_20230331"
      id="Fxbrl_20221108051943260_Fact_64"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_20221231"
      id="Fxbrl_20221108051943260_Fact_65"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Liabilities
      contextRef="C_20230331"
      decimals="-3"
      id="FFact_66"
      unitRef="USD">7059000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_67"
      unitRef="USD">6840000</us-gaap:Liabilities>
    <us-gaap:CommonStockNoParValue
      contextRef="C_20221231"
      decimals="0"
      id="Fxbrl_20220505092446513"
      unitRef="USD_per_share">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockNoParValue
      contextRef="C_20230331"
      decimals="0"
      id="Fxbrl_20220719155003261"
      unitRef="USD_per_share">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20220505092709497"
      unitRef="Share">650000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20230331"
      decimals="INF"
      id="Fxbrl_20220719155025581"
      unitRef="Share">650000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20230501162335964"
      unitRef="Share">232636700</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20230501162324131"
      unitRef="Share">232636700</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20230331"
      decimals="INF"
      id="Fxbrl_20230501162302866"
      unitRef="Share">232636700</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20230331"
      decimals="INF"
      id="Fxbrl_20230501162254717"
      unitRef="Share">232636700</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="C_20230331"
      decimals="-3"
      id="Fxbrl_20220505093047469"
      unitRef="USD">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220505093055381"
      unitRef="USD">0</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockShares
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20230501130301925"
      unitRef="Share">11640460</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="C_20230331"
      decimals="INF"
      id="Fxbrl_20230501130254826"
      unitRef="Share">11640460</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="C_20230331"
      decimals="-3"
      id="Fxbrl_20230501130942230"
      unitRef="USD">1218000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230501131017943"
      unitRef="USD">1218000</us-gaap:TreasuryStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_20230331"
      decimals="-3"
      id="FFact_78"
      unitRef="USD">101744000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_79"
      unitRef="USD">101260000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20230331"
      decimals="-3"
      id="FFact_80"
      unitRef="USD">-72572000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_81"
      unitRef="USD">-63819000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_20230331"
      decimals="-3"
      id="Fxbrl_20220719200901554_Fact_84"
      unitRef="USD">27954000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220719200901554_Fact_85"
      unitRef="USD">36223000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20230331"
      decimals="-3"
      id="FFact_84"
      unitRef="USD">35013000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20221108131652038"
      unitRef="USD">43063000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="FFact_88"
      unitRef="USD">6887000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_89"
      unitRef="USD">2745000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="FFact_92"
      unitRef="USD">2162000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_93"
      unitRef="USD">2575000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="FFact_96"
      unitRef="USD">9049000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_97"
      unitRef="USD">5320000</us-gaap:OperatingExpenses>
    <cmmb:FinanceIncomeExpensesNet
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="Fxbrl_20221026182150611"
      unitRef="USD">317000</cmmb:FinanceIncomeExpensesNet>
    <cmmb:FinanceIncomeExpensesNet
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="Fxbrl_20230501164940410"
      unitRef="USD">216000</cmmb:FinanceIncomeExpensesNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="Fxbrl_20220808224756229"
      unitRef="USD">-8732000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="Fxbrl_20220808224804527"
      unitRef="USD">-5104000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="Fxbrl_20220728231430174"
      unitRef="USD">21000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_101"
      unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="FFact_104"
      unitRef="USD">-8753000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_105"
      unitRef="USD">-5104000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20230101to20230331"
      decimals="3"
      id="Fxbrl_20221108042029242"
      unitRef="USD_per_share">0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20230101to20230331"
      decimals="3"
      id="Fxbrl_20220801220211119"
      unitRef="USD_per_share">0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20220101to20220331"
      decimals="3"
      id="Fxbrl_20221108042048740"
      unitRef="USD_per_share">0.022</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20220101to20220331"
      decimals="3"
      id="Fxbrl_20220801220307005"
      unitRef="USD_per_share">0.022</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20230101to20230331"
      decimals="INF"
      id="Fxbrl_20230501140837133"
      unitRef="Share">220996240</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20230101to20230331"
      decimals="INF"
      id="Fxbrl_20230501140723514"
      unitRef="Share">220996240</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20220101to20220331"
      decimals="INF"
      id="Fxbrl_20230501141120971"
      unitRef="Share">228090300</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20220101to20220331"
      decimals="INF"
      id="Fxbrl_20230501141042185"
      unitRef="Share">228090300</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:SharesOutstanding
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220719171142064_xbrl_20220504161436664"
      unitRef="Share">232636700</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220719171142064_xbrl_20220505093740414"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="INF"
      id="Fxbrl_20230501151602018"
      unitRef="Share">-11640460</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="-3"
      id="Fxbrl_20230501151611321"
      unitRef="USD">-1218000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230501151742804"
      unitRef="USD">101260000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230501152649480"
      unitRef="USD">-63819000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230501152914617"
      unitRef="USD">36223000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220719171155021_xbrl_20220505093821193"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="-3"
      id="Fxbrl_20230501153041825"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220719171155021_xbrl_20220504161917493"
      unitRef="USD">484000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220719171155021_xbrl_20220505093815054"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="Fxbrl_20220719171155021_xbrl_20220504161939600"
      unitRef="USD">484000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220719171210751_xbrl_20220505093843525"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="-3"
      id="Fxbrl_20230501153100009"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220719171210751_xbrl_20220505093847704"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20230331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230501152819814"
      unitRef="USD">-8753000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="Fxbrl_20230501152925490"
      unitRef="USD">-8753000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230501152450068"
      unitRef="Share">232636700</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220719171143948_xbrl_20220505093740414"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="INF"
      id="Fxbrl_20230501152541868"
      unitRef="Share">-11640460</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockMember"
      decimals="-3"
      id="Fxbrl_20230501152556917"
      unitRef="USD">-1218000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230501152618776"
      unitRef="USD">101744000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20230331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230501152728382"
      unitRef="USD">-72572000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20230331"
      decimals="-3"
      id="Fxbrl_20230501152949713"
      unitRef="USD">27954000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220504161436664"
      unitRef="Share">228090300</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220505093740414"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220504161607482"
      unitRef="USD">97639000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220504161812745"
      unitRef="USD">-36173000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220504161847247"
      unitRef="USD">61466000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220505093821193"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220504161917493"
      unitRef="USD">874000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220505093815054"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="Fxbrl_20220504161939600"
      unitRef="USD">874000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220505093843525"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220505093847704"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220504162015389"
      unitRef="USD">-5104000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="Fxbrl_20220504162029289"
      unitRef="USD">-5104000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220504162054050"
      unitRef="Share">228090300</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220505093917037"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220504162134224"
      unitRef="USD">98513000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220504162140381"
      unitRef="USD">-41277000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220331"
      decimals="-3"
      id="Fxbrl_20220504162145961"
      unitRef="USD">57236000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="FFact_193"
      unitRef="USD">-8753000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_194"
      unitRef="USD">-5104000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="FFact_195"
      unitRef="USD">16000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_196"
      unitRef="USD">13000</us-gaap:Depreciation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="FFact_205"
      unitRef="USD">484000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_206"
      unitRef="USD">874000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="FFact_197"
      unitRef="USD">-814000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="Fxbrl_20220719185926153"
      unitRef="USD">363000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="Fxbrl_20220719190053059"
      unitRef="USD">-3000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="Fxbrl_20220504154924941"
      unitRef="USD">12000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="FFact_199"
      unitRef="USD">529000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_200"
      unitRef="USD">151000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="Fxbrl_20230501141051534"
      unitRef="USD">-214000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_202"
      unitRef="USD">693000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="Fxbrl_20230501141057759"
      unitRef="USD">-59000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_204"
      unitRef="USD">13000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="FFact_207"
      unitRef="USD">1567000</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="Fxbrl_20220719185858022"
      unitRef="USD">1393000</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="FFact_209"
      unitRef="USD">-7186000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_210"
      unitRef="USD">-3711000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <cmmb:ProceedsFromSaleOfDeposits
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="FFact_211"
      unitRef="USD">14433000</cmmb:ProceedsFromSaleOfDeposits>
    <cmmb:ProceedsFromSaleOfDeposits
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="Fxbrl_20220719190124821"
      unitRef="USD">2396000</cmmb:ProceedsFromSaleOfDeposits>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="FFact_215"
      unitRef="USD">1000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_216"
      unitRef="USD">14000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="FFact_217"
      unitRef="USD">14432000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_218"
      unitRef="USD">2382000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="FFact_229"
      unitRef="USD">0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_230"
      unitRef="USD">0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="FFact_231"
      unitRef="USD">7246000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="Fxbrl_20230501141209877"
      unitRef="USD">-1329000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_233"
      unitRef="USD">13596000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_234"
      unitRef="USD">15241000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20230331"
      decimals="-3"
      id="FFact_235"
      unitRef="USD">20842000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_236"
      unitRef="USD">13912000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NatureOfOperations
      contextRef="C_20230101to20230331"
      id="Fxbrl_20221108050710796">

&lt;div&gt;

&lt;div style="text-align:justify;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Note
1 - General.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:36pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;A.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;Chemomab Therapeutics
        Ltd. (the &#x201c;Company") is an Israeli-based company incorporated under the laws of the State of Israel in September 2011. The Company&#x2019;s
        registered office is located in Kiryat Atidim, Tel Aviv, Israel. The Company is a clinical-stage biotech company discovering and developing
        innovative therapeutics for conditions with high-unmet medical need that involve inflammation and fibrosis.&#160;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;
  &lt;tr&gt;
    &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:36pt;vertical-align:top;font-weight:bold"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;B.&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;The Company currently
        has no products approved for sale. The Company&#x2019;s operations are funded primarily by its Shareholders. The Company has incurred operating
        losses in each year since its inception and does not expect to generate significant revenue unless and until it obtains marketing approval
        for its products. Continuation of the Company&#x2019;s development programs depend on its future ability to raise sources of financing.
        The Company believes that its existing liquidity resources as of March 31, 2023 will enable it to fund its operations through June 30,
        2024 with the ability to perform cost reductions in order to extend the operations even further, if required to do so.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:36pt;vertical-align:top;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:36pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;C.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width:auto;vertical-align:top"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;On April 30, 2021,
        the Company entered into an At the Market Offering Agreement (the "ATM Agreement") with Cantor Fitzgerald &amp;amp; Co., ("Cantor"). According
        to the ATM Agreement, the Company may offer and sell, from time to time, its ADSs having an aggregate offering price of up to $75
        million through Cantor or the ATM Agreement. From April 30, 2021, through March 31, 2023 the Company issued 699,806
        ADSs at an average price of $22.75
        per ADS under the ATM Agreement, resulting in gross proceeds of $15,917
        thousand.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="text-align:justify;margin-left:72pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;text-align:justify"&gt;
  &lt;tr&gt;
    &lt;td style="font-size:10pt;vertical-align:top;width:36pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;vertical-align:top;width:36pt"&gt;&lt;strong&gt;D.&lt;/strong&gt;&lt;/td&gt;
    &lt;td style="font-size:10pt;vertical-align:top;width:auto;margin-top:0pt;margin-bottom:0pt"&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;On April 25, 2022, the Company filed a prospectus supplement with the SEC for the issuance
        and sale of up to&#160; $18,125,000
        of its ADSs in connection with the reactivation of the ATM Facility and pursuant to General Instruction I.B.6 of Form S-3, which, subject
        to certain exceptions, limits the amount of securities the Company is able to offer and sell under such registration statement to one-third
        of our unaffiliated public float. During the year ended December 31, 2022, the Company issued 130,505
        ADSs at an average price of $2.11
        per ADS under the ATM Agreement, resulting in gross proceeds of $275
        thousand.&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;On March 22, 2023 the Company filed
        with the SEC an amendment to registration statement on form S-1/A for the issuance and sale of up to&#160; $10
        million of its ADSs.&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;br/&gt;On March 27, 2020 and December
        27, 2020, the President of the United States signed and enacted into law the Coronavirus Aid, Relief, and Economic Security Act (CARES
        Act) and the Consolidated Appropriations Act, 2021 (CAA). Among other provisions, the CARES Act and the CAA provide relief to U.S. federal
        corporate taxpayers through temporary adjustments to net operating loss rules, changes to limitations on interest expense deductibility,
        and the acceleration of available refunds for minimum tax credit carryforwards. The CARES Act also includes provisions for a carryback
        of any net operating loss (NOL) arising in a taxable year beginning after December 31, 2017, and before January 1, 2021, to each of the
        five taxable years preceding the taxable year in which the loss arises (carryback period).&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Chemomab Therapeutics Inc., a wholly
        owned subsidiary of the Company, filed an application with the US Internal Revenue Service to carryback net operating losses. The Company
        received $351
        thousand in 2022 and $187
        thousand in March 2023.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; </us-gaap:NatureOfOperations>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember"
      decimals="-6"
      id="Fxbrl_20230504064019754"
      unitRef="USD">75000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember"
      decimals="INF"
      id="Fxbrl_20230504064033619"
      unitRef="Share">699806</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_20230331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember"
      decimals="2"
      id="Fxbrl_20230504064050529"
      unitRef="USD_per_share">22.75</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="C_20230101to20230331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember"
      decimals="-3"
      id="Fxbrl_20230504064101257"
      unitRef="USD">15917000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="C_20220401to20220425_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember"
      decimals="-3"
      id="Fxbrl_20230504064130218"
      unitRef="USD">18125000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember"
      decimals="INF"
      id="Fxbrl_20230504064138848"
      unitRef="Share">130505</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_20221231_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember"
      decimals="2"
      id="Fxbrl_20230504064151056"
      unitRef="USD_per_share">2.11</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="C_20220101to20221231_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember"
      decimals="-3"
      id="Fxbrl_20230504064202553"
      unitRef="USD">275000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="C_20230301to20230322_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesMember"
      decimals="-6"
      id="Fxbrl_20230504064230261"
      unitRef="USD">10000000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <cmmb:CarrybackNetOperatingLosses
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="Fxbrl_20230504064257425"
      unitRef="USD">351000</cmmb:CarrybackNetOperatingLosses>
    <cmmb:CarrybackNetOperatingLosses
      contextRef="C_20230101to20230331"
      decimals="-3"
      id="Fxbrl_20230504064307409"
      unitRef="USD">187000</cmmb:CarrybackNetOperatingLosses>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_20230101to20230331"
      id="Fxbrl_20220505134338955">

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note
2 - Basis of Presentation and Significant Accounting Policies&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:36pt"&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;A.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td style="vertical-align:top;width:auto"&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Basis
        of Preparation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:35.45pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;The
condensed interim consolidated financial statements included in this quarterly report are unaudited. These financial statements have been
prepared in accordance with U.S. GAAP and applicable rules and regulations of the SEC regarding interim financial reporting and reflect,
in the opinion of management, all adjustments of a normal and recurring nature that are necessary for a fair statement of the Company&#x2019;s
financial position as of March 31, 2023, and its results of operations for the three ended March 31, 2023, and 2022, changes in shareholders&#x2019;
equity for the three months ended March 31, 2023 and 2022, and cash flows for the three months ended March 31, 2023 and 2022. The results
of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the year ending
December 31, 2023 or for any other future annual or interim period. These financial statements should be read in conjunction with the
audited financial statements included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2022 and Form
10-Q for the three months ended March 31, 2023 filed with the SEC. The Company&#x2019;s significant accounting policies are disclosed in
the audited financial statements for the year ended December 31, 2022 included in the Company&#x2019;s Annual Report on Form 10-K. Since
the date of such financial statements, there have been no changes to the Company&#x2019;s significant accounting policies.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:36pt"&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;B.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td style="vertical-align:top;width:auto"&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Use
        of estimates&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;text-indent:-0.55pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and
liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual
results could differ materially from those estimates.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt;  &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_20230101to20230331"
      id="Fxbrl_20221108051936803">

&lt;div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:36pt"&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;A.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td style="vertical-align:top;width:auto"&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Basis
        of Preparation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;margin-left:35.45pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;The
condensed interim consolidated financial statements included in this quarterly report are unaudited. These financial statements have been
prepared in accordance with U.S. GAAP and applicable rules and regulations of the SEC regarding interim financial reporting and reflect,
in the opinion of management, all adjustments of a normal and recurring nature that are necessary for a fair statement of the Company&#x2019;s
financial position as of March 31, 2023, and its results of operations for the three ended March 31, 2023, and 2022, changes in shareholders&#x2019;
equity for the three months ended March 31, 2023 and 2022, and cash flows for the three months ended March 31, 2023 and 2022. The results
of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the year ending
December 31, 2023 or for any other future annual or interim period. These financial statements should be read in conjunction with the
audited financial statements included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2022 and Form
10-Q for the three months ended March 31, 2023 filed with the SEC. The Company&#x2019;s significant accounting policies are disclosed in
the audited financial statements for the year ended December 31, 2022 included in the Company&#x2019;s Annual Report on Form 10-K. Since
the date of such financial statements, there have been no changes to the Company&#x2019;s significant accounting policies.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt; </us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_20230101to20230331"
      id="Fxbrl_20221108051959534">

&lt;div&gt;

&lt;div&gt;

&lt;table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt"&gt;
  &lt;tr style="vertical-align:top"&gt;
    &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align:top;width:36pt"&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;B.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/td&gt;
    &lt;td style="vertical-align:top;width:auto"&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Use
        of estimates&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;text-indent:-0.55pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The
preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and
liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual
results could differ materially from those estimates.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; </us-gaap:UseOfEstimates>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_20230101to20230331"
      id="Fxbrl_20220728222325384">

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div style="text-align:justify;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Note
3 - Contingencies&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

&lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt"&gt;During 2022, the
Israeli tax authority ("ITA&#x201d;) notified the Company that it had initiated a routine VAT audit to include tax years 2017 through 2020.
The ITA raised several claims, mainly in respect with the recoverability of VAT with respect to Merger Agreement related expenses and
the classification of the Company as a holding company. On July 2022, the ITA proposed a settlement, which the Company rejected. As a
result, the ITA issued an assessment. The Company plans to appeal the ITA&#x2019;s assessment. The Company has recorded a provision in
2022 which is inherently subjective due to the inherent uncertainty of these matters and the judicial process. Therefore, the outcome
may differ from the estimated liability recorded by the Company during the period.&lt;/span&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fxbrl_20220801220211119"
          xlink:label="Fxbrl_20220801220211119"
          xlink:type="locator"/>
        <link:footnote id="FN20220809022016820" xlink:label="FN20220809022016820" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">20 Ordinary Shares are equal to 1 American Depositary Share (ADS).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220801220211119"
          xlink:to="FN20220809022016820"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20221108042029242"
          xlink:label="Fxbrl_20221108042029242"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20221108042029242"
          xlink:to="FN20220809022016820"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220801220307005"
          xlink:label="Fxbrl_20220801220307005"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220801220307005"
          xlink:to="FN20220809022016820"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20221108042048740"
          xlink:label="Fxbrl_20221108042048740"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20221108042048740"
          xlink:to="FN20220809022016820"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230501140723514"
          xlink:label="Fxbrl_20230501140723514"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230501140723514"
          xlink:to="FN20220809022016820"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230501140837133"
          xlink:label="Fxbrl_20230501140837133"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230501140837133"
          xlink:to="FN20220809022016820"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230501141042185"
          xlink:label="Fxbrl_20230501141042185"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230501141042185"
          xlink:to="FN20220809022016820"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230501141120971"
          xlink:label="Fxbrl_20230501141120971"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230501141120971"
          xlink:to="FN20220809022016820"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>23
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" #L,*M69G8P/9,&  #T)   &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;+6:76_;-A2&[_LK" \86B".)3*QG2XQX#C-%C1)TSCKT V[8"3:%BJ)'D7%
M\;_?H21+;DH?JT+4BT:R=%[QY>''0TJG*ZF^)0LA-'F.PC@YZRRT7K[O]1)O
M(2*>',JEB.'*3*J(:SA5\UZR5(+[65 4]JCC]'L1#^+.Z#3[[4Z-3F6JPR 6
M=XHD:11QM3X7H5R===S.YH?[8+[0YH?>Z'3)YV(J])_+.P5GO5+%#R(1)X&,
MB1*SL\[8?3]A0Q.0W?$E$*MDZY@8*X]2?C,G5_Y9QS$E$J'PM)'@\.=)3$08
M&B4HQW^%:*=\I@G</MZH7V;FP<PC3\1$AG\%OEZ<=88=XHL93T-]+U=_B,+0
ML='S9)AD_Y-5?N_128=X::)E5 1#":(@SO_RYZ(BM@+Z_1T!M B@+P)<MB.
M%0$L,YJ7++-UP34?G2JY(LK<#6KF(*N;+!K<!+%)XU0KN!I G!Y=2"^%K&C"
M8Y]\B'6@U^0JSIN'J>8N219<B>2TI^%I)J;G%<KGN3+=H<S(C8SU(@%57_C?
MQ_>@E&51Z::HYQ05O.'JD##W@%"',DMY)OO"U\09VJ*_*PTK*XYE<FQ?Q3VL
ME\)6.WBXZW0_VSR@4:9/OT^6W!-G'>BTB5!/HC/Z]1>W[_R&6#HJ+1VA92K2
M/P%7BH?0#'SQ3#Z*M<T=KN0XCGO,CNC1T.81C6WH\;CT>%PO;7="!=(T>9]
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MP7VAS UP?2:EWIR8!Y0?.HW^!U!+ P04    " #L,*M6BRYL)]D%  #Q&0
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M$$?SU>SAD(YM!?$<+ENK'LZPQ1EZ<=YF7"B@J"AT?I;?=$YNN61NF$VD\!
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M)9["H&P!/E](:1X[=J/OSO7L+U!+ P04    " #L,*M6>/-G!#4$  !V#@
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MS5;J%_9LLL,;\D#DX^X^5RV[8DEH1IB@G(&<K*?6)WBS@IXV*!!_47(0)\]
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MF@659H%1LS_4SBCE0@"U P)R2\!.+2H\L5\(SKMT"_J<G =]RBYZ.99MQ"B
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M&J"^KSF7KPU]'U9=R<[^ U!+ P04    " #L,*M6@\P&]><$   G%   &
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MG;XQ<!IR:EJM+=!BM'^6=CRJ5<9BXMG+,BZAQIU03S&5;&":=H1"D8*2J5;
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M,8.]L#0&\/M:"/UV8UY0G@TN_@=02P,$%     @ [#"K5HZR,0;4!@  ]PX
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MF[Y>_+R[7(S^'"%'=V3:C@+K!DY8+XHVG@L;HYC(;O@7>4 ;9;WDY''>"X7
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MKWD'/R6W#ZNW;RZR;'KU,UC'NM18! ?!JQME=S)6#)JA4@5HJUDK%@L%7GJ
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M<AL5N!3C;!Z$Q6U\M3$?I#$MHHFC/B-A@++[R\17MM4%L^ !S7%!F7YN39J
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M"UB^KF\FYO5@I&_VC7M;QW;,9AU/4:,:?CBU'TZG'],$6>23%%S,*(^$W'/
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M.>-#*1JM[]CW@[X9J881.HS_F]]02P,$%     @ [#"K5G!2D.OL    J <
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M![[H_HSFGU!+ 0(4 Q0    ( .PPJU8'04UB@0   +$    0
M  "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ [#"K5I,O\#3O
M    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L!
M A0#%     @ [#"K5IE<G",0!@  G"<  !,              ( !S0$  'AL
M+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #L,*M69G8P/9,&  #T)
M&               @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!
M A0#%     @ [#"K5HLN;"?9!0  \1D  !@              ("!UPX  'AL
M+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( .PPJU:T6E1ZL@(
M .,'   8              " @>84  !X;"]W;W)K<VAE971S+W-H965T,RYX
M;6Q02P$"% ,4    " #L,*M6>/-G!#4$  !V#@  &               @('.
M%P  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ [#"K5C,[
M9QB !   GA4  !@              ("!.1P  'AL+W=O<FMS:&5E=',O<VAE
M970U+GAM;%!+ 0(4 Q0    ( .PPJU:#S ;UYP0  "<4   8
M  " @>\@  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " #L
M,*M6CK(Q!M0&  #W#@  &               @($,)@  >&PO=V]R:W-H965T
M<R]S:&5E=#<N>&UL4$L! A0#%     @ [#"K5IH;D2W^!    @T  !@
M         ("!%BT  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0
M   ( .PPJU;)3T2CH ,  +@'   8              " @4HR  !X;"]W;W)K
M<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " #L,*M6PTPPX X%   I#0
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M+G)E;'-02P$"% ,4    " #L,*M6P4LW6ND!  """   #P
M@ %.1   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ [#"K5G!2D.OL
MJ <  !H              ( !9$8  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ [#"K5G'F1LQ! 0  (0D  !,              ( !
MB$<  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     !, $P#\!   ^D@

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>37</ContextCount>
  <ElementCount>100</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>8</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="zk2329603.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="zk2329603.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="zk2329603.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="zk2329603.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0004 - Statement - Condensed Consolidated Interim Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>Condensed Consolidated Interim Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="zk2329603.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0005 - Statement - Condensed Consolidated Interim Statements of Changes in Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/InterimStatementsOfChangesInEquity</Role>
      <ShortName>Condensed Consolidated Interim Statements of Changes in Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="zk2329603.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0006 - Statement - Condensed Consolidated Interim Statements of Cash flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Interim Statements of Cash flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="zk2329603.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0007 - Disclosure - General</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/General.</Role>
      <ShortName>General</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="zk2329603.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0008 - Disclosure - Basis of Presentation and Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="zk2329603.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0009 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="zk2329603.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0011 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPolicies</ParentRole>
      <Position>10</Position>
    </Report>
    <Report instance="zk2329603.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0013 - Disclosure - General (Detail Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/General.Details</Role>
      <ShortName>General (Detail Textuals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/General.</ParentRole>
      <Position>11</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept TreasuryStockShares in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. zk2329603.htm 1963</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept TreasuryStockMember in us-gaap/2022 used in 6 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. zk2329603.htm 2684, 2692, 2740, 2785, 2830, 2838</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="zk2329603.htm">zk2329603.htm</File>
    <File>cmmb-20230331.xsd</File>
    <File>cmmb-20230331_cal.xml</File>
    <File>cmmb-20230331_def.xml</File>
    <File>cmmb-20230331_lab.xml</File>
    <File>cmmb-20230331_pre.xml</File>
    <File>exhibit_31-1.htm</File>
    <File>exhibit_31-2.htm</File>
    <File>exhibit_32-1.htm</File>
    <File>exhibit_32-2.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="168">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="34">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>29
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "zk2329603.htm": {
   "axisCustom": 0,
   "axisStandard": 3,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 168,
    "http://xbrl.sec.gov/dei/2022": 34
   },
   "contextCount": 37,
   "dts": {
    "calculationLink": {
     "local": [
      "cmmb-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cmmb-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "zk2329603.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cmmb-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cmmb-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cmmb-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 186,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 4
   },
   "keyCustom": 3,
   "keyStandard": 97,
   "memberCustom": 4,
   "memberStandard": 4,
   "nsprefix": "cmmb",
   "nsuri": "http://www.anchiano.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20230101to20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20230101to20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20230101to20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0011 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "10",
     "role": "http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20230101to20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20230101to20230331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cmmb:CarrybackNetOperatingLosses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0013 - Disclosure - General (Detail Textuals)",
     "menuCat": "Details",
     "order": "11",
     "role": "http://www.anchiano.com/role/General.Details",
     "shortName": "General (Detail Textuals)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20230101to20230331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cmmb:CarrybackNetOperatingLosses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20230331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0002 - Statement - Condensed Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20230331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockNoParValue",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20230331",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockNoParValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD_per_share",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.anchiano.com/role/BalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockNoParValue",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20230331",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockNoParValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD_per_share",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20230101to20230331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0004 - Statement - Condensed Consolidated Interim Statements of Operations (Unaudited)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations",
     "shortName": "Condensed Consolidated Interim Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20230101to20230331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0005 - Statement - Condensed Consolidated Interim Statements of Changes in Equity (Unaudited)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity",
     "shortName": "Condensed Consolidated Interim Statements of Changes in Equity (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20230101to20230331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0006 - Statement - Condensed Consolidated Interim Statements of Cash flows (Unaudited)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows",
     "shortName": "Condensed Consolidated Interim Statements of Cash flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20230101to20230331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20230101to20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0007 - Disclosure - General",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://www.anchiano.com/role/General.",
     "shortName": "General",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20230101to20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20230101to20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0008 - Disclosure - Basis of Presentation and Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20230101to20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20230101to20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0009 - Disclosure - Contingencies",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.anchiano.com/role/Contingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329603.htm",
      "contextRef": "C_20230101to20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 8,
   "tag": {
    "cmmb_AccountReceivableDueToExerciseOfOptions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of account receivable due to exercise of options.",
        "label": "Account Receivable Due To Exercise Of Options",
        "terseLabel": "Account receivable Due to Exercise of Options",
        "verboseLabel": "Receivable related to exercise of options"
       }
      }
     },
     "localname": "AccountReceivableDueToExerciseOfOptions",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_AccruedShareIssuanceExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of accrued issuance expenses non-cash investing and financing activities.",
        "label": "Accrued share issuance expenses"
       }
      }
     },
     "localname": "AccruedShareIssuanceExpenses",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_AmericanDepositarySharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Shares [Member]",
        "label": "American Depositary Shares [Member]"
       }
      }
     },
     "localname": "AmericanDepositarySharesMember",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_AmericanDepositorySharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for American Depository Shares.",
        "label": "American Depository Shares [Member]",
        "terseLabel": "American Depositary Share (\"ADS\") [Member]"
       }
      }
     },
     "localname": "AmericanDepositorySharesMember",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of total sale and transfer of compounds and products kestrel paid.",
        "label": "Amount Of Total Sale And Transfer Of Compounds And Products Kestrel Paid",
        "terseLabel": "Amount of total sale and transfer of compounds and products kestrel paid"
       }
      }
     },
     "localname": "AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for At the Market Offering Agreement with Cantor Fitzgerald &amp; Co.",
        "label": "At Market Offering Agreement With Cantor Fitzgerald And Co [Member]",
        "terseLabel": "At The Market Offering Agreement With Cantor Fitzgerald &amp; Co. [Member]"
       }
      }
     },
     "localname": "AtMarketOfferingAgreementWithCantorFitzgeraldAndCoMember",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_CarrybackNetOperatingLosses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of carryback net operating losses.",
        "label": "Carryback Net Operating Losses",
        "verboseLabel": "Carryback net operating losses"
       }
      }
     },
     "localname": "CarrybackNetOperatingLosses",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_CashAcquiredInReverseRecapitalization": {
     "auth_ref": [],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "represents cash acquired from acquisition",
        "label": "Cash acquired in reverse recapitalization",
        "terseLabel": "Cash acquired in reverse recapitalization"
       }
      }
     },
     "localname": "CashAcquiredInReverseRecapitalization",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_FinanceIncomeExpensesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of finance income earned and finance expenses incurred during the period.",
        "label": "Finance Income Expenses Net",
        "negatedLabel": "Financing income, net",
        "terseLabel": "Financing expense, net"
       }
      }
     },
     "localname": "FinanceIncomeExpensesNet",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_FormerChemomabSecurityHoldersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents former Chemomab security holders.",
        "label": "Former Chemomab Security Holders [Member]"
       }
      }
     },
     "localname": "FormerChemomabSecurityHoldersMember",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_IssuanceOfSharesNetOfIssuanceCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 30.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of shares net, of issuance costs.",
        "label": "Issuance Of Shares Net Of Issuance Costs",
        "terseLabel": "Issuance of shares net, of issuance costs",
        "verboseLabel": "Issuance of shares, net of issuance costs"
       }
      }
     },
     "localname": "IssuanceOfSharesNetOfIssuanceCosts",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of liabilities assumed, net of non-cash assets received in reverse merger.",
        "label": "Liabilities Assumed Net Of Non Cash Assets Received In Reverse Merger",
        "terseLabel": "Liabilities assumed, net of non-cash assets received in reverse merger"
       }
      }
     },
     "localname": "LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents Merger Agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company inclued proposed merger of CMB Acquisition Ltd, wholly owned subsidiary of our company.",
        "label": "Merger Agreement With Chemomab Israeli Limited Company And Clinical Stage Biotech Company [Member]",
        "terseLabel": "Merger agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company [Member]"
       }
      }
     },
     "localname": "MergerAgreementWithChemomabIsraeliLimitedCompanyAndClinicalStageBiotechCompanyMember",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_NatureOfOperationsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Nature Of Operations Disclosure [Abstract]"
       }
      }
     },
     "localname": "NatureOfOperationsDisclosureAbstract",
     "nsuri": "http://www.anchiano.com/20230331",
     "xbrltype": "stringItemType"
    },
    "cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of ADS issued and outstanding after the merger.",
        "label": "Number of ADS issued and outstanding after the merger"
       }
      }
     },
     "localname": "NumberOfAdsIssuedAndOutstandingAfterMerger",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_NumberOfOrdinarySharesConsistedInDS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the number of ordinary shares consisted in one American depository share (ADS).",
        "label": "Number Of Ordinary Shares Consisted In D S",
        "terseLabel": "Number of ordinary shares represented by each ADS (in shares)"
       }
      }
     },
     "localname": "NumberOfOrdinarySharesConsistedInDS",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock for each preferred share converted before merger.",
        "label": "Number Of Ordinary Shares For Each Preferred Share Converted Prior To Date Of Merger",
        "terseLabel": "Number of common shares for each preferred share converted"
       }
      }
     },
     "localname": "NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_NumberOfSharesDilutedAfterMerger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares diluted after the merger.",
        "label": "Number of shares diluted after the merger"
       }
      }
     },
     "localname": "NumberOfSharesDilutedAfterMerger",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One employee one officer consultant and six Board [Member]",
        "label": "One Employee One Officer Consultant And Six Board [Member]",
        "verboseLabel": "One employee one officer consultant and six Board [Member]"
       }
      }
     },
     "localname": "OneEmployeeOneOfficerConsultantAndSixBoardMember",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_OrdinarySharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ordinary Shares [Member]",
        "label": "Ordinary Shares [Member]"
       }
      }
     },
     "localname": "OrdinarySharesMember",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_OrdinarySharesNoParValuePerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ordinary Shares, No Par Value Per Share [Member]",
        "label": "Ordinary Shares, No Par Value Per Share [Member]"
       }
      }
     },
     "localname": "OrdinarySharesNoParValuePerShareMember",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_PaymentsToPurchaseOfDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 30.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to purchase of deposits.",
        "label": "Payments To Purchase Of Deposits",
        "negatedLabel": "Increase in deposits"
       }
      }
     },
     "localname": "PaymentsToPurchaseOfDeposits",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_ProceedsFromSaleOfDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of deposits.",
        "label": "Proceeds From Sale Of Deposits",
        "terseLabel": "Decrease in bank deposits"
       }
      }
     },
     "localname": "ProceedsFromSaleOfDeposits",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_RetainedEarningsAccumulatedDeficits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficits.",
        "label": "Retained Earnings Accumulated Deficits",
        "negatedLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficits",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Security holders of anchiano as of immediately prior to merger.",
        "label": "Security Holders Of Anchiano As Of Immediately Prior To Merger [Member]",
        "verboseLabel": "Security holders of Anchiano as of immediately prior to the merger [Member]"
       }
      }
     },
     "localname": "SecurityHoldersOfAnchianoAsOfImmediatelyPriorToMergerMember",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_ShareholdingPercentageImmediatelyFollowingMerger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "shareholding percentage immediately following the merger.",
        "label": "Shareholding percentage immediately following the merger"
       }
      }
     },
     "localname": "ShareholdingPercentageImmediatelyFollowingMerger",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "percentItemType"
    },
    "cmmb_SharesConvertiblePerShareOfAcquireeEntity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the shares convertible in merger.",
        "label": "Shares Convertible Per Share Of Acquiree Entity",
        "terseLabel": "Number of shares after merger for each share of Chemomab"
       }
      }
     },
     "localname": "SharesConvertiblePerShareOfAcquireeEntity",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_TwoThousandFifteenPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2015 Plan [Member]",
        "label": "Two Thousand Fifteen Plan [Member]",
        "terseLabel": "2015 Plan [Member]"
       }
      }
     },
     "localname": "TwoThousandFifteenPlanMember",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_WarrantsExercisablePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the warrants exercisable period.",
        "label": "Warrants exercisable period",
        "terseLabel": "Warrants exercisable period"
       }
      }
     },
     "localname": "WarrantsExercisablePeriod",
     "nsuri": "http://www.anchiano.com/20230331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "durationItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Legal or Registered Name of an entity",
        "label": "Entity Information, Former Legal or Registered Name"
       }
      }
     },
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Name of Exchange on which Security is Registered"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r136",
      "r137",
      "r138",
      "r139",
      "r157",
      "r192",
      "r200",
      "r208",
      "r209",
      "r215",
      "r218",
      "r223",
      "r252",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r136",
      "r137",
      "r138",
      "r139",
      "r157",
      "r192",
      "r200",
      "r208",
      "r209",
      "r215",
      "r218",
      "r223",
      "r252",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r136",
      "r137",
      "r138",
      "r139",
      "r156",
      "r157",
      "r159",
      "r160",
      "r161",
      "r191",
      "r192",
      "r200",
      "r208",
      "r209",
      "r215",
      "r218",
      "r223",
      "r248",
      "r252",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r136",
      "r137",
      "r138",
      "r139",
      "r156",
      "r157",
      "r159",
      "r160",
      "r161",
      "r191",
      "r192",
      "r200",
      "r208",
      "r209",
      "r215",
      "r218",
      "r223",
      "r248",
      "r252",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290"
     ],
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r246",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r0",
      "r13"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Trade payables"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 20.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r8",
      "r222"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 20.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r162",
      "r163",
      "r164",
      "r242",
      "r243",
      "r244",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional paid in capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method.",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Adjustments for operating activities"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r53",
      "r58",
      "r71",
      "r85",
      "r119",
      "r121",
      "r123",
      "r125",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r172",
      "r176",
      "r181",
      "r222",
      "r250",
      "r251",
      "r283"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets [Default Label]",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r68",
      "r75",
      "r85",
      "r125",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r172",
      "r176",
      "r181",
      "r222",
      "r250",
      "r251",
      "r283"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r85",
      "r125",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r172",
      "r176",
      "r181",
      "r250",
      "r251",
      "r283"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 10.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "totalLabel": "Total non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Preparation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r170",
      "r216",
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r49",
      "r50",
      "r170",
      "r216",
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Capital": {
     "auth_ref": [
      "r197"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of total capital as defined by regulatory framework.",
        "label": "Market capitalization amount"
       }
      }
     },
     "localname": "Capital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r31",
      "r70",
      "r211"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r26",
      "r31",
      "r32"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r26",
      "r51"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Change in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosure of non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r72",
      "r73",
      "r74",
      "r85",
      "r102",
      "r103",
      "r105",
      "r107",
      "r110",
      "r111",
      "r125",
      "r140",
      "r142",
      "r143",
      "r144",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r181",
      "r210",
      "r231",
      "r240",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation",
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Warrant exercise price"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r17",
      "r55",
      "r62"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 10.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and contingent liabilities"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r40",
      "r134",
      "r135",
      "r207",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/Contingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r242",
      "r243",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Ordinary shares [Member]",
        "terseLabel": "Ordinary Shares [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockNoParValue": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount per share of no-par value common stock.",
        "label": "Common Stock, No Par Value"
       }
      }
     },
     "localname": "CommonStockNoParValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r7",
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r7",
      "r222"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Ordinary shares no par value - Authorized: 650,000,000 shares as of September 30, 2021 and 500,000,000 shares as of December 31, 2020; Issued and outstanding: 227,956,060 ordinary shares at September 30, 2021 and 9,274,838 ordinary shares at December 31, 2020",
        "terseLabel": "Ordinary shares no par value - Authorized: 650,000,000 shares as of March 31, 2022 and as of December 31, 2021; Issued and outstanding: 228,090,300 ordinary shares at March 31, 2022 as of December 31, 2021",
        "verboseLabel": "Ordinary shares no par value - Authorized: 650,000,000 shares as of March 31, 2023 and December 31, 2022; Issued and outstanding: 232,636,700 Ordinary shares as of March 31, 2023 and December 31, 2022;"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositsAssetsCurrent": {
     "auth_ref": [
      "r234"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 10.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.",
        "label": "Short term bank deposits"
       }
      }
     },
     "localname": "DepositsAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "auth_ref": [
      "r233"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "localname": "DepositsAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r29",
      "r38"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r81",
      "r92",
      "r93",
      "r94",
      "r95",
      "r96",
      "r100",
      "r102",
      "r105",
      "r106",
      "r107",
      "r108",
      "r179",
      "r180",
      "r194",
      "r198",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Basic and diluted loss per Ordinary Share",
        "terseLabel": "Basic loss per Ordinary Share"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r81",
      "r92",
      "r93",
      "r94",
      "r95",
      "r96",
      "r102",
      "r105",
      "r106",
      "r107",
      "r108",
      "r179",
      "r180",
      "r194",
      "r198",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted loss per Ordinary Share"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 10.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee and related expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r41",
      "r66",
      "r78",
      "r79",
      "r80",
      "r87",
      "r88",
      "r89",
      "r91",
      "r97",
      "r99",
      "r109",
      "r126",
      "r155",
      "r162",
      "r163",
      "r164",
      "r166",
      "r167",
      "r178",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r190",
      "r201",
      "r202",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 10.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r20",
      "r52",
      "r56",
      "r64",
      "r119",
      "r120",
      "r122",
      "r124",
      "r195",
      "r214"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "negatedTotalLabel": "Loss before taxes",
        "totalLabel": "Loss before taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r86",
      "r98",
      "r99",
      "r118",
      "r165",
      "r168",
      "r169",
      "r199"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 10.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Taxes on income (benefit)",
        "terseLabel": "Taxes Expenses (Income)",
        "verboseLabel": "Taxes on income"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 30.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
        "label": "Change in trade payables"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 40.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Change in accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 50.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Change in employees and related expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r238",
      "r281"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Change in operating lease liability",
        "verboseLabel": "Change in operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Change in other receivables and prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r14",
      "r85",
      "r125",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r173",
      "r176",
      "r177",
      "r181",
      "r213",
      "r250",
      "r283",
      "r284"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r12",
      "r54",
      "r60",
      "r222",
      "r241",
      "r247",
      "r280"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND SHAREHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r16",
      "r69",
      "r85",
      "r125",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r173",
      "r176",
      "r177",
      "r181",
      "r222",
      "r250",
      "r283",
      "r284"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r85",
      "r125",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r173",
      "r176",
      "r177",
      "r181",
      "r250",
      "r283",
      "r284"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 10.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r112",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "verboseLabel": "General"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General."
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r26",
      "r27",
      "r30"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r21",
      "r30",
      "r57",
      "r63",
      "r67",
      "r76",
      "r77",
      "r80",
      "r85",
      "r90",
      "r92",
      "r93",
      "r94",
      "r95",
      "r98",
      "r99",
      "r104",
      "r119",
      "r120",
      "r122",
      "r124",
      "r125",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r180",
      "r181",
      "r214",
      "r250"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net loss for the period",
        "negatedTotalLabel": "Net loss for the year",
        "positiveLabel": "Net loss for the period/year",
        "totalLabel": "Net loss for the period"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity",
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "negatedTotalLabel": "Total operating expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r189"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 30.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r189"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating lease liabilities - long term"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r188"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 20.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r235"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 30.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Other receivables and prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseNoncurrent": {
     "auth_ref": [
      "r233"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 30.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.",
        "label": "Long term prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromOtherEquity": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the issuance of equity classified as other.",
        "label": "Proceeds from Other Equity",
        "verboseLabel": "Issuance of shares and warrants, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromOtherEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyHeldForSale": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of formerly productive land held for sale, anything permanently fixed to it, including buildings, structures on it, and so forth.",
        "label": "Proceeds from Sale of Property Held-for-sale",
        "terseLabel": "Sale of asset held for sale"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyHeldForSale",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r25",
      "r47"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Exercise of options",
        "terseLabel": "Exercise of Shares",
        "verboseLabel": "Exercise of options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r237"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds from Warrant Exercises",
        "terseLabel": "Proceeds from exercise of warrants"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r67",
      "r76",
      "r77",
      "r82",
      "r85",
      "r90",
      "r98",
      "r99",
      "r119",
      "r120",
      "r122",
      "r124",
      "r125",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r171",
      "r174",
      "r175",
      "r180",
      "r181",
      "r195",
      "r214",
      "r220",
      "r221",
      "r236",
      "r250"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "verboseLabel": "Net loss for the period"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r39",
      "r61",
      "r196",
      "r222"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 40.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r48",
      "r65",
      "r291"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r232",
      "r239"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 20.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "verboseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r206",
      "r233",
      "r239"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 10.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r9",
      "r42",
      "r59",
      "r204",
      "r205",
      "r222"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 30.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r66",
      "r87",
      "r88",
      "r89",
      "r91",
      "r97",
      "r99",
      "r126",
      "r162",
      "r163",
      "r164",
      "r166",
      "r167",
      "r178",
      "r201",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit [Member]",
        "terseLabel": "Accumulated Deficit [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Aggregate offering price"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.",
        "label": "Gross proceeds from sale under agreement"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedPerTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Shares issued under agreement"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Average price of shares issued under agreement"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 60.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based compensation expense",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share based payment options vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Number of shares authorized, increase"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Options to purchase ADs"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Exercise price per ADs",
        "verboseLabel": "Value of ADS"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (In shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r33",
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r72",
      "r73",
      "r74",
      "r85",
      "r102",
      "r103",
      "r105",
      "r107",
      "r110",
      "r111",
      "r125",
      "r140",
      "r142",
      "r143",
      "r144",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r181",
      "r210",
      "r231",
      "r240",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation",
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r19",
      "r41",
      "r66",
      "r78",
      "r79",
      "r80",
      "r87",
      "r88",
      "r89",
      "r91",
      "r97",
      "r99",
      "r109",
      "r126",
      "r155",
      "r162",
      "r163",
      "r164",
      "r166",
      "r167",
      "r178",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r190",
      "r201",
      "r202",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation",
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r87",
      "r88",
      "r89",
      "r109",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation",
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of preferred stock and warrants for common stock issued.",
        "label": "Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants",
        "terseLabel": "Isuuance and sale value of ADSs and warrants"
       }
      }
     },
     "localname": "StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r6",
      "r7",
      "r42",
      "r46"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Share-based compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r7",
      "r10",
      "r11",
      "r37",
      "r222",
      "r241",
      "r247",
      "r280"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 20.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity",
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
        "label": "Reverse stock split conversion ratio"
       }
      }
     },
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r18",
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury share [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r18",
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury Stock, Shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r18",
      "r44",
      "r45"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 10.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury share at cost (11,640,460 Ordinary shares as of March 31, 2023 and December 31, 2022)",
        "terseLabel": "Treasury share at cost (11,640,460 ordinary shares as of March 31, 2023 and December 31, 2022)"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r34",
      "r35",
      "r36",
      "r113",
      "r114",
      "r115",
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r101",
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average number of Ordinary Shares outstanding, diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r100",
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted average number of Ordinary Shares outstanding, basic, and diluted",
        "terseLabel": "Weighted average number of Ordinary Shares outstanding, basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(c)(1)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=117337116&loc=SL5958568-112826",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r224": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r225": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r226": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r227": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r228": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r229": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>30
<FILENAME>0001178913-23-001807-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-23-001807-xbrl.zip
M4$L#!!0    ( .PPJU:A1E7TF0D   9)   1    8VUM8BTR,#(S,#,S,2YX
M<V3M6UMSV[82?N^O8/64/LBR[":G]MCIV+JDFN-8&DMM\]:!R*6$"0@P !A+
M^?5=@*1$2B)-24["=/QBD\3>/BRPN[CHZO=%P)S/(!45_+K1/CEM.,!=X5$^
MNVY$VF_^UOC][4]7RIU#0!PDYNK2#8+I=6.N=7C9:CT^/IX0[LXIX>+$%4'K
M[/3L_/3\O-V(J7.$C^<G0LZ0Y+3=^O#^;FRE)H27C/*/.>K%5+*4_KQEFJ=$
M04IN6CV]8L@2OV[%C2M25B+WPQT*S@JE)<24*XUHUT9L&9U ;%]<7+1L:TK*
M848T>(7"+UI2,&@E9"F7!+^0XTT+6U-"#T()[A,:B'2M$I^XN@F+D!%.M)#+
M/KZO!&G9U,L0U&XYV-PRS<;/I\W3=O.LO3:!YMVAP#V9B<\M;##D9RFA*R*N
MY7(W<=*89XBDQ&%9Q)&TYEA@X<YWDYN6'"DGU%6[:6U3CEA1=S<I-N0)=2@+
M*+$E1QJIC1[WB9K:WDY;\I*EWJ;$CYM$14)739M&S @)=]I@&A)B3>0,]#T)
M0(7$A2IQ !@$P'5?R* +/HD8FO\I(HSZ% ?ZVY\<Y^KG9M,9W$]Z[P8?G.G2
MZ7UI?KA]N'.:3=M*@U!([?"=2HLF:!RR[@3."1O;"EG,6S/E:YI/S?99\[Q]
MLE!>H[6O >LPM9\!*=^>!NP.>Q55IPQ&Y^M#X&[&K"IZF90Y+J/\P@!NOSG*
MA(JP,^KUT:K+XVE5<[)2>FLA>UI7$'%W&:&*R,U#TSSLK3 ?M2LIS;*D+P<J
MSR> :MJS/*NWP_1G,DHEW2MZ^W28SFQFJJ1TS1 _'J9VG>4J*4W)S<.!"M?)
MLIK&E-X^5=99E'%+=>Y,D2U@6JW$[&_ .I%7TYW2QWI-;C]$Y0&@MQ4?B#A?
M8!S1X^9+9?5/5[5%ECS%:=]5Q@;"N=!6B'DU'\*0<E_$;_ANDO^ER0$3Y'3,
MPY\/@^+2RF:+KG C4U:E_V^XU^.:ZN4 )<O JFLX%)<#E2A36U)K// II];F
M4URN.4TG9<\^$NXYL2PG(^RJM2EB0WBDP!ORM_89ERT*15E&LQ1+F!.2$L:U
M^+W87,+<B)6K2SZF'CG*3V.$9NO?CN ><-2##THPZIGJYY8P4W:.YP!:Q>[:
MAZ'<:V?HJI4T?%X)=+(2G42D$\M\<5[&>;G>'A&L$?0<-$4S8E^5M)>[YOP0
MUSBO<BI^>7'5KGGV)R>11[6=-MOS9T6FAOXP!&D-W)QY!XDH=_BOU1P^X!HD
M#=:DRA&^L];BO%K9]N+^K/N3CLOZIC,G? 9JP'N?(LQ0L8\KT)4[\O4QCDQ4
M.90[L;(7?S[?=.X0->\S\7CX;%Y+*!\#;XX: ZC$\8V6%^<7./\=< QX["1V
MY.JMW"G_,X4I52X3*I* +PG?2\_F"AI%<:"/,C!Q.3"F,TY]K"EP<>#:K1C*
M9R,<QRX%E58Z^S.6^^NW37]9%6:&9)78)49&C;/6XZ2*7CR<\3!&(-,YP->^
MRW\J]\K%IE=RS"\]?=Q<.GI.59M;[?:SS2U<<R1/+REJ5XKJ@B:4J7RF2C^6
M.^F\(&$YKV)^9P(+'1'V7^]Y\\<<?3V []@C\TNS@7;=4#0(F3EJM]_F]BC<
MW#UHID>+_R#4DT7 4A(CON2<S?IMLW<2Q:F(Y"RF_$@?A0A<D6F<%.OSOM9S
M@4(W[ LJ[[GZ06)DNB\D9 %63S0XX/=%LS%'GAO352NSHXPON?WFJ^3\W>Z!
M7S>2&/\ +M#/9,J@&\%$]!8@7:K [&AD=D0,\'\J<\0=:._07 :"8Q"3RP&N
M?,R4;SADJK0DKKYN^!C33 ];0L1$A3>QK%XDDWUK%2$UU9%Y>R=%%*9R<;$4
M-!Q.&3.67#>TC%:BIO%N&9HM 5=5R>[[%GSD\,9S(F&@5&08>HO0K-XV,)>0
MU0:H!],BG &JPZ3>A5 H:@RT6-1["*8@LTB?((RQKFX%77HB()1_$[05<(FJ
MN+8(J^/*]OS7@V6FV-"?X,1E8\( "\&))%SY((=^1P0AMGL*OXZD\")7J_\#
MV@=L1*B70WV4G!]A8.OW1'X$Q(B0L%*]F4FP[7]3/>]@%2MDG^HO,U-)>8BS
M([:'QL$BZC5H;B-%.2B%;IU2;L5BD!98SW\!;^ A(1;V1L:-4J#5C?LIHA@9
M$=$=?J:,FF2";5& 'PW)'\"\OI!FW&2ZZ^NJ.7K(Q5>W]-<;<<^)OV,OFNAL
M0YQI=N2@;ZRW+HXH2=X=(N5R2MR/]SAYXS,1/KL3*M]OI52UB7"E,-4\]>8
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MTF3[I<R_#4GLTBCI:[/31S$Q\ 83X,F(50?TI$ZV /&,B/&%SQY>$^&RCSE
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M,Q/C%:&SVK>BQ\J+K5$:AH,&<V_DN4O&Z9\DZ6KQ&EI%9W6?Y08G/8[Y#?-
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MYG[VP#*9K;-WC[Z_>@]8C]Z3.,_D3Q#]$4,N?C#CH>CW_HN(1C\A":Q"56%
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M8,L6L:X/> _^KG<%9\4!8<X'0X>N2-:%;4LMP''PM\#%55F$L41WO.TVLUH
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M&@P_2=LP4XZ(+292TA.B[@\?9,2.#&[$U?9<_I#EQU!VF2Q1<1Y!\P[PGT5
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ML3!Y+%EY[4-F@685[_4Q!8LQ\AJZQAB-KV5E?T#NHKYB6"%S5I6X[.FPK\N
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M=JDMN))=\. V5& ,AVGFYS64=JDO*NQ:=T)5>F38M0Z%HO38=$;K4BA*._!
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M[QF\*ZCPS_\"_X#_/X#'\>?_#U!+ P04    " #L,*M6F53MV$P9   W:@$
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M7=6_]=+AJE]LM#S*&/9&6X)CG6C/  ='W5H+*HQA6#:M28Q>,Z:.C=1]":)
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MV/R!.#WH"=S?;9S*GV3U727&>;J3_F;[,=H9@WOM9995@Z&M#Z9/-K8GYEL
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MAJ.T2DQS)FR5!8;E\!:/'$Z5D5&A#.X]PVWX!=SK14C4ROO.<_&H5XB/SMO
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M.ODP.IK,S.E?AY._832>JYF.975>IX'_DZ62^<OO9WD08_"(8^I*QF,X9S(
M&5#XG!&!(H5+.*$)%Q*X#^. 1DC"@7E !4EH)IF;PJ'T6M!4>]ZM;7<Z5G^<
MYR+=L_OK@&3WN8@P4IF?$9O0]+_F]('&'N:F3T2X 71M0V<9 T@**C5Y%9XR
MM,ZHFPDF&4I$8@\F%VY 8DQ&R#-B::I$P)]BX&'2PR I* *OH\O%*<$9<&#
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M@P#S'\9+21%X'5TA3@7.@D,+LR8GL0'QC7$+Q60TA /&"?<9B6$:AIAUI=:
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M9NK("-Y9O45'EKIRJR%)S6:KE;=N2LM'Y@>U>!7E,]'T)?B!/7[&)CGX:5G
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MZP7SUE5,%Z1>7SH,W= 6NJ',<_2PZ!2$%/D&]?8<O <Z8CGB)%0 8V/YT7.
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M-:;PM( 5/K&5:- U20<OM(")FIT$!QCK:&/U5&OX@R=AWGDNTVD@PHFLTI*
MP?#40_8C/](2$&RH@R?M_'YR<_MIGG],;U+7++?NWW)R(<LUJ=FK=>59?82
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MU2=BI"X^Q3/VEJM%(2[[R01]9\ZI_:+:PS%IR#6B2$I#,,%A,,&[;Z;J:3K
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M=!:'8DX@YCLQ59]H?6!3]4=='4$?SE3C67UU3F#,QG9PDX^=7 8DX/C8R#%
MQ2N^G$C2K^<^8V&LC3M,OTCLO[@GY5\X(1^ OJ296SV/Z9A^Q8>E,[K>Q8ER
M#O0_/Q;8]-^Y/@%T6GA O&6>P:A3&[L%GM1?K[_<?>E_/#YZ_.OU??_K];?'
MF\L'\OGQBO1OK\C-XP-Y^/;QX>;JIG]_<_VPA*NV_;/=!)1B@'WV6B:9C"]6
MC/N[3W?W7Z[O/__[^*A_>_G7F_[M'5F<@=-8LMI.AGNI5\-,AYM;H/^F__GA
ML?]X_>7Z]O'A.X-S_:5O#L=6CH"8@S3<WCU>/X HW)'+N]NKZ]N'ZRO\]'#W
M^>8*N@?R</MX?7_SA<RZ3<)^9SQ9*^9L-=@1W\2[]28P6L.%X\YD6>I*+:DC
M2YU>S-Z[55W/IG>CNRGE@Y-J(SH%"VZ* VM[]"05LNXV>K0I]]R"L7)\)),Z
M^0LU86",F)U1W.2RNYGY1X;4,'Q+]/<34)SX'<W*X'O"L,0M4\)'AG#;='Y\
MHXH\,GD&';GSVOQD>=B2-]%HXVPENG6Q^\X7C&_0JN5DBWYF;+!\0%3/M1(&
M9,Z#G"8/P_FJCL]/^YS]LFCXXB]QT<5]7G0";0T(&/?@Q% /:'1"LCZ[VBEY
MAX;\GW[I@N-W?LFM_Y/W1,< +;EQ;)4:>GV@<AN?707S'G!YBM ,/S)D9LZ
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MC9/EV?"X.@(AT5D0?>H-#'V(ASZI8 I?><RU03)88(NRZ-D5,"B+V/MF\(+
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M2TUM:NE^M;QPAEW+F*4,!;F+H8TX9SQ2<PARH#XQRR;H-.YBH=B/Z#N"Q9;
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M8O<4J?]1<3^K]JIN/A8,B^RA^/F^%';F9:J\%._RTC>;'2ZU^9/[^/Z\V;A
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M?DJ=I!(_5#)!'AZ\'<KD)HA@52..L-)_:S[F$UQ 9#Y0E4K63@&5-S"Y_N6
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M(6B^R.6E4 %,WJ<!564XP)>?V@?MXA4$8D>G#P&Q9J.?Q$-ZEJ$,S2$/D7!
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M3.I+9&2NRS 8XA1Q5#F,\X@$^/+JF:!909(XO*O*@YHFTQRN5& R;?&(\:B
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MAO_JMU_27ZQ@'0D7V]=^G&9/N9*7/H6'4FB[_302W4HX6CO";P7[_RZ':E4
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M,/Q-_']02P$"% ,4    " #L,*M6H495])D)   &20  $0
M@ $     8VUM8BTR,#(S,#,S,2YX<V102P$"% ,4    " #L,*M6IW8.OPP(
M  "N9   %0              @ '("0  8VUM8BTR,#(S,#,S,5]C86PN>&UL
M4$L! A0#%     @ [#"K5FGH9X1M#@  O[0  !4              ( !!Q(
M &-M;6(M,C R,S S,S%?9&5F+GAM;%!+ 0(4 Q0    ( .PPJU9I;,Q(ID0
M &XH P 5              "  :<@  !C;6UB+3(P,C,P,S,Q7VQA8BYX;6Q0
M2P$"% ,4    " #L,*M6F53MV$P9   W:@$ %0              @ & 90
M8VUM8BTR,#(S,#,S,5]P<F4N>&UL4$L! A0#%     @ [#"K5M-"9#_4"
M?$4  !               ( !_WX  &5X:&EB:71?,S$M,2YH=&U02P$"% ,4
M    " #L,*M6>X+B>@ )  #22   $               @ $!B   97AH:6)I
M=%\S,2TR+FAT;5!+ 0(4 Q0    ( .PPJU9_F_QN\P0  %X=   0
M      "  2^1  !E>&AI8FET7S,R+3$N:'1M4$L! A0#%     @ [#"K5E@5
M2^;P!   [1P  !               ( !4)8  &5X:&EB:71?,S(M,BYH=&U0
M2P$"% ,4    " #L,*M66\Q&_5BD  !KH@D #0              @ %NFP
C>FLR,S(Y-C S+FAT;5!+!08     "@ * 'X"  #Q/P$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
